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1. Preface and acknowledgements  
 
The structure of the thesis 
 
According to the “Rules and regulations, a guide to the PhD study” from the Faculty of Health 
Science, University of Copenhagen a PhD thesis encompassing more than one article should be 
accompanied by an account of the articles’ publishing status. The account can be structured as 
follows: 
A. a brief, general presentation of the research problem dealt with by the included articles 
B. a brief presentation of the results achieved with an assessment of the methods used and a 
critical review of the conclusions that can be drawn from the results 
C. a comparison with and assessment of published results of other researchers to the extent that 
they are relevant to the author’s analysis of the research problem 
D. a summarising conclusion 
 
This PhD thesis encompasses four scientific papers. The structure of the thesis follows the structure 
suggested by the University, so that point A covers the introduction, background and aims of the 
thesis (pages 5 to 25). The introduction is followed by the four scientific articles (pages 26 to 102). 
Each article is followed by a discussion of the current study. This discussion is structured so that it 
encompasses the following: major findings, assessment of methods, justification of conclusion and 
contribution to current knowledge in fulfilment of points B and C. The conclusion of the thesis 
(page 104) covers point D. 
 
Financial support 
 
This thesis is based on studies carried out during an appointment with the Department of General 
Practice, Institute of Public Health, University of Copenhagen from 2000 to 2006 funded by 
external research grants. Therefore, I would like to thank all of the contributors (alphabetically):  
• AstraZenecas rejselegat for almen medicin 
• Fonden vedrørende finansiering af forskning i almen praksis og sundhedsvæsenet i øvrigt 
• Fridriksons mindelegat 
• Margot Fribergs fond 
• Praktiserende Lægers Uddannelses- og udviklingsfond 
• Det Psykosociale Forskningsudvalg, Kræften Bekæmpelse 
• Sygekassernes Helsefond 
• Tvergaard Fonden 
 
The origins of this project 
 
As a medical student and a doctor I was taught, above all else, to do no harm. Therefore, it was an 
eye opener for me when Inga Marie Lunde, a general practitioner, demonstrated at the theoretical 
course of the specialist education of general practice how medical screening has the potential to be 
as harmful as it is beneficial.  Jack Hoffman, head of the Breast Surgical Clinic at Hørsholm 
Hospital where I worked as a trainee, was the second person to spark my interest in this area. Our 
discussions about the reactions of women to false positive diagnostics in the outpatient treatment 
area, where women with breast tumours were examined were invaluable. The third person I wish to 
thank is John Sahl Andersen, assistant professor and general practitioner, who encouraged me to 
begin this project. I am very thankful for the support John gave me in the beginning of my project 
and for his role as my supervisor during my first years as a PhD student. 
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Supervisors and collaborators on the project 
 
It was simply by chance that I meet Hanne Thorsen, senior researcher, at the Department of General 
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planning this project and has brought the standards of the methods used to highest attainable level. 
Because of Hanne’s mentorship, this project is significantly more academic, relevant and exciting. I 
will be forever grateful for her introduction to the world of psychometrics. 
My supervisor professor Marjukka Mäkelä taught me how to structure a report and how to organise 
the writing process. Because of Marjukka’s in depth knowledge of breast cancer screening and 
teaching ability, writing the account of this thesis became a pleasure. I am very thankful for 
Marjukka’s help and for accepting the role as my supervisor for the last period of my PhD project. 
I would like to thank my clinical supervisor, head of the Breast Cancer Screening Clinic in 
Copenhagen, Ilse Vejborg, for her critical comments and for assisting me in getting access to the 
women screened. In relation to this, I also wish to thank the staff at the two screening clinics 
(Copenhagen and Funen) for their collaboration and help in recruiting the women screened. A 
special thanks is given to all of the secretaries at the two screening clinics for their help identifying 
relevant women for interviews, asking women for participation in the questionnaire survey and 
mailing questionnaires to women in the control group.  
I am in great debt to the late professor Jill Cockburn for her strong support and encouragement in 
this project and for her inspiration and co-authorship in the first paper in this thesis. 
Last but not least, I would like to express my sincere gratitude to the more than one thousand 
women that have either participated as interviewees or respondents in this project. Without their 
contribution I would not have been able to conduct this thesis. 
 
Other supportive individuals and environments 
 
Being a part of the research environment of general practice at the University of Copenhagen has 
been essential for me as a PhD student. For their contribution to making this environment the great 
resource it is, I would like to thank all of my present and former colleagues at the Department and 
Research Unit of General Practice. In addition, I would like to give a special thanks to Anja 
Drikkjær, Lise Høyer and Lone Merio for their secretarial assistance. 
I wish to acknowledge the support from fellow members of the Risk Group and the Screening 
Group, both former interest-groups attached to the Danish College of General Practitioners. I also 
wish to thank all the fellow members of the Nordic Risk Group, which is a group of academically 
active Nordic general practitioners sharing the vision “to promote general practice which is 
salutogenic, empowering and sustainable” and the fellow members of the Matilda Bay Club, which 
is a group of academics using Rasch analysis. In addition, I would like to give Svend Kreiner, 
assistant professor, a special thanks for our many and fruitful talks about Rasch analysis. 
 
Finally, I wish to thank my friends, mother, parents-in-law and family for their support, tolerance, 
help and love. To my children, Franciska and Markus - I thank you most of all for inspiring me with 
your happiness and joy of life. To my wife Annette - without your love, support, courage and hard 
work, especially in relation to the two periods with no financial support, I would not have made it - 
thank you! 
 
John Brodersen 
Copenhagen, August 2006 
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2. Summary  
 
Objectives 
 
The overall purpose of this PhD study was to identify, adapt and validate an instrument to measure 
the psychosocial consequences of false-positive screening mammography (hereafter referred to as 
false positives) in Denmark. The thesis encompasses four scientific articles covering the aims: 
• to review quantitative studies on women’s experiences of short-term and long-term 
consequences of false positives and to identify and asses the adequacy of the most 
frequently used instruments for measuring these consequences 
• to translate and adapt into Danish the negative part of the Psychological Consequences 
Questionnaire and to assess the content validity of the Danish version of the instrument in 
the setting of abnormal screening mammography later confirmed to be false-positive 
• to statistically validate a new condition-specific instrument measuring psychosocial 
consequences of abnormal screening mammography 
• to develop and validate a new condition-specific instrument measuring long-term 
psychosocial consequences of false positives 
 
 
Material and method 
 
A systematic literature review was conducted identifying papers reporting quantitative studies on 
the consequences of false positives using the MEDLINE, CINAHL, EMBASE and PsycInfo 
databases. Articles citing the development and psychometric properties of the most frequently used 
measures were also retrieved. Finally, the review focussed on studies that had used at least one of 
the most frequently used measures. 
 
The translation and adaptation into Danish of the most adequate measure included a bilingual panel 
and a lay panel. Content validity was ensured by conducting six focus group interviews including 
34 women who had previously received an abnormal screening mammography that was later 
confirmed to be a false positive. The acceptability of the instrument was ensured by conducting 
fifteen individual telephone interviews with women who had had an invitation to attend breast 
cancer screening and with women who had never been invited and screened.  
 
The draft version of the new instrument with high content validity for women having false positives 
was completed by women who had received an abnormal, a false-positive and a normal screening 
mammography. Item Response Theories (the Rasch model) and Classical Test Theories were used 
to analyse data. Construct validity, concurrent validity, known group validity, dimensionality, 
additivity, objectivity, internal consistency and reliability were established. 
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Results 
 
Twenty-three quantitative studies on women’s experiences of short-term and long-term 
consequences of false positives were identified.  The most commonly used measures were the 
General Health Questionnaire (GHQ), the Hospital Anxiety and Depression Scale (HADS), the 
Psychological Consequences Questionnaire (PCQ) and the State-Trait Anxiety Inventory (STAI). 
One or more of these was used in 17 of the 23 studies.  
 
The GHQ, the HADS and the STAI had problems with language, content relevance, and content 
coverage in studies of false positives. These instruments should not be used to measure 
psychological consequences of any kind of cancer screening. The PCQ was found to be the most 
adequate questionnaire for capturing short-term psychosocial consequences of screening 
mammography. However, there was little evidence that the PCQ was able to adequately detect all 
long-term psychosocial consequences of screening mammography.  
 
Six of the twelve original items in the negative part of the PCQ were found to be ambiguous or 
poorly worded and, as a result, were reformulated. This increased the number of items in the Danish 
version to 18 items. All of these items were found to be relevant to negative psychosocial 
consequences of abnormal screening mammography. However several areas were not covered. 
Fifteen new items were generated resulting in a draft version of a new 33-item questionnaire 
measuring negative psychosocial consequences of abnormal screening mammography (part 1). 
In the focus group interviews it was revealed that some issues could be raised both at invitation to 
screening, at time of screening, in the critical period and after diagnosis. These issues were covered 
by part 1 of the new instrument. However, other issues could be raised only after the women had 
been declared “free from” cancer suspicion by knowing that their abnormal screening 
mammography was false-positive. 
 
To cover these specific issues of long-term psychosocial consequences of false positives thirteen 
items with seven response categories each were generated during the focus group interviews (part 
2). In the interviews some women stated that is was difficult to choose between some of the seven 
response options.  
 
In the statistical analyses of part 1 six dimensions covering: anxiety, behavioural impact, sense of 
dejection, impact on sleep, breast examination and sexuality were identified. One item belonging to 
the dejection dimension had uniform differential item functioning. Two items not fitting the Rasch 
models were retained because of high face validity. A sick-leave item added useful information 
when measuring side effects and socioeconomic consequences of breast cancer screening. Five 
“poor items” identified were deleted from the final version of part 1 of the instrument. 
 
In the statistical analyses of part 2, four dimensions covering the impact on the women’s existential 
values, relationship with their social network, being less or more relaxed/calm, and less or more 
anxious about breast cancer/less or greater belief in not-having breast cancer were identified. Rasch 
analyses confirmed that the response categories also had statistical problems. Therefore, a future 
reduction from seven to five response categories resulting in a new lay out of the questionnaire is 
suggested. 
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Conclusion and perspectives 
 
Given the inadequacy of the measurement instruments used in previous quantitative studies on 
psychosocial aspects of false positives, any current conclusions about the psychosocial long-term 
consequences of false positives must remain tentative. 
 
Preliminary evidence for a valid and reliable condition-specific measure for women having an 
abnormal and false-positive screening mammography has been established. The new instrument, the 
Consequences of Screening – Breast Cancer (COS-BC) consists of two parts. The first part includes 
27 items measuring different attributes of the same overall latent construct – the psychosocial 
consequences of abnormal screening mammography. Part 1 also includes an item measuring sick-
leave. Part 2 of COS-BC measures long-term psychosocial consequences of false positives. 
This study shows that there are substantial negative psychosocial consequences associated with 
having an abnormal screening mammography later confirmed to be false-positive. Consequently, 
the number of women receiving false positives should be kept to a minimum.  
 
Letters and folders posted at invitation to breast cancer screening should contain information on the 
negative psychosocial consequences arising from abnormal and false-positive screening results.  
 
The new understanding of psychosocial consequences of screening mammography revealed in this 
PhD study contributes to the balance sheet of benefits and harm of breast cancer screening and 
should be included in the decision-making process of whether or not to implement breast screening. 
 
It is a goal to establish a core-questionnaire from COS-BC relevant for any kind of cancer 
screening. Such a core-questionnaire, COS, should consist of core-items and core-scales relevant 
for all kind of cancer screening programmes. Specific items, depending on the specific cancer 
screened for could be added to this core-questionnaire. Consequently, the COS would make it 
possible to potentially compare the extent of the psychosocial consequences of false-positive cancer 
screening results in different screening programmes.  
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3. Resumé (Danish summary) 
 
Måling af psykosociale konsekvenser ved falsk positive screeningsresultater 
- mammografiscreening som et eksempel 
 
 
Formål 
 
Det overordnede formål med denne ph.d.-afhandling har været at identificere, tilpasse og validere et 
spørgeskema til måling af psykosociale konsekvenser ved falsk positive screenings-mammografi-
svar i Danmark. Afhandlingen indeholder fire videnskabelige artikler, som dækker følgende formål: 
1. at gennemgå kvantitative studier, der belyser korttids- og langtidskonsekvenser af et falsk 
positivt svar ved mammografiscreening, samt at identificere og vurdere anvendeligheden og 
relevansen af de mest anvendte spørgeskemaer til måling af disse konsekvenser.  
2. at oversætte og tilpasse første del af spørgeskemaet Psychological Consequences 
Questionnaire (PCQ) til dansk og vurdere indholdsvaliditeten af den danske version af PCQ 
i forbindelse med et abnormt og et falsk positivt svar ved mammografiscreening. 
3. at validere statistisk et nyt specifikt spørgeskema til måling af psykosociale konsekvenser af 
abnormt svar ved mammografiscreening 
4. at udvikle og validere et nyt specifikt spørgeskema til måling af psykosociale konsekvenser 
af falsk positivt svar ved mammografiscreening 
 
 
Materiale og metode 
 
Et systematisk litteraturstudium identificerede og vurderede kvantitative undersøgelser om falsk 
positiv mammografiscreening fra databaserne: MEDLINE, CINAHL, EMBASE og PsycInfo. 
Artikler, der beskrev udvikling og psykometriske egenskaber ved de mest anvendte spørgeskemaer, 
blev også identificeret. Hovedvægten blev lagt på de undersøgelser, som havde brugt mindst ét af 
de hyppigst anvendte spørgeskemaer.  
Det spørgeskema, som umiddelbart blev vurderet til at være mest anvendeligt til måling af 
psykosociale konsekvenser ved mammografiscreening, blev oversat til dansk af et panel af 
personer, der var dobbeltsprogede i dansk/engelsk og kvalitetsvurderet af et panel bestående af 
lægfolk. Indholdsvaliditeten af det oversatte spørgeskema blev vurderet i fokusgrupper med i alt 34 
kvinder, som alle havde fået et abnormt svar ved mammografiscreening, et svar der senere viste sig 
at være falsk positivt. For at teste om dette spørgeskema var acceptabelt og ikke virkede anstødeligt, 
blev der også gennemført 15 telefoninterviews, dels med kvinder, der var inviteret til 
mammografiscreening, dels med kvinder, der aldrig havde været inviteret til eller deltaget i 
mammografiscreening. 
Efter interviewene blev en foreløbig version af et nyt spørgeskema med høj indholdsvaliditet 
besvaret af kvinder, der havde fået et abnormt, et falsk positivt og et normalt svar ved 
mammografiscreening. Item Respons Teori (Rasch modellen) og Klassisk Test Teori blev anvendt 
til at analysere de indsamlede data og teste spørgeskemaets pålidelighed og gyldighed herunder 
begrebsvaliditet, konvergens og divergens validitet, spørgeskemaets evne til at måle forskelle 
mellem grupper, dimensionalitet, additivitet, objektivitet, og intern konsistens. 
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Resultater 
 
Treogtyve kvantitative studier om korttids- og langtidskonsekvenser af falsk positivt svar ved 
mammografiscreening blev fundet og vurderet. De mest anvendte spørgeskemaer var: General 
Health Questionnaire (GHQ), Hospital Anxiety and Depression Scale (HADS), Psychological 
Consequences Questionnaire (PCQ) og State-Trait Anxiety Inventory (STAI). Ét eller flere af disse 
spørgeskemaer var anvendt i 17 ud af de 23 studier.  
 
De tre spørgeskemaer GHQ, HADS og STAI havde alle problemer hvad angår sprog, relevans og 
dækningsgrad, når de blev anvendt i undersøgelser af konsekvenser af falsk positivt svar ved 
mammografiscreening. Desuden syntes ingen af disse tre spørgeskemaer at være tilstrækkelige til 
måling af psykosociale konsekvenser ved screening uanset typen af kræft. PCQ blev vurderet som 
det spørgeskema, der var bedst egnet til måling af psykosociale korttidskonsekvenser ved 
mammografiscreening. Imidlertid blev det også vurderet, at PCQ ikke i tilstrækkelig grad ville 
kunne opfange alle langtidskonsekvenser af falsk positivt svar ved mammografiscreening.  
 
Seks af 12 originale spørgsmål i den første del af PCQ var tvetydige ved f.eks. at ét spørgsmål 
indeholdt to spørgsmål. Ved at omformulere disse steg antallet af spørgsmål fra 12 til 18 i den 
danske version af PCQ. Disse 18 spørgsmål blev af deltagerne i fokusgruppeinterviewene fundet 
relevante til måling af negative psykosociale konsekvenser af abnormt svar ved 
mammografiscreening, men dækkede ikke alle psykosociale områder. For at dække alle disse 
psykosociale konsekvenser, som kvinderne i fokusgrupperne gav udtryk for blev 15 nye spørgsmål 
udviklet. Dette resulterede i et udkast til et spørgeskema med 33 spørgsmål (del 1) 
 
Det kom frem under fokusgruppeinterviewene at nogle spørgsmål kunne stilles såvel ved 
invitationen til mammografiscreening, ved selve screeningen, i den kritiske periode fra abnormt 
svar til kendt diagnose, og efter at diagnosen var bekræftet som falsk positiv. Derimod var der 
spørgsmål, der kun kunne stilles efter mistanke om brystkræft var afkræftet, og der var sikkerhed 
for at det abnorme screeningssvar var falsk.  
 
For at dække dette specifikke område af psykosociale langtidskonsekvenser af falsk positivt 
screeningssvar, blev der udviklet 13 nye spørgsmål, hver med 7 svarkategorier (del 2). Under 
interviewene gav nogle kvinder udtryk for, at de havde svært ved at skelne mellem nogle af de 7 
svarmuligheder.  
 
De statistiske analyser af del 1 afslørede seks dimensioner: angst, adfærdsmæssig påvirkning, 
modløshed, søvnproblemer, brystundersøgelse og seksualitet. Ét spørgsmål, der tilhørte 
modløshedsdimensionen, viste sig at have uniform differential item functioning. Der var to 
spørgsmål, som ikke passede ind i Rasch modellen og ikke hørte til nogen af de seks dimensioner. 
Disse to spørgsmål blev bevaret i spørgeskemaet, da gruppeinterviewene viste, at de begge havde 
høj indholdsvaliditet. Et spørgsmål om antal sygedage, gav vigtig og anvendelig information til 
måling af bivirkninger af screening samt socioøkonomiske beregninger af mammografiscreening. 
De statistiske analyser identificerede også fem ”dårlige items”, der foreslås fjernet fra den endelige 
udgave af del 1 af spørgeskemaet.  
 
I de statistiske analyser af del 2 blev fire dimensioner afsløret: ændring af eksistentielle værdier, 
forhold til socialt netværk, følelse af mere eller mindre afslappethed/indre ro, større eller mindre 
bekymring for brystkræft/større eller mindre tillid til ikke at have brystkræft. Rasch-analyser 
bekræftede, at der også var statistiske problemer med nogle af svarkategorierne. Derfor er det blevet 
foreslået at reducere antallet af svarkategorier fra 7 til 5 med en deraf følgende ændring af layout. 
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Konklusion og perspektiver 
 
Dette ph.d.-studium har vist, at de tidligere gennemførte kvantitative undersøgelser har anvendt 
utilstrækkelige spørgeskemaer til måling af psykosociale aspekter ved mammografiscreening. 
Derfor må konklusioner vedrørende psykosociale langtidskonsekvenser af falsk positivt svar ved 
mammografiscreening forblive tentative. 
 
Dette studium har fremlagt foreløbig evidens for gyldighed og pålidelighed af et spørgeskema til 
kvinder, der har fået et abnormt og et falsk positivt svar ved mammografiscreening. Det nye 
spørgeskema kaldes COS-BC (akronym for Consequences of Screening – Breast Cancer) og består 
af to dele. Den første del indeholder 27 spørgsmål, som måler forskellige aspekter af et 
bagvedliggende overordnet begreb – psykosociale konsekvenser af abnormt svar ved 
mammografiscreening. Del 1 indeholder også et spørgsmål om antal sygedage. Del 2 af COS-BC 
måler de psykosociale langtidskonsekvenser af falsk positivt svar ved mammografiscreening. 
 
Dette studium viser, at det har betydelige negative psykosociale konsekvenser at få et abnormt svar 
ved mammografiscreening, som senere viser sig at være et falsk positivt svar. Derfor bør antallet af 
falsk positive screeningssvar holdes på et minimum. 
 
De breve og informationsfoldere, der vedlægges en invitation til mammografiscreening, bør 
indeholde informationer om de negative psykosociale konsekvenser af at få et abnormt og et falsk 
positivt screeningssvar. 
 
Der er under dette ph.d.-studium fremkommet ny viden om psykosociale konsekvenser ved 
mammografiscreening. Denne viden og indsigt kan bidrage til afvejning af fordele og ulemper ved 
mammografiscreening, og bør medtages i en beslutningsproces om hvorvidt mammografiscreening 
skal eller ikke skal implementeres generelt i Danmark. 
 
Det er målet i fremtiden at få udviklet et kerne-spørgeskema ud fra COS-BC, som kan være relevant 
for screeningsprogrammer for kræftsygdomme generelt. Et sådant kerne-spørgeskema, COS, kunne 
bestå af kerne-spørgsmål og kerne-skalaer relevante for alle slags screeningsprogrammer for 
kræftsygdomme og suppleres med specifikke spørgsmål for den kræftsygdom man screener for. På 
denne måde vil det forhåbentlig blive muligt at sammenligne omfanget af psykosociale 
konsekvenser af falsk positive svar mellem screeningsprogrammer. 
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4. Introduction 
4.1. Medical screening 
The term “screening” is used for the mechanical process of separating particles of different sizes. 
For example huge grids are used in coal mines to screen the coal separating coal particles by size 
and remove trash and pieces of rock. In 1951 the United States Commission of Chronic Illness 
defined screening as "the presumptive identification of unrecognised disease or defect by the 
application of tests, examinations, or other procedures which can be applied rapidly. Screening 
tests sort out apparently well persons who probably have a disease from those who probably do not. 
A screening test is not intended to be diagnostic. Persons with positive or suspicious findings must 
be referred to their physicians for diagnosis and necessary treatment”.1 This definition was also 
used by the World Health Organisation (WHO) in 19682 and has been adapted into Danish in the 
report from the Danish National Board of Health in 1990 on criteria for medical screening 
programmes3 and in the Danish Council of Ethics’ report about medical screening from 19994 
(English version from 2001).5 
 
4.2. Sensitivity, specificity and positive predictive value 
The aim of medical screening is to identify disease in a healthy asymptomatic population when the 
disease is in a symptomless phase and therefore hopefully still curable. As implied in the definition 
medical screening is a gross filtration and is not a perfect process. The screening test has two 
qualities: the ability to find persons with disease (sensitivity) and the ability to identify healthy 
persons (specificity). As no screening test is perfect, the sensitivity and specificity are never both 
100% perfect. Therefore, persons with disease suspicion may be healthy (false positive finding) and 
persons with normal screening results may have disease (false negative finding), see table 1: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“A” symbolises persons with disease that are identified in the screening programme. In contrast,  
“C” is the number of persons with disease that the screening test misses. “B” is the number of 
healthy persons that will have an abnormal screening result. Finally, “D” symbolises the healthy 
persons having a negative result.  
 
The positive predictive value of a screening test expresses how many persons with a positive 
screening result actually have the disease. The positive predictive value of a screening test depends 
on the prevalence of the disease screened for. Table 2 and 3 illustrate this phenomenon: 
 
Table 1. The possible outcomes of medical screening 
 
 Persons with disease Healthy persons  
Positive screening test A (TP) B (FP) A + B 
Negative screening test C (FN) D (TN) C + D 
 A + C B + D N = A + B + C + D
Sensitivity: A/(A+C) 
Specificity: D/(B+D) 
Positive predictive value: A/(A+B) 
TP: True Positive finding, FP: False Positive finding,  
FN: False Negative finding, TN: True Negative finding. 
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These examples illustrate that the performance of a screening test does not only depend on the 
sensitivity and the specificity of the test, but also on the prevalence of the disease. The examples 
also illustrate that with a tenfold increase in disease prevalence in a high risk group, the positive 
predictive value is not ten times better. A low positive predictive value of a test is always found in a 
population of low prevalence despite a high specificity. In the two scenarios above the rates of false 
positive results are 83.7% and 32.2% respectively, with a specificity of 98%.  
 
4.3. Screening criteria 
In 1968 WHO published a report with ten criteria that should be checked when a screening 
programme is to be implemented or evaluated.2 These criteria were mostly based on the paradigm 
of screening programmes for infectious diseases e.g. pulmonary tuberculosis. Therefore, one of the 
major concerns was the occurrence of false negative screening results, as unidentified persons with 
disease would continue to be a source of infection. In the last fifteen to twenty years screening 
programmes for cancers have been implemented increasingly in the industrialised countries. This 
was one of the reasons why the Danish National Board of Health (DNBH) in 1990 updated the 
criteria for medical screening programmes.3 The report clarified the WHO’s ten criteria and added 
four more criteria.  
In 1999 the Danish Council of Ethics published a report on screening in order to emphasise that the 
previous suggested criteria from the WHO and the Danish National Board of Health were important 
and that the council wanted to contribute to the ongoing debate of medical screening.4;5 
 
Table 2: If the prevalence of a cancer in a general population was set at 0.5%, if the sensitivity of 
the screening test was set to 80%, the specificity to 98%, and if 1,000 persons were screened, the 
first scenario would be: 
 
 Persons with cancer Healthy persons  
Positive screening test 4 20 24 
Negative screening test 1 975 976 
 5 995 1,000 
Sensitivity: 4/(4+1) = 80% 
Specificity: 975/(20+975) = 98% 
Positive predictive value: 4/24 = 16.7% 
 
Table 3. In the second scenario, screening is conducted in a high risk group instead of mass 
screening in a general population. The cancer prevalence is ten times higher than in the general 
population (5%). The sensitivity and the specificity of the screening test are similar as before: 
80% and 98% respectively. 
 
 Persons with cancer Healthy persons  
Positive screening test 40 19 59 
Negative screening test 10 931 941 
 50 950 1,000 
Sensitivity: 40/(40+10) = 80% 
Specificity: 931/(19+931) = 98% 
Positive predictive value: 40/59 = 67.8% 
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In 1994 the EU published a report which is in line with the recommendations of the WHO and the 
Danish National Board of Health.6 The fourteen criteria of the WHO and the Danish National Board 
of Health are listed below: 
 
1. The condition sought should be an important health problem (WHO) 
2. There should be an accepted treatment for patients with recognised disease (WHO)  
3. Facilities for diagnosis and treatment should be available (WHO) 
4. There should be a recognisable latent or early symptomatic stage (WHO) 
5. There should be a suitable test or examination (WHO) 
6. The test should be acceptable to the population (WHO) 
7. The natural history of the condition, including development from latent to declared disease, 
should be adequately understood (WHO) 
8. There should be an agreed policy on whom to treat as patients (WHO) 
9. The cost of case-finding (including diagnosis and treatment of patients diagnosed) should be 
economically balanced in relation to possible expenditure on medical care as a whole 
(WHO) 
10. Case-finding should be a continuing process and not a “once and for all” project (WHO) 
11. Before making any decision on the initiation of a screening activity, the following must be 
evaluated (DNBH): 
• validity of the testing system 
• technical efficiency 
• predictive values of test results 
12. An evaluation must have been made of (DNBH): 
• the ethical and psychological consequences for the examinees 
• stigmatisation 
• the consequences of “false positive” and “false negative” test results 
13. An economic evaluation must be performed (DNBH): 
• cost-benefit, cost-effectiveness, and/or cost-utility analysis 
• cash-economic evaluation 
• marginal economic evaluation 
• cost-effectiveness 
14. There must be a detailed description of (DNBH): 
• programme organisation  
• steering committee (make-up, competence) 
• registration system 
• triage planning 
• provision of information to the target group 
• staff training 
• test result dissemination 
 
This thesis contributes to an understanding of the twelfth criterion concerning ethical and 
psychological consequences of screening, with particular reference to the consequences of false-
positive screening results. 
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4.4. Breast cancer screening 
In industrialised countries, breast cancer is the most frequent cancer occurring in women. For a 
Danish woman the lifetime risk of having breast cancer is approximately 10%, and this is one of the 
highest incidences in the European countries.7 Screening mammography programmes have been 
suggested as a method to prevent deaths from breast cancer with the EU recommending a biannual 
screening test for women aged 50 – 69 years.8  
 
4.5. Sensitivity, specificity and positive predictive value of screening mammography 
The sensitivity of a screening mammography for asymptomatic women ranges from 71% to 96% 
for one year intervals and from 56% to 86% for biannual screening.9-11 The range of the specificity 
is 94% to 97%.9-11 The sensitivity and specificity and thereby the positive predictive value of a 
screening mammography depends on factors other than the quality of the X-ray machine and the 
experience of the radiograph and radiologist, notably:12  
• the mammographic breast density, which explains why the sensitivity and specificity are 
lower among younger women9;13 and women taking hormone replacement therapy14-16 
• the specificity is poorer among obese women who have a higher rate of false-positive results 
compared with underweight and normal weight women.17  
The sensitivity, specificity and positive predictive value also differ between screening clinics and 
countries18, with the reported positive predictive value of a screening mammography ranging from 
4% to 22%.11 On an individual level there is a large variation in the likelihood of having a false-
positive screening mammography. By the ninth screening mammography the likelihood “can be as 
low as 5% for women with low-risk variables and as high as 100% for women with multiple high-
risk factors”.19  
 
4.6. Effect of breast cancer screening 
The latest meta-analysis on breast cancer screening concluded that “In the randomized, controlled 
trials, (screening) mammography reduced breast cancer mortality rates among women 40 to 74 
years of age. Greater absolute risk reduction was seen among older women. ……In addition, each 
screening has associated risks and costs”. The number needed to screen (NNS) to prevent one death 
from breast cancer after approximately 14 years of observation was 1224 (NNS 665 - 2564) for the 
age group 40-74. Among women younger than 50 years of age, the number needed to screen in 14 
years was 1792 (NNS 764 – 10540).11 The Swedish randomised control trials of screening 
mammography found a significant 29% relative risk reduction of the breast cancer mortality among 
women aged 50-69 years.20 Expressed in number needed to screen the Swedish trials showed that 
1,000 women were needed to be screened biannually for ten years in order to prevent one death 
from breast cancer.21  
 
4.7. False-positive screening mammography 
There is a large variation in the positive predictive value of a screening mammography across 
screening centres, national borders and from one individual to another. Therefore, the estimated 
lifetime risk for having a false-positive screening mammography (hereafter referred to as a false 
positive) also varies. The lifetime risk for a woman to have a false positive in Denmark if she 
participates in all ten screening rounds during 20 years from the age of 50 – 69 has been estimated 
to be 20-25%.22 In other words, every fourth to fifth woman participating in all screening rounds in 
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a Danish breast cancer screening programme will receive a false-positive result. The lifetime risk 
for having a false positive in other countries is given in table 4. 
 
Table 4. The lifetime risk for having a false positive in other countries 
 
Country Age group Lifetime risk of a false positive 
The United States 40 – 69  49.1% after ten mammographies in ten years23 
The United States 40 – 69  43.1% after nine screening rounds19 
Australia 50 – 69  37.5% biannual screened in ten rounds24 
Spain 50 – 69  32.4% biannual screened in ten rounds25 
Norway 50 – 69  20.8% biannual screened in ten rounds26 
 
While the rate of true positive result is the same for the United States and the United Kingdom the 
rate of false positives is twice as high in the USA compared to the UK.27 One of the reasons for this 
difference is probably the different ways the programmes of breast cancer screening are organised 
in the two countries.28 Another possible reason is the age group screened in the two countries: in 
United Kingdom women aged 50 to 65 are offered screening, while women in the United States 
aged 40 to 69 are screened. 
 
4.8. Breast cancer screening in Denmark 
Breast screening programmes were implemented in the city of Copenhagen in two rounds: in 1991 
in the municipality of Copenhagen and in 1994 in the Frederiksberg municipality. In the county of 
Funen a breast cancer screening programme was implemented in 1993. However, no Danish pilot 
studies on psychosocial consequences of false positives were conducted prior to the implementation 
of these programmes. Nor were any studies conducted during programme implementation. This is 
probably one of many reasons for the conclusion in the report from the Danish Council of Ethics 
from 1999: “The Danish Council of Ethics takes a concerned view of the current situation, in which 
most screening programmes are initiated on an inadequate basis with too great a degree of 
haphazardness in the decision-making process. The National Board of Health, Denmark’s, 
guidelines – and WHO’s recommendations – are not being followed on a number of central points, 
and there is a lack of knowledge and clarity surrounding important factors relating to social and 
psychological effects, false negative and false positive test results, priority-setting bases and 
information. The debate on the possible introduction or expansion of screening programmes is 
often characterised by that same inadequacy.”  
 
4.9. Other harmful consequences of breast cancer screening 
Besides false positives other harms of breast cancer screening may occur such as: 
• over-diagnosis and over-treatment 
• identification of carcinoma in situ 
• false-negative screening mammography29 
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4.9.1. Over-diagnosis and over-treatment 
Over-treatment is inextricably linked to over-diagnosis and over-diagnosis is an inevitable side 
effect of medical screening.30;31 Over-diagnosis in screening mammography may occur in three 
different scenarios: 
1. diagnosis of breast cancer  
2. diagnosis of carcinoma in situ 
3. diagnosis of benign lesions that primarily are supposed to be malign 
Re 1) The cancers identified in screening have an overrepresentation of slow growing cancers.32 
dentifying a slow growing cancer in an older person that might die from other reasons a 
short time after screening will result in over-diagnosis. In the prevalence round a peak of 
cancer incidence is always seen. This peak will correspondingly occur with a decline in 
incidence after screening has stopped. Observational studies have reported an increase in the 
incidence of breast cancer21;24;33-35 and two of these also without the corresponding decline 
in incidence among the women older than 69 years old that were no longer screened.33;34 A 
follow-up study 15 years after the end of the randomised Malmö mammographic screening 
trial has shown an over-diagnosis of 10%.36 
Re 2)  Approximately two third of the women diagnosed with carcinoma in situ can be seen as 
being over-diagnosed, because approximately only one third of carcinoma in situ lesions 
will progress to invasive cancer.37 Treatment of carcinoma in situ can therefore in some 
cases be regarded as over-treatment (see also the paragraph about carcinoma in situ below). 
Re 3)  Some of the women having an abnormal screening mammography later confirmed to be 
false positive will have further examination before declared free from cancer suspicion. 
These invasive procedures (needle biopsies and surgery) can be regarded as over-treatment. 
However, a woman having mastectomy as a result of a false positive has been reported.38 
 
4.9.2. Carcinoma in situ 
Carcinoma in situ (CIS) is a condition in between being healthy and having a cancer. CIS in the 
breast range from a biologically aggressive lesion with a substantial risk of progression into 
invasive carcinoma, to a lesion with a very low malignant potential.39 A prospective 10 year follow-
up study estimated that approximately one third of CIS lesions would progress to invasive cancer.37  
In 110 consecutive, medicolegal autopsies of women aged 20 – 54 years old, 20 (18%) had CIS and 
9 of those had bilateral CIS-lesions.40 Prior to the implementation of breast cancer screening very 
few in situ carcinomas were diagnosed. However, after screening had been implemented 11% of the 
screen-detected malignant lesions were carcinoma in situ.41 In the prevalence round of the 
Copenhagen screening programme 12% of the women diagnosed with malignant lesions had CIS 
and 11% in the first incidence round.42 In the United States, where annual screening is common and 
women younger than 50 are also screened, 20-25% of the malignant lesions were carcinoma in 
situ.43 Treatment of CIS is controversial and ranges from excision only, to drug treatment, to 
excision with radiation therapy, through to mastectomy.44  
 
4.9.3. False-negative screening mammography and interval cancer 
In the European guidelines for quality assurance in mammography screening false-negative 
screening mammography and interval cancer has been classified as seen in table 5.45;46 
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Table 5. Classification of false-negative screening mammography and interval cancer 
 
Categories Subtypes Screening films Diagnostic mammogram 
True interval  Negative Positive 
Minimal signs  Minimal signs Minimal signs or positive 
False negative Reading error 
Technical error 
Positive 
Negative (for technical reasons) 
Positive 
Positive 
Unclassifiable  Any Not available 
Occult  Negative Negative 
 
It might have negative psychosocial consequences to have a false-negative screening 
mammography. It depends on the time of the diagnosis. If the woman is diagnosed just after the 
screening it seems to have the greatest psychosocial impact, while the impact is less when 
diagnosed with breast cancer more than a year after screening.47 
Another possible side effect of a false-negative screening result is that it might lead to treatment 
delay and therefore an advanced clinical stage of the breast cancer when diagnosed.26 
 
4.10. The biopsychosocial model and cancer screening 
In the 1970s the biomedical model was considered too reductionistic. The need for a new medical 
model resulted in the emergence of the biopsychosocial model.48 It was argued that, to provide a 
better basis for understanding the determinants of health and disease a medical model should take 
into account both the context in which the person lives and the person’s health/illness. The 
psychosocial aspects of the new model includes psychological, social, behavioural and cultural 
factors.48 The model encompasses both the psychosocial dimension and the biomedical 
dimension.48;49 It is not a one-way model - it is dynamic. In the biopsychosocial model people are 
not regarded as passive, because they are not only influenced by their surroundings but also interact 
with, and have an influence on, their environment. People are actively involved in their 
environment; they act and react if diagnosed with a disease.50;51 In a situation where a healthy 
person is screened for cancer and a suspicion of cancer is raised with an abnormal screening result 
this may have an impact on the person’s life. 
In Jill Cockburn’s work on psychological consequences of screening three domains were suggested 
to cover the psychological aspects; emotional, social and physical. A deficit in functioning in one or 
more of the domains was regarded as a negative consequence and hence, detrimental.52 In cervical 
cancer screening psychosexual and psychosocial consequences have been described after an 
abnormal screening test. Most notably, anxiety, stress, emotional, psychological and sexual side-
effects have been reported.53-55  
In this thesis the term “psychosocial” will be used according to the biopsychosocial model 
encompassing psychological, emotional, sexual, social, behavioural, physical and cultural aspects. 
For example, if anxiety reaches a level that has a significant impact on a person resulting in 
dysfunction it is regarded as a negative consequence and detrimental for the person’s health.  
 
4.11. International studies on consequences of false positives 
The first quantitative study on “psychiatric morbidity associated with screening for breast cancer” 
was published in 1989.56 Since then more than 20 quantitative studies have been published 
internationally covering different aspect of consequences of false positives.57 The emotional 
reactions and the women’s own experiences of having a false positive have also been explored in 
 18 
one international qualitative study.58 This study showed that having a false positive can cause 
negative psychosocial consequences such as anxiety and fear.  
It is likely that attitudes and values towards medical screening programmes vary from one culture to 
another. Therefore, is seems logical to investigate screening programmes in a national context.  
 
4.12. Danish studies on consequences of false positives 
The first Danish publication on the possible psychosocial consequences women could experience 
when having a false positive was a qualitative study published in 1997.59 Nineteen women were 
interviewed, ten of whom had received a normal screening mammography and nine, a false 
positive. The conclusion was that women might experience negative psychosocial consequences 
when having a false positive. A review on psychological consequences of breast cancer screening 
among healthy women was published in 2000 by a Dane,60 but no Danish studies except for the 
qualitative study mentioned above were included. The Danish Agency of Health Technology 
Assessment has published a report of the breast cancer screening programme in the county of Funen 
covering the period 1993 - 1997.47 The report included a qualitative study where women having a 
false positive were interviewed. The qualitative part of this report was also concluded that false 
positives might have negative psychosocial consequences. 
 
4.13. Why and how to measure the impact of false positives? 
Numerically, false-positive screening results are the largest harm of screening. The number needed 
to screen biannually over ten years to prevent one death of breast cancer among women aged 50-69 
has been found to be 1,000 women.20;21 Biannual mammography screening of 1,000 women for ten 
years will result in more than 100 false-positive screening results.22 The approximate proportion 
between prevented deaths versus false positives is therefore 1:100. 
The different aspects of psychosocial consequences of false positives are not measurable as in 
diagnostic tests (e.g. laboratory tests, radiology etc.) or by other technical means (e.g. blood 
pressure, weight, lung capacity etc.). Instead, other methods must be sought for their assessment. To 
measure comprehensively the harm associated with receiving a false positive, assessment 
instruments ought to capture: 
• the quality of psychosocial consequences 
• the extent of psychosocial consequences 
• the changes in psychosocial consequences over time 
 
4.14. The use of generic questionnaires 
Generic questionnaires are designed to be used in any disease population and cover a broad aspect 
of the construct measured. Condition-specific instruments have been especially developed to 
measure those aspects of outcome that are of importance for a particular population.61 Generic 
measures may or may not be relevant depending on the target population and the setting in which 
the instrument is used. One generic questionnaire will rarely be sufficient to address the whole area 
covered by a research question. To overcome the lack of content coverage researchers often use a 
battery of questionnaires.62-68 Using more questionnaires concurrently in a survey may present a 
number of problems such as: 
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• redundancy, because items measuring the same matter or issue are repeated in different 
questionnaires 
• overloading the respondent with numerous questions 
• asking irrelevant questions 
• offering the respondent different response patterns and options, which can make it difficult 
and confusing to respond validly61 
The advantage of widely used generic questionnaires is that results from different surveys 
comparing the impact of different health conditions may be comparable. This presupposes that the 
psychometric properties of the questionnaire are the same in the different settings. In fact, statistical 
re-evaluation of generic questionnaires in a new setting does not always confirm the previously 
estimated properties.69 Furthermore, the advantage of using generic questionnaires will be less 
compared to the disadvantages if the content of the questionnaire does not validly covers the 
research question.  
 
4.15. Generic questionnaires in cancer screening  
The psychosocial consequences of false-positive cancer screening results have been investigated in 
numerous questionnaire surveys reported in a recently published literature review.67 The studies had 
predominantly used generic questionnaires.70 Some of the frequently used measures and health 
status scales were: the General Health Questionnaire,71 the SF-3672, the Hospital Anxiety and 
Depression Scale73 and the State Trait Anxiety Inventory.74 A finding in the review was: “The 
overwhelming majority of research indicated that short-term effects were transient.” However, the 
validity of the measures was not evaluated. If instruments were inadequate in the setting of false-
positive screening then the results and conclusions of the studies would be highly questionable.75 
The question: “Assessing psychosocial/quality of life outcomes in screening: how do we do it 
better?” has recently been raised.76 To improve the quality of the measurement of psychosocial 
outcome when screening for a disease the questioner suggested that three conditions should be 
respected: 
• the need for a control group (preferably created by randomisation) 
• the need for baseline and follow up measurements 
• the need for reliable measurement tools with high criterion and content validity76 
 
4.16. Selecting a questionnaire 
It is costly and time consuming to develop and validate a new questionnaire from scratch. However, 
it may be possible to identify from the literature an existing validated questionnaire developed for a 
similar purpose.  
If an apparently adequate questionnaire is identified it is likely to have been developed in another 
language and in a culture that may differ from the culture of the target population. In such a case it 
would be necessary to translate and adapt the measure. The translation and adaptation should follow 
an internationally accepted method including a bilingual panel and a lay panel and afterwards 
checked item by item in a field test with people from the target population.77 A back translation is 
not regarded as a sufficient quality control of a translation process.78  
Once the translation and adaptation process has been finished there is no guarantee that the 
psychometric properties of an adapted version will be the same as the properties of the original 
questionnaire.61 Statistical re-evaluations of questionnaires in new language versions have shown 
that previously estimated psychometric properties differ when the questionnaires are used in 
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different countries and cultures.79;80 It is therefore compulsory to re-validate a translated and 
adapted questionnaire, as if it were newly developed.61 
 
4.17. Content validity 
To ensure the overall validity of a measure it is essential to ensure high content validity of a scale or 
a questionnaire.61;76;81 Content validity – including content relevance and content coverage61 - is the 
“Achille’s heel” when using generic questionnaires in contrast to using questionnaires specifically 
developed for a certain purpose.81  
Therefore, after having conducted a translation and adaptation of a questionnaire it is recommended 
that the second step be to test the content validity of the questionnaire.61 The most appropriate 
source of knowledge about the relevance and coverage of questionnaire content is the target 
population. Hence, the content is best tested in either single or focus group interviews with the 
target population.61 If lack of content validity is revealed during this step it may be necessary to add 
new items. Deleting redundant and irrelevant items may also be necessary. 
If major changes are made to an existing already validated questionnaire there is only a small 
chance that the psychometric properties of the questionnaire will have remained constant. 
Therefore, a statistical re-evaluation of the modified questionnaire is needed.61 
 
4.18. Statistical methods 
The statistical methods for testing questionnaire data are concentrated in two theories: Classical 
Test Theory and Item Response Theory.  
 
4.18.1. Classical Test Theory 
In the Classical Test Theory (CTT) normal distribution of data is assumed. It is also assumed that 
the responses are variables on an interval scale and that raw scores are linearly correlated.61 When 
following CTT and using for example factor analysis the purpose is to reveal one or more latent 
variables by exploring or confirming a linear correlation between the actual variables (the manifest 
variables) and the latent variable.82 
 
4.18.2. Item Response Theory 
It is not necessary to make an assumption of normal distribution of data when using an Item 
Response Theory (IRT) model. The responses (item parameters) can be regarded as variables on an 
ordinal scale. In Figure 1 below, a ruler illustrates a hypothetical example of the difference between 
an ordinal scale and an interval scale. 
 
Figure 1. A ruler with an ordinal scale on the top and an interval scale at the bottom. 
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From the ruler it can be seen that the distance between a score of 3 and a score of 4 on the ordinal 
scale is not the same as the distance between for example a score of 8 and 9. However, the distances 
between these scores (or any scores next to each other) are always the same on an interval scale. 
Another example illustrating the differences between an ordinal scale and an interval scale is 
illustrated by the item below: 
  
Not at all 
 
A bit 
 
Quite a bit
 
A lot 
 
I have felt scared. ? ? ? ? 
 
It is not obvious that the item parameters (sometimes described as threshold parameters)83 in the 
item above are variables on an interval scale. It is actually more likely that the distances between 
the thresholds are unequal and the response categories are variables on an ordinal scale. 
In CTT the emphasis is on item parameters and their linear correlation. In contrast to the CTT, the 
emphasis in the IRT “is on item and person parameters, which are non-linear transformations of 
raw scores, and on variances of these estimates”.84;85 In the IRT the idea of unidimensionality is 
that a person may be represented by a single value on a single latent continuum (latent variable).85 
 
4.18.2.1. The Guttman pattern 
The Guttman scale86 is seen as the ideal in terms of evidence of unidimensionality,85 figure 2. 
 
Figure 2. The Guttman scale. Persons illustrated by letters and items by numbers. 
 
  Items 
  1 2 3 4 5 6 7 8 9 10
A 1 0 0 0 0 0 0 0 0 0 
B 1 1 0 0 0 0 0 0 0 0 
C 1 1 1 0 0 0 0 0 0 0 
D 1 1 1 1 0 0 0 0 0 0 
E 1 1 1 1 1 0 0 0 0 0 
F 1 1 1 1 1 1 0 0 0 0 
G 1 1 1 1 1 1 1 0 0 0 
H 1 1 1 1 1 1 1 1 0 0 
I 1 1 1 1 1 1 1 1 1 0 
Pe
rs
on
s 
J 1 1 1 1 1 1 1 1 1 1 
 
In Figure 2, person A to person J represents ten persons completing a questionnaire and item 1 to 
item 10 represents ten items in the questionnaire. The response “1” denotes that the item is affirmed 
and “0” denotes that the item is not affirmed. For example, if the 10 items in Figure 2 formed an 
anxiety dimension then person A would be the least anxious person and person J the most anxious 
person. Item 1 would be the item measuring the mildest aspects of anxiety and item 10 the most 
severe aspects of anxiety. The unidimensionality of the Guttman scale is of absolute importance 
because the response pattern is perfect. 
In an IRT-model the latent variable (in this case the trait of anxiety) is a hypothesis and 
unidimensionality is of relative matter and thereby the response pattern in an IRT-model is relative. 
Figure 3 illustrates such a hypothetical example of an anxiety scale. 
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Figure 3. A hypothetical example of ten persons completing an anxiety scale of ten items. 
 
  Items 
  2 5 4 6 1 3 10 9 7 8 
H 1 0 0 0 0 0 0 0 0 0 
C 1 0 1 0 0 0 0 0 0 0 
J 1 1 0 1 0 0 0 0 0 0 
E 1 1 0 1 1 0 0 0 0 0 
D 1 0 1 1 1 1 0 0 0 0 
F 1 1 1 1 0 1 0 0 1 0 
G 1 1 1 1 1 1 1 0 0 0 
A 1 1 1 1 1 1 1 0 1 0 
B 1 1 1 1 1 1 0 1 1 1 
Pe
rs
on
s 
I 1 1 1 1 1 1 1 1 1 1 
 
In Figure 3, person I is most anxious of all ten persons and item 2 is the item measuring the mildest 
aspects of anxiety. All the responses marked with yellow are responses that are not perfect 
compared to the Guttman pattern. The IRT-model “allows” a certain illogical and non-perfect 
response pattern illustrated in figure 4 as the green zone. 
 
Figure 4. A hypothetical example of ten persons completing an anxiety scale of ten items. 
 
  Items 
  2 5 4 6 1 3 10 9 7 8 
H 1 0 0 0 0 0 0 0 0 0 
C 1 0 1 0 0 0 0 0 0 0 
J 1 1 0 1 0 0 0 0 0 0 
E 1 1 0 1 1 0 0 0 0 0 
D 1 0 1 1 1 1 0 0 0 0 
F 1 1 1 1 0 1 0 0 1 0 
G 1 1 1 1 1 1 1 0 0 0 
A 1 1 1 1 1 1 1 0 1 0 
B 1 1 1 1 1 1 0 1 1 1 
Pe
rs
on
s 
I 1 1 1 1 1 1 1 1 1 1 
 
The likelihood of responses in the green zone in Figure 4 can also be illustrated as in Figure 5 
where the likelihood of affirming the items towards the severity (going right) is decreasing and the 
likelihood of not affirming the items increases. 
 
Figure 5. The likelihood of responses in the Rasch model 
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4.18.3. The Rasch model 
The Rasch model is a logistic IRT-model. The simplest Rasch model with a dichotomous outcome, 
has been explained using the example of jumpers jumping fences.87 The jumpers vary in strength 
from weak to strong, and the fences are of various heights posing different challenges. The 
probability (p) that a jumper will have a successful attempt on a fence depends on the strength of 
the jumper and the height of the fence. This is illustrated in Figure 6: 
 
Figure 6. The stochastic interpretation of observations of jumpers over fences87 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Figure 6, jumper A to jumper J represents ten jumpers with increasing strength and fence 1 to 
fence 10 represents ten fences with increasing height. The example of jumping fences can be 
compared with measurement of anxiety. The extent of a person’s anxiety then replaces the jumper 
strength in the example of Figure 6. The height of the fence is replaced by the severity of anxiety-
item; a low fence is replaced by an item measuring mild aspects of anxiety and a high fence is 
replaced by an item measuring severe aspects of anxiety. An item measuring mild aspects of anxiety 
item could for example be “have you been worried about your future? yes/no” and an item 
measuring severe aspects of anxiety could be “have you been terrified? yes/no”.  
 
4.18.3.1. The dichotomous Rasch model 
 
 
The formula of the Rasch model with dichotomous outcome is: 
 
 
Like in the Guttman scale the Rasch model assumes that: A) the “milder” the item is, the more 
likely it will be affirmed; and B) the more affected the respondent is, the more likely the respondent 
will affirm an item compared to a less affected individual.88 However, the Guttman scale assumes a 
perfect response pattern while the Rasch model assumes a probabilistic Guttman response pattern. 
In the formula of the dichotomous Rasch model p(β) is the probability that a person who is affected 
to a certain degree “β” will affirm an item measuring the severity “δ”. Thereby, the probability of a 
person affirming an item depends on how much the person is affected and the severity of the item. 
j\f 1 2 3 4 5 6 7 8 9 10
A           
B           
C           
D           
E     P      
F           
G           
H           
I           
J           
e(β – δ)  p(β) = 1 + e(β – δ) 
Height 
Jumper 
Fence 
Strength 
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If a person responds to an item where the severity of the item is exactly the same as the degree to 
which the person is affected then β = δ and p(β) = 0.5 (50%). If the severity of the item is less than 
the person’s level of affection (β > δ) the probability will be greater than 50% and when β < δ the 
probability will be less than 50%. 
To explain the formula of the dichotomous Rasch model and the calculation in the previous 
paragraph a set of dichotomous items forming an anxiety dimension is used. The anxiety-item 
parameters would be manifest variables on a latent anxiety-continuum most likely on an ordinal 
scale. A person with a certain degree of anxiety would have a certain location on such a latent 
continuum (latent variable). The person would affirm items that are located below the person’s 
location with a probability of more 50% and the probability of affirmation would increase the 
milder the item was (beginning in the centre of Figure 5 and going left). The person would affirm 
the items located above the person’s location with a probability of less than 50% and the probability 
of affirmation would decrease with the more severe aspects of anxiety the item is measuring 
(beginning in the centre and going right in Figure 5). The Rasch model takes into account that 
measurement error always exists, that no respondents are 100% logical in their responses and that 
the pattern is not perfect (Figure 2) but allows for probabilistic variations (Figure 3-5). 
 
4.18.3.2. The advantages of the Rasch model 
The Rasch model tests whether the manifest variables are fitting a probabilistic Guttman pattern and 
if that is the case, then the hypothesised latent variable is confirmed. If there is a misfit of the 
manifest variables to the Rasch model then the items having misfit to the model can be identified. 
After deleting the item with the most misfit the remaining items can be tested in the model. The 
items that do not fit the model should be treated either as single items or “poor” items depending on 
there face and content validity.  
Where items are shown to fit a Rasch model the measure can be shown to posses criterion-related 
construct validity, unidimensional, additive, specifically objective, sufficient and reliable.89-92 The 
Rasch model is the only IRT-model that possesses specific objectivity and sufficiency. If 
measurement has specific objectivity in relationship to the latent variable, then a comparison 
between two persons using a selected set of items that represents the range of the scale (dimension) 
does not differ systematically from comparisons using another set of valid items from the scale. 
Similarly, comparison of two persons should not depend on measurements of other persons.89 The 
sufficient statistic contains all available information about the parameter of interest. If for example, 
it is known how many dichotomous items that have been affirmed on a Rasch fitting scale (the 
score on the dimension is known) more knowledge is not gained by knowing which of the items on 
the scale were affirmed. The score on the scale contains all the available information.90 
The Rasch model is considered a valuable “gold standard” because the Rasch model: 
• has no presumption of normal distribution of data 
• can include data on an ordinal scale 
• provides formal representation of perfect measurement, because a measure fitting the Rasch 
model possesses: 
o criterion-related construct validity 
o unidimensionality 
o additivity 
o specific objectivity 
o sufficiency 
o reliability 
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4.19. The purpose of the thesis 
The overall purpose of this PhD study was to identify, adapt and validate an instrument to measure 
the psychosocial consequences of false-positive breast cancer screening results in Denmark. 
The aims of the four papers included in this thesis are: 
1. to review quantitative studies on women’s experiences of short-term and long-term 
consequences of false positives and to identify and asses the adequacy of the most 
frequently used instruments for measuring these consequences (I) 
2. to translate and adapt into Danish the negative part of the Psychological Consequences 
Questionnaire and to assess the content validity of the Danish version of the instrument in 
the setting of abnormal screening mammography later confirmed to be false-positive (II, III) 
3. to statistically validate a new condition-specific instrument measuring psychosocial 
consequences of abnormal screening mammography (IV) 
4. to develop and validate a new instrument measuring long-term psychosocial consequences 
of false positives (II, III, V) 
 
4.20. The steps of the PhD study 
 
The Roman numerals in the flow chart correspond to the steps of the study described in the papers. 
 
 
 
 
I - The Psychological Consequences Questionnaire (PCQ) 
A Danish version of the PCQ (PCQ-DK) 
II - Translation and adaptation process including a bilingual panel and a lay panel 
 
Abnormal screening mammography False-positive screening mammography 
Consequences of Screening – in Breast Cancer (COS-BC part 1 and part 2) 
IV - Statistical test of the psychometric 
properties of the instruments  
V - Statistical test of the psychometric 
properties of the instruments 
III - Focus group interviews assessing the content validity of the PCQ-DK including women 
who had had an abnormal screening mammography later confirmed to be false-positive 
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5. Article 1 
 
The adequacy of measurement of short and long term consequences of false-positive screening 
mammography. Journal of Medical Screening 11 (1):39-44, 2004. 
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ORIGINAL PAPER
The adequacy of measurement of short and long-term
consequences of false-positive screening mammography
John Brodersen, Hanne Thorsen, Jill Cockburn
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J Med Screen 2004;11:39–44
Objectives: The aim of this study is to review quantitative studies on women’s experiences of
consequences of false-positive screening mammography to assess the adequacy of the most frequently
used instruments for measuring short-term and long-term psychological consequences.
Methods: Relevant papers reporting quantitative studies on consequences of false-positive screening
mammography were identied using MEDLINE, CINAHL, EMBASE and PsycInfo databases. Articles
citing development and psychometric properties of the most frequently used measures were also
retrieved. Finally, the review focused on studies that had used at least one of the most frequently used
measures.
Results: Twenty-three relevant studies were identied. The most commonly used measures were the
General Health Questionnaire (GHQ), the Hospital Anxiety and Depression Scale (HADS), the
Psychological Consequences Questionnaire (PCQ) and the State-Trait Anxiety Inventory (STAI). One or
more of these was used in 17 of the 23 studies.
Conclusions: The GHQ, the HADS and the STAI have problems with language, content relevance, and
content coverage in studies of false-positive screening mammography. These instruments should not be
used to measure psychological consequences of any kind of cancer screening. The PCQ is an
adequate questionnaire for measuring short-term consequences, and the PCQ is preferable to other
measures because of its higher sensitivity. However, there is little evidence that the PCQ is able to
adequately detect all long-term consequences of screening mammography. Given the inadequacy of
the measurement instruments used, any current conclusions about the long-term consequences of false-
positive results of screening mammography must remain tentative.
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INTRODUCTION
Specicity of biennial screening mammography has beenreported as 97%,1 with positive predictive values of 9%and 17% for women aged 50–59 and 60–69, respec-
tively.2 Consequently, 10 out of 11 women in their  fties
and ve out of six in their sixties receiving an initial abnor-
mal screening mammography do not have cancer. Thus, an
abnormal screening mammography more often provides a
false-positive than a true-positive result. In the UK, where
three-yearly screening is offered to women aged 50–65,
more than 50,000 women per year will receive a false-
positive mammography.3
The WHO recognise that cancer screening may have a
negative affect on the target population,4 even when their
‘Ten Commandments’5 for medical screening are adhered to.
Gray and Austoker are more direct about the potential
negative affects of screening: ‘All screening programmes do
harm; some also do good’.6 The ultimate damage caused by a
screening program arises when healthy people die, either
from diagnostic procedures or from medical interventions
following a false-positive result. This has been reported after
ovarian cancer screening,7 colorectal cancer screening,8 and
lung cancer screening.9 In breast cancer screening, a case of
suicide following receipt of a recall letter has been reported.10
Mortality data indicate some benets of cancer screening
programs. It is possible to calculate nancial burden and time
consumption of screening on participants, medical practice
and society. However, adverse effects such as psychosocial
impact of a false screening result on the individual, are
dif cult to dene and measure.11
The aim of this paper is to review quantitative studies on
women’s experiences of consequences of false-positive
screening mammography to assess the adequacy of the most
frequently used instruments for measuring short-term and
long-term consequences.
METHODS
Relevant papers reporting quantitative studies on conse-
quences of false-positive screening mammography were
identied using MEDLINE, CINAHL, EMBASE and PsycInfo
databases. Reference lists were manually searched for
articles not identied through the electronic means. This
process was continued until no more relevant papers were
identied. Articles citing development and psychometric
properties of the most frequently used measures were also
retrieved. Finally, the review focused on studies that had
used at least one of the most frequently used measures. The
adequacy of measures was based on whether eld-tests and
psychometric analyses were appropriately conducted in the
setting of false-positive screening mammography.
RESULTS
The search identied 30 papers (including three reviews),
covering 23 studies measuring the consequences of false-
positive mammography.12–41 The search also identied ve
papers dealing with women’s attitudes, experiences, satis-
faction and consequences of attending a breast screening
program,42–46 one pilot study on the same issues,47 and one
study of false-positive thermography.48
Fifteen studies investigated only short-term consequences
of false-positive mammography i.e. up to three months after
women were informed that they did not have breast
cancer.12–17,19–22,27,32,34–38 All reported adverse short-term conse-
quences.
Seven studies measured short-term and long-term conse-
quences (over more than three months).18,23–26,28,29,31,33 They
also consistently report adverse short-term consequences but
results regarding long-term consequences are ambiguous. One
study found that 15% of the women receiving a false-positive
mammography had measurable adverse consequences after
six months;28 Brett et al. found adverse long-term conse-
quences at ve, eleven, and 35 months follow up;25,31 and
three studies found no long-term consequences.18,26,33
Interpretation of results in two of the seven studies is
unclear.24,29 One study measured only long-term conse-
quences and found that they were present after two years.30
In the 23 different studies at least  fteen different
measures have been used. Those used most often were the
General Health Questionnaire (GHQ), the Hospital Anxiety
and Depression Scale (HADS), the Psychological
Consequences Questionnaire (PCQ) and the State-Trait
Anxiety Inventory (STAI). One or more of these was used in
17 of the 23 studies. Table 1 summarises the results of the
review. Item generation and scale development, scoring
system, psychometric properties and results of measuring
consequences of false-positive screening mammography are
reported for each of the four scales.
General Health Questionnaire (GHQ)
The GHQ is a self-administered questionnaire designed as a
screening tool of psychiatric disorders in non-psychiatric
clinical settings such as primary care or general medical
out-patients.51 The original version, developed in 1972,
contained 60 items covering four areas; depression, anxiety,
objectively observable behaviour and hypochondriasis. The
four dimensions arose mainly as a result of interviews
conducted with 2460 non-hospitalised adults about aspects
of adjustment and distress in 196052 and from interviews
using the Cornell Medical Index53,54 with 120 residents of a
Jewish housing project in 1965. Discussions were also con-
ducted with experienced psychiatrists.51 The anxiety scale
used Fried and Lindemann’s work of ‘role-satisfaction’.55
Items were also taken from other scales and inventories and
30 items were developed specically for the GHQ.51
Items enquire about recent experience of symptoms or
behaviour, with four response options (‘less than usual’, ‘no
more than usual’, ‘rather more than usual’, and ‘much more
than usual’) scored 0-1-2-3, as an adjectival scale on a con-
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Table 1 Quantitative studies on consequences of false positive mammography, reviews, and related papers. The articles are
listed by year of publication and include two qualitative studies on consequences of false positive mammography.49,50
Publication
Authors year PCQ GHQ HADS STAI Other questionnaires/items
Ellman et al. 1989 GHQ-28
Gram et al. 1990 Own questionnaire
Bull et al. 1991 +
Lerman et al. 1991 Self conducted telephone interview
Lerman et al. 1991 Self conducted telephone interview
Gram et al. 1992 Own questionnaire
Cockburn et al. 1994 +
Lidbrink et al. 1995 Coping test and MACL
Sutton et al. 1995 GHQ-28* STAI-Y
Chen et al. 1996 GHQ-12 EPI & CSI
Swanson et al. 1996 + Plus one other item
Ong, Austoker & Brett 1997 + STAI, 6-items form Plus others items
Scaf-Klomp et al. 1997 GHQ-12 + SOM, Fear of Cancer
Brett, Austoker & Ong 1998 + STAI-Y, anxiety-trait scale Plus others items
Gilbert et al. 1998 + HQ
Lowe et al. 1999 + GHQ-28§ Plus others items
Olsson et al. 1999 +
Aro et al. 2000 STAI-X Illness Attitude Scale, Beck’s depression scale
plus own questionnaire and other items
Lipkus et al. 2000 CED-S plus other items
Brett & Austoker 2001 + Plus other items
Ekeberg et al. 2001 + Plus other items
Lampic et al. 2001 + Numerical anxiety scale
Lindfors et al. 2001 Own questionnaire plus other items
Meystre-Agustoni et al. 2001 + Plus one other item
Hislop et al. 2002 + STAI Items on women’s satisfaction
Sandin et al. 2002 SCL-90 plus other questions
Bowland et al. 2003 + SSQ, LOT, a coping scale, plus other items
Reviews:
Rimer & Bluman 1997
Steggles et al. 1998
von Bulow 2000
Other Related studies:
Dean et al. 1986 + PAS
Bartolucci et al. 1989 SQ and IAS
Elkind et al. 1990 Own questionnaire
Olsson et al. 1993 SCL90 and interview
Lightfoot et al. 1994 + POMS
Walker et al. 1994 +
Ong and Austoker 1997 Own questionnaire
Qualitative studies:
Lunde 1997
Padgett et al. 2001
* 7 items from the GHQ-28 anxiety sub-scale
§ The depression sub-scales excluded
tinuum with discrete responses.56 Items are added to give a
total score.57 The measure can also be scored dichotomously,
with ‘0’ given for ‘less than usual’ and ‘no more than usual’,
and ‘1’ for ‘rather more than usual’ and ‘much more than
usual’.57 For the latter method, scores are added and if a
person scores more than a given threshold they are classied
as a ‘case’.57 A 140-item version of the GHQ was published
with the original 60 items.51 Several different shorter
versions have also been developed, namely GHQ-12, GHQ-
28 and GHQ-30.58 The ‘case’ thresholds vary with different
versions.58
The versions of the GHQ have been found to be reliable
and valid, when subjected to traditional psychometric
analysis such as test-retest reliability, internal, and concur-
rent validity in a variety of settings.58 Two studies using item
response theory (latent trait model) have tested the
GHQ-1259 and the GHQ-3060 respectively. Both studies
found a difference between positively and negatively
orientated items, indicating that the GHQ may not be a uni-
dimensional measure and perhaps it would be appropriate to
split it up into a positive and a negative component.
Five of the reviewed studies used the GHQ-12 or GHQ-28
(Table 1).12,20,21,24,27 In one study only the GHQ-28 anxiety
sub-scales was used20 and in another, the depression
sub-scale was excluded from the GHQ-28.27 An overall GHQ
score has been calculated in three of the four studies,12,20,27
while the other classied women as ‘cases’ or ‘non-cases’.21
Lowe et al. reported ‘acceptable’ Cronbach’s alphas for the
three subscales that were used from the GHQ-28.27 None of
these studies have reported pre-testing or test-retest
reliability in these settings.
Hospital Anxiety and Depression Scale (HADS)
The HADS is a patient-completed measure developed in
1983 to provide a reliable screening test for psychiatric
disorders in patients in non-psychiatric hospital depart-
ments.61 The HADS has fourteen items equally distributed in
two subscales: depression and anxiety. The depression
subscale was developed from the anhedonic state,62 as the
authors argue that this responds well to antidepressant drug
treatment.62 The anxiety subscale was developed using
modi ed items from the Hamilton Anxiety Scale (a rating
scale for patients already diagnosed with neurotic
anxiety)63,64 and the Present State Examination (a structured
interview that assesses the present mental state of adult
patients suffering from either neuroses or functional
psychoses).65 All items in the PSE were selected by
psychiatrists and physicians.
Each item has four response options. Subjects select the
option that best describes how they have been feeling over
the previous week. These are scored 0-1-2-3, as an adjectival
scale on a continuum with discrete responses. Items added
to give a total score.61
The HADS was rst validated by comparing scores of 98
adult outpatients from a general medical clinic with ratings
of clinicians blinded to patients’ scores. These were used to
determine score thresholds for ‘non-cases’ (score of seven or
less), ‘doubtful cases’, (eight to 10) and ‘cases’ (11 or over).
Secondly, a selection of patients were matched for age and
gender with a ‘normal’ sample to test if the HADS scores
were inuenced by physical illness apart from mood
disorders. The HADS has been used in a range of disease
areas, with approximately 500 studies identied. Few have
used a healthy person comparison group. Traditional psy-
chometric assessments, mainly in studies that involve
patients, have shown acceptable results.66
The HADS has been used in ve of the reviewed studies
(Table 1).14,24,26,32,33 These do not report pre-testing, test-
retest reliability, or analyses of internal consistency in these
settings.
Psychological Consequences Questionnaire (PCQ)
The PCQ was developed in Australia in 1992 as a self-
administered measure of psychological consequences of
screening mammography.67 Items encompassing emotional,
social and physical domains were generated by reviewing
published scales and research. Scales reviewed included the
GHQ,51 the Sickness Impact Pro le,68 a scale measuring
whether screening programs cause morbid concern in the
community,69 and a number of oncology quality of life
measures.70,71 Interviews were also conducted with women
attending screening and recall for further investigations after
initial screening.
A sorting procedure showed high level of agreement
between expert judges as to whether the postulated
physical, social and emotional dimensions could be distin-
guished on the basis of item content. After pilot testing with
other samples of women from the screening program, ve
items measuring emotional issues, four measuring physical
and three measuring social issues were retained.
The questionnaire asks ‘Over the last week how often
have you experienced the following because of thoughts and
feelings about breast cancer?’ followed by the items.
Response options are ‘not at all’, ‘rarely’, ‘some of the time’,
and ‘quite a lot of the time’, scored from 0–3. Ratings for
items within each dimension are added to give respective
subscale scores. A higher score indicates greater dysfunction
on that dimension. A pilot version of the PCQ was eld-
tested in screening and recall clinics.67 Items were tested for
oor effect, ability to measure differences between groups of
women and women’s perceptions of ease of completion.
Responses of women at initial screening and assessment
clinics were compared with ratings of a clinical interviewer,
who was blinded to the PCQ score. The high level of agree-
ment for each subscale was taken as an indicator for concur-
rent validity. Women’s initial scores (obtained at the
screening clinic) were compared with scores obtained during
the recall visit. As scores varied in the predicted direction
(higher scores, indicating greater dysfunction were found at
the recall clinic) this was taken as evidence for construct
validity.
The PCQ has been used in ten of the reviewed papers
(Table 1).18,22,23,25,27,28,31,35,36,38 A Swedish version of the PCQ
together with the Symptom Check List (SCL-90) was com-
pleted by 220 women in a pilot study but data on concurrent
validity were not reported.28 PCQ has been shown to be
more sensitive than a 6-item short form of the STAI,23 the
anxiety-trait scale of the STAI-Y,25 and the GHQ-28 (exclud-
ing the depression subscale).27 Three studies have performed
factor analyses on the PCQ. Ong et al. found a single factor
with an eigenvalue of 7.7, explaining 65% of the variance.23
Olsson et al. did not report their results, other than saying
that the ‘analysis did not suggest three underlying factors’.28
Hislop et al. also do not report results but state that two
dimensions were found.35 Cronbach’s alpha values are
presented in Table 2.
State-Trait Anxiety Inventory (STAI)
The development of the STAI was initiated in 1964 with the
purpose of producing ‘an objective, self-reported research
instrument that could be used to measure both state and trait
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anxiety in normal adults’.72 A large number of items from
three widely used anxiety-trait scales73–75 were reformulated
so that each could be used as a measure of both anxiety-state
and anxiety-trait.72 A number of tests were performed with
college and university students, who were asked either to
imagine hypothetical situations such as being relaxed or at
being at an examination or by giving the questionnaire to the
students in a period of non-examination and later in a period
of examination. The result was a single scale, the Form-A of
the STAI (STAI-A).
Psycholinguistic problems led to the development of the
STAI-X, which comprises a 20-item anxiety-trait scale
(describing how the respondent feels in general) and a 20-
item anxiety-state scale (describing how the respondent
feels at a particular moment).72 Further renement after
testing with high school students led to the 40 item STAI-Y,
where weaker items from STAI-X were replaced either by
equal or better psychometric items or by items that were
more consistent with the concept of state and trait anxiety.76
There are four response options for each item in all the forms
of the STAI, scored on a scale of 1-2-3-4 as an adjectival scale
on a continuum with discrete responses.56 The higher score
the higher the likelihood of either state or trait anxiety.72,77
Reliability and validity of the many forms of the STAI have
been tested in several studies using traditional psychometric
assessments. Results are acceptable.77 One study reports
analyses based on item response theory on STAI-X data.78
Rasch analyses indicated that several items in both scales of
the STAI-X ‘produce mist responses, share identical
locations on the continuum, and do not produce equal units
of measure’. Furthermore, the STAI-X was not accurate
enough to differentiate the trait and state anxiety levels.
Only ten items of the trait-scale and nine from the state-
scale were applicable, and there was a lack of items covering
the measures of ‘light’ and ‘severe’ trait and state anxiety.78
The STAI has been used in ve of the reviewed papers but
each study used a different version (Table 1).20,23,25,29,36
Sutton et al. used the STAI-Y;20 Ong, Brett and Austoker used
a 6-item short form of the STAI79 in their pilot study23 and in
a later study they used the anxiety-trait scale of the
STAI-Y25. Aro et al. used the anxiety-state scale from the
STAI-X29 and Hislop et al. do not report which version of
the STAI was used.36 The ve studies in this setting did not
report pre-testing or test-retest reliability. Only one of the
ve studies reports analyses of internal consistency
(Cronbach’s alpha 0.96).36
DISCUSSION
The review has uncovered a number of issues with existing
measures that cast doubts about their overall adequacy for
measuring consequences of false-positive screening mammo-
graphy.
Firstly, the language used in items may not be relevant for
current use. The GHQ, the HADS, and the STAI originate
from the 1970s and 1980s and their item generation goes as
far back as the 1950s. The language of a questionnaire must
be kept up to date as the linguistic value of words and terms
can take on new meanings over time.56 Both the wording of
the items and the construct behind the measures could be
different if the measures had been developed more recently.
Secondly, the content of items in some measures is not
relevant for women attending for breast cancer screening
and who may experience a false-positive mammography.
The GHQ was developed to tap psychiatric disorders in non-
psychiatric clinical settings and the HADS to tap psychiatric
disorders in non-psychiatric hospital departments. Middle-
aged healthy women participating in breast cancer screening
and experiencing false-positive screening mammography
can hardly be categorised as suffering from psychiatric
disorders as such. Therefore, it is questionable whether the
GHQ and the HADS can accurately capture the conse-
quences of such an experience.
The STAI was developed to tap state and trait anxiety in
normal adults. However, it is doubtful that the anxiety
experienced by students before an examination equals the
anxiety experienced by women threatened by breast cancer.
Furthermore the lack of items in the STAI covering ‘light’
and ‘severe’ state and trait anxiety, shown by Rasch
analyses,78 throws doubt on the STAI’s ability to capture the
full construct of anxiety.
Moreover as the GHQ, the HADS, and the STAI cover
psychiatric and psychological disorders in a broader sense,
they may impose irrelevant items on women experiencing
false-positive mammography. Streiner and Norman have
warned that if items appear irrelevant, the respondent may
object to them and omit them, irrespective of the instru-
ments ‘possibly superb psychometric properties’.56 Using
more than one such measure could exacerbate the
perception of irrelevance.
Thirdly, the variety of additional measures used in the 23
studies included in this review (Table 1) shows that the
researchers acknowledge the necessity of supplementing the
overall psychological and psychiatric measures to ensure
content coverage. However, such variation makes it dif cult
to compare studies.39,40 Response burden is another dis-
advantage. It would be preferable if the same level of infor-
mation could be achieved by using a short questionnaire
specically developed to cover a target.56
Despite the different questionnaires used, all studies found
adverse short-term consequences of false-positive screening
mammography.12–24,26–29,32–38 This indicates at least some
relevance of the batteries of measures chosen by the
researchers. However, it does not indicate content coverage.
Surprisingly, there is no evidence to suggest pre-testing of
content relevance and coverage of the GHQ, the HADS and
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Table 2 Cronbach’s alpha of the subscales and the total scale of the PCQ in
studies where internal consistency is reported.
Total scale Social Emotional Physical
Negative consequences
Cockburn et al., 1992 0.78 0.89 0.77
Ong et al., 1997 0.95
Lowe et al., 1999 0.87 0.91 0.80
Hislop et al., 2002 0.94 (Emotional state subscale) 0.85 (Functional state subscale)
Bowland et al., 2003 0.64 0.92 0.77
Positive consequences
Lowe et al., 1999 0.75 0.82 0.87
the STAI in any of the studies using these measures in this
setting. If pre-testing had been conducted it might have
shown that these measures do not cover all short-term and
long-term consequences of false-positive mammography.
Fourthly, in all the reviewed studies little attention has
been paid to the applicability of the measurements. Cockburn
et al. rst contributed to this discussion67 and developed a
new questionnaire (PCQ) specic to the area. Sutton also
addresses the applicability of measurement, and acknowl-
edges that there could have been a different pattern of results
in his study if a more specic instrument such as the PCQ had
been used. The better sensitivity of the PCQ to detect psycho-
logical consequences of false-positive mammography com-
pared with a six item short form of the STAI,23 the
anxiety-trait scale of the STAI-Y25 and the GHQ-28 exclusive
the depression subscale,27 also suggests that the PCQ is more
applicable to this setting than other instruments.
Fifthly, there are few assessments of the psychometric
properties of instruments in the setting of false-positive
consequences of screening mammography. Only two studies
have reported analyses of internal consistency of three of
four subscales of the GHQ-28 and an unknown version of
the STAI in this setting. However, the relevance of adequate
internal consistency is questionable when there has been no
examination of the measure’s content validity in the setting.
In contrast, the consistently high levels of internal con-
sistency of the PCQ that have been reported in various
studies, along with the demonstrated content validity of the
measure (at least for short-term consequences) gives further
condence of the adequacy of the PCQ for this setting.
Lastly, there is insufcient evidence that any of the
current measures adequately describe the longer term
consequences of receiving a false-positive result. This could
explain the ambiguity of results in this area. The PCQ was
used in two of the three studies that found some long-term
consequences. It appears that the method of development of
the PCQ ensured that at least some items are relevant for
consideration of long-term consequences. However,
development of PCQ items did not involve women for
whom some time had passed since receiving their false-
positive result. Thus, there may be other relevant long-term
consequences that have been missed. For example, Gram et
al. report that one long-term consequence described by
women after diagnostic surgery, was reduced sexual
sensitivity of the breast.13 Women also mention sexual
consequences of false-positive mammography in a Canadian
study about women’s attitude to breast screening 80.
CONCLUSIONS
This review has revealed that the GHQ, the HADS and the
STAI have problems with language, content relevance, and
content coverage when these measures are used in studies of
false-positive screening mammography. Given that the
adequacy of these measures in this setting is doubtful, it is
suggested that these instruments should not be used to
measure psychological outcomes related to the conse-
quences of any kind of cancer screening. It is worrying,
therefore, that studies in colorectal screening are using these
measures.81
The review suggested that the PCQ is an adequate
questionnaire for measuring short-term consequences of
receiving a false-positive mammography and that the PCQ is
preferable to other measures because of its higher sensitivity.
However, the review also revealed that this instrument has
some deciencies when measuring long-term consequences
of screening. There is little evidence that the PCQ is able to
adequately detect all long-term consequences of screening
mammography. The items were developed on women who
were waiting to hear about their false-positive result, and
did not include women who were told that their abnormal
screening mammography was false. Women on early recall,
women who had diagnostic surgery before being given a
benign result and women whose false-positive result had
occurred at some time in the past, were also not included.67
This is an important issue that needs to be examined further
in rigorously conducted qualitative studies that explore the
range of issues for women viewing their false-positive results
in the longer term, as a rst step to develop a relevant
measure in this setting. Until this is achieved, any
conclusions about the long-term consequences of false-
positive results of screening mammography must remain
tentative.
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6. Discussion of article 1 
 
6.1. Major findings 
The literature search identified 30 papers (including three reviews) covering 23 studies measuring 
consequences of false-positive screening mammography (hereafter referred to as false positives). 
Fifteen of the 23 studies investigated only short-term consequences of false-positive mammography 
i.e. up to three months after women were informed that they did not have breast cancer. All reported 
adverse short-term consequences. Seven studies measured short-term and long-term consequences 
(more than three months). While these studies all reported adverse short-term consequences, results 
regarding long-term consequences were ambiguous. One study measured only long-term 
consequences and found that they were present after two years.  
In the 23 different studies at least fifteen different measures have been used. The most commonly 
used measures were the General Health Questionnaire (GHQ), the Hospital Anxiety and 
Depression Scale (HADS), the Psychological Consequences Questionnaire (PCQ) and the State-
Trait Anxiety Inventory (STAI). One or more of these was used in 17 of the 23 studies. 
The GHQ, the HADS and the STAI had problems with language, content relevance and content 
coverage in studies of false positives. Therefore, these instruments are not adequate for measuring 
psychological consequences in cancer screening. The PCQ was found to be an adequate 
questionnaire for measuring psychosocial consequences of abnormal screening mammography and 
preferable to other measures because of the PCQ’s higher sensitivity. However, there is little 
evidence that the PCQ is able to adequately detect all long-term psychosocial consequences of 
screening mammography. The PCQ was developed in Australia and the original version is 
reproduced in appendix I (page 120). 
 
6.2. Assessment of methods 
6.2.1. Feasibility of the comprehensive literature search 
The search strategy involved no language restriction and was conducted in four different databases: 
MEDLINE, CINAHL, EMBASE and PsycInfo.  
The following words were used in different combinations: 
“stress", "nervous system physiology", "diagnostic errors", "behavioral disciplines and activities", 
"psychological phenomena and processes", "behavior and behavior mechanisms", "adverse effects", 
"arousal", "adaptation, psychological", “coping”, “adverse”, “consequences”, “false positive 
reactions”, “false positive”, “diagnostic errors", “emotional”, “mammography", "breast", 
“screening”, “mass screening” "outcome assessment (health care)" and "questionnaires". 
The overall search strategy for the MEDLINE database is reported in appendix II (page 122). 
The abstracts of the papers that emerged from the literature search were read to identify relevant 
papers. A relevant paper was defined as one reporting a study of psychosocial consequences in 
relation to breast cancer screening (or related issues; quality of life, stress, etc. according to the 
words used in the literature search). When a relevant paper was identified then the reference list was 
manually searched for articles not identified through the electronic means. This process was 
continued until no more relevant papers were identified. 
Two non-English papers written in Danish were identified; a qualitative study59 and a review.60 
Two other English reviews were identified.93;94 One of these was published prior to the Danish 
qualitative study.93 All of the papers identified by the current review were also identified by these 
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other published reviews with the exception of the Danish qualitative study.59 This qualitative study 
was also not included in a review published after the current review.57 
Although many different instruments had been used the adequacy of only four measures was 
explored: 
• The first criterion for choosing these four measures was that the development and validation 
of the instruments identified should have been published. Only with such publications 
available it would be possible to discuss the instruments adequacy in the setting of false 
positives.  
• The second criterion was that only questionnaires used in at least two different studies were 
explored. If the same instrument had been used by at least two different researchers it might 
have been more relevant and adequate. 
 
6.3. Update of literature searched 
An updated literature search covering the period December 2003 to 2005 using the same four 
databases reported above has been conducted following the same search strategy (appendix II, page 
122). Four questionnaire surveys on psychosocial aspects of breast cancer screening were identified 
and are listed in table 6: 
 
Table 6. Quantitative studies on consequences of mass screening when screening for breast cancer 
published in the period December 2003 – 2005. The articles are listed by year of publication and the 
measures used in the studies are provided (not including sociodemographic variables). 
 
Authors: Publication 
year 
Questionnaires/items 
Barton et al95 2004 The Impact of Events Scale and the Hopkins Symptom Checklist 
anxiety and depression subscales 
Domar et al96 2004 STAI, McGill Pain Questionnaire and two VAS-scales from 1 to 
10 as self-reported levels of anxiety and pain 
Heckmann et al97 2004 STAI and Ways of Coping Questionnaire 
Brunton et al98 2005 Self developed questionnaire and an anxiety level measured by a 
4-point Likert scale 
 
None of the studies reported tests on content validity of the instruments used or statistical 
explorations of the psychometric properties of the measures. The four studies have used 
questionnaires and items not evaluated in the present review. However, no new measures had to be 
explored according to the two previously mentioned criteria. The number of different questionnaires 
used in surveys on psychosocial aspects of screening mammography is more than 20 after this 
updated literature search. The four studies published in Table 6 would not have resulted in any 
important changes in the discussion and conclusion of the present review if it was to be updated.  
 
6.4. Justification of conclusion 
The PCQ was developed by Jill Cockburn to assess the psychological consequences of the actual 
act of participation in breast cancer screening. As a part of the development process, interviews 
were conducted with women who had received a normal screening mammography and with women 
who had received an abnormal screening mammography. The interviews revealed that the women 
experienced impact in emotional, physical and social areas.52 Impact on sleep Cockburn categorised 
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as a physical impact. Other studies have reported more frequent breast self-examination as a 
consequence of false positives.62;99-101 In the setting of cervical cancer screening adverse sexual 
consequences have been reported.53-55 Therefore, the three generic questionnaires; the GHQ, the 
HADS and the STAI lack content validity in the setting of psychosocial consequences of false-
positive cancer screening. None of these instruments on their own include all reported domains; 
emotional, physical, social, sleep, sexual and breast self-examination.  
The PCQ is the most preferable instrument because it covers, albeit not comprehensively, the above 
domains and it has been developed from interviews with some of the women from the target 
population. The PCQ has also been developed and validated in the setting of screening 
mammography.52 
No qualitative study on the long-term consequences of false positives has been identified. Neither 
have any tests been reported on the content validity of these instruments in the setting of long-term 
psychosocial consequences. Therefore, there is little evidence that the PCQ (or any other measure) 
is able to adequately detect all long-term psychosocial consequences of false positives. Given the 
inadequacy of instruments in measuring the long-term psychosocial consequences no valid 
conclusions can be drawn on this issue from the questionnaire surveys.  
 
6.5. Contribution to the current knowledge 
The lack of content validity of generic instruments in the setting of false positives was made clear in 
the present review.  
The psychometric properties of generic measures are not necessarily the same when measures are 
applied in two different populations.69 Furthermore, none of the papers included in the present 
review reported re-evaluation of the generic instruments in the setting of screening mammography.  
If no generic questionnaires are found adequate a condition-specific measure should be developed 
and validated. After the present review was published “the need for reliable measurement tools with 
high criterion and content validity” was raised in an editorial on how to assess better the 
psychosocial consequences of screening.76 The present review was used as an argument for the use 
of condition-specific measures because they are more sensitive. Among criteria raised by the 
editorial on how to deal with false positives the issue on content validity and sensitivity of the 
applied instruments was especially emphasised. As described in the review the PCQ is more 
sensitive than the STAI and the GHQ in the setting of false positives. This is probably caused by a 
higher content validity of this instrument compared to the generic questionnaires.  
7. Article 2 
Psychosocial consequences of abnormal screening mammography – development of a new measure 
based on a translated version of the Psychological Consequences Questionnaire. Submitted 
 
John Brodersen (MD, GP, PhD student) and Hanne Thorsen (MD, PhD, senior researcher) both 
Department and Research Unit of General Practice, University of Copenhagen, Denmark 
 
This paper is dedicated to Professor Jill Cockburn with whom we have had rewarding discussions 
and who agreed with our project of adapting the PCQ for use especially in the setting of abnormal 
and false-positive screening mammography. 
 
Abstract 
Objectives 
The aim of this study is to translate and adapt into Danish the original Australian version of the 
Psychological Consequences Questionnaire (PCQ), including an assessment of the content validity 
of the Danish version in the setting of abnormal screening mammography. 
 
Method 
The translation process included a bilingual panel and a lay panel. The adaptation and content 
validity process was ensured by conducting six focus group interviews including 34 women and 
fifteen individual telephone interviews.  
 
Results 
Six of the twelve original items in the PCQ were ambiguous or poorly worded and were 
reformulated increasing the number of items in the Danish version to 18 items. All of the 18 items 
were found relevant as negative consequences of abnormal screening mammography, however 
several areas were not covered. As a result, 15 new items were generated. Altogether these 33 items 
covered the negative consequences of abnormal screening mammography. 
In the focus group interviews it was revealed that some issues could be raised both at invitation to 
screening, at time of screening, in the critical period, and after diagnosis. Other issues could be 
raised only after the women had been declared “free from” cancer suspicion.   
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Conclusion 
The first part of the PCQ captures important negative consequences of abnormal screening 
mammography. However, it lacks content coverage for women after abnormal and false-positive 
screening mammography. A 33-item questionnaire was developed covering more negative 
consequences of an abnormal screening mammography than the original first part of the PCQ The 
resulting 33-item questionnaire can be regarded as a new instrument that needs to be statistically 
tested for its’ psychometric properties. 
 
Introduction 
The distinction between normality and abnormality is not always clear cut and disease in 
populations exists as a continuum of severity rather than as an all-or-none phenomenon.1 Normality 
and abnormality are defined from different, often mutually exclusive, perspectives e.g. statistical, 
clinical, prognostic, and from the patients view. The prerequisite for medical screening is a 
technology capable of distinguishing normality from abnormality which can never be fully 
achieved.  
Breast cancer is a substantial health problem in the western world. In Denmark the life time risk for 
breast cancer is 10% for women.2 When following the EU-recommended biennial breast cancer 
screening for women aged 50 - 69,3 the incidence of breast cancer diagnosed in each screening 
round is between 0.4 – 0.6%.4 In populations where a disease has low prevalence the positive 
predictive value of the technology used in screening procedures is low despite high specificity.5 A 
low positive predictive value results in a high rate of false positive results e.g. if a woman follows 
the EU-recommended screening programme for breast cancer for twenty years, her lifetime-risk for 
a false-positive screening mammography will be 20 - 25%, possibly even higher6, and similar to 
other cancer screening programmes, 80 - 90% of abnormal screening mammographies are false-
positive. False-positive screening mammography (hereafter referred to as a false positive) cause 
significant adverse economic consequences including costly follow-up tests.7;8 In addition, 
numerous studies have shown that women recalled for further investigations after an abnormal 
screening mammography, later confirmed as a false positive, experience significant adverse 
psychosocial effects such as worries, anxiety, sleeping problems, social isolation etc.9 
The Psychological Consequences Questionnaire (PCQ) was developed by Jill Cockburn in Australia 
in 1992. The questionnaire is in two parts. The first measures the negative psychological 
consequences of the actual act of participation in breast cancer screening and the second measures 
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the positive consequences of participation.10 However, the PCQ has been applied mostly in studies 
of adverse consequences of false positives11; in nine of ten studies, only the negative-consequences-
part was used.12-20 
The items of the PCQ were developed after reviewing relevant questionnaires and interviewing 
women attending screening mammography, including women recalled for further investigation after 
an abnormal screening mammography.10;11  
McCaffery and Barrat underline the importance of high content validity when using questionnaires 
to measure the psychosocial outcome of screening.21 None of the studies using the PCQ to measure 
the consequences of false positives report examining the content relevance and content coverage 
before using it.11   
Women with the most negative psychosocial consequences of false positives are those who undergo 
surgery or early recall.14;15;17 However, these groups of women were not represented in the 
interviews preceding the development of the PCQ.10 Therefore, the original version of the PCQ may 
not capture all meaningful adverse psychosocial consequences of false positive; particularly longer-
term or more severe consequences. 
This paper reports the adaptation into Danish of the negative-consequences part of the PCQ, 
including a study to assess the content validity of the measure in the setting of abnormal and false-
positive screening mammography. 
 
Material and methods 
 
Translation 
Following an internationally accepted method, the translation process included a bilingual panel and 
a lay panel.22 
 
Bilingual panel. The first panel consisted of four members; all were female academics but without 
medical background. They were bilingual in English/Danish with Danish as their mother tongue. 
Each member of the panel independently translated the original Australian version of the PCQ into 
Danish. The panel members and the authors of this paper met and discussed the translations until 
they reached consensus. If consensus could not be reached, alternative translations of single items 
or sentences were left for the next panel. The bilingual panel produced the initial translations of the 
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items but it was left to the lay panel to decide upon the final wording and divide up the item if 
necessary. 
Lay panel. The four members of the second panel were female state school teachers aged from 55-
65; all taught Danish and none had ever taught English. For each item and each sentence of the 
instructions the lay panel was asked if the translated version of the PCQ was comprehensible and 
expressed in lay language. If it was not, panel members were asked to discuss and suggest 
alternative wording. Where the bilingual panel had suggested alternatives panel members were 
asked to choose the translation closest to lay Danish. 
 
Adaptation and content validity in the setting of abnormal and false-positive screening 
mammography 
Six focus group interviews were conducted with five to seven women in each group. The women 
had all been screened for breast cancer in the year prior to the interviews and all had experienced 
being told that their screening mammography was abnormal. All had also undergone additional 
medical procedures before the cancer suspicion was disproved. Women were grouped according to 
their additional examinations after abnormal screening mammography (table 1). Those living in a 
county offering breast cancer screening were included in the first four focus groups and those who 
had undergone opportunistic screening were included in the last two groups (table 1).  
 
Table 1. All women in the focus groups had had an ultrasound examination and a clinical 
mammography (UCM) as a minimum after the abnormal screening mammography. 
  
UCM 
UCM and 
needle biopsy
UCM and 
surgical biopsy
UCM and 
Early recall 
UCM and 
needle biopsy* 
UCM and 
surgical biopsy*
No. of women 5 7 5 5 5 7 
Age range (mean) 52 – 67 (58.2) 52- 67 (58.7) 52 – 60 (55.8) 52 – 69 (59.6) 28 – 71 (53.6) 49 – 65 (57.7) 
*opportunistic screening 
 
Issues for further exploration during the group interviews were decided upon after discussions with 
researchers, visits to a screening clinic, and after taking into account the relevant literature. The 
group interviews lasted approximately two hours and were divided into two parts. The first part was 
an open-ended discussion on consequences of an abnormal and a false positive screening 
mammography. The moderators also suggested more specific issues for discussion, i.e. physical, 
psychological, social and sexual consequences.  
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In the second part of the interview the women were asked to complete the Danish test version of the 
questionnaire; and comment on the wording of the items and the instructions, and easiness to 
complete. Timing was recorded. The women were then asked to “think aloud”23 and to discuss how 
they had responded to the questions according to the instructions. A cognitive group interview as an 
item-by-item discussion was also conducted. 24;25 Finally, the women were asked if the items 
included in the test version covered all possible consequences they had experienced or were still 
experiencing after an abnormal and false positive screening mammography.  
The response options were tested for relevance and comprehensiveness, and the layout was tested 
for clarity.  
If problems were revealed, the women in the focus groups were asked to suggest alternative 
questions, wording, or response options. If changes or new items were suggested in one group 
interview these were incorporated in the test version of the questionnaire presented to the following 
focus group. 
Each interview was tape-recorded and independently audited by the two authors who conducted 
thematic analysis to determine key consequences of abnormal and false-positive screening 
mammography. Results were compared and if they did not correspond, the relevant sequences from 
the tape recording were re-audited and discussed until consensus was reached. 
Ten additional telephone interviews were conducted with women at the time of their invitation for 
breast cancer screening and with five women from a county without screening. The women had 
received and completed the questionnaire before they were telephoned.  
 
Results 
Translation 
The translations for five items were accepted by the lay panel without change. The translations for 
four other items were reformulated into more everyday language while still retaining the meaning of 
the original items. These changes were made because the lay panel found the language of the 
translated items too academic. The remaining three items (item 3, 4 and 5) created some problems. 
Item 3: Both panels considered this item to be ambiguous insofar as it appeared to be addressing 
two separate issues. The lay panel split item 3 into two because they regarded the meaning of the 
two words “unhappy” and “depressed” as covering different constructs. 
Item 4: Item 4, asking if the women had been “scared” and “panicky”, was also found by both 
panels to be double-barrelled. In addition, the translator panel suggested two Danish synonyms for 
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the word “scared”. The lay panel split item 4 into two items because they regarded the meaning of 
the two words “scared” and “panicky” to cover different constructs and chose one of the 
alternatives suggested by the translator panel for the word ”scared”. 
Item 5: This item was found to be double-barrelled by the bilingual panel and the translation into 
Danish of the two words “nervous” and “strung up” was found redundant as they covered the same 
construct. Therefore item 5 was kept as one item with only one Danish word covering the meaning 
of “nervous” and “strung up”. The translation was accepted by the lay panel. 
The changes in item 3, 4 and 5 resulted in a test version of the questionnaire containing 14 items. 
The changes are summarised in table 2. 
 
TABLE TWO ABOUT HERE 
 
The bilingual panel suggested two different modes of response options. They argued that 
linguistically in Danish some of the items were more correctly followed by a response option 
expressing “frequency” instead of the uniform way of using “degree” in the original version. The 
changes in response options were later accepted by the lay panel and the focus groups. 
Adaptation and quality control of the translation 
The introduction in the PCQ is: “Over the last week how often have you experienced the following 
things because of thoughts and feelings about breast cancer”. The women in the lay panel and in 
the focus groups argued that they did not have thoughts and feelings about breast cancer, they only 
had thoughts. Therefore the word “feelings” was omitted in the Danish version.  
The first focus group considered one of the translated items to be too academically formulated. This 
item was reformulated and accepted by the next focus groups. 
All items in the Danish version of the PCQ were found to be relevant by the participants in the 
group interviews; however, three ambiguous and poorly worded items (item 1, 8 and 9) were 
changed because they were misunderstood by the women. These three items were extended into 
seven items, which cover in more detail the content of the original ones, see table 2. 
The number of items therefore increased from 12 in the original Australian version of the PCQ to 
18 items in the Danish version (PCQ-DK18), see table 2.  
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Content validity 
During the first group interview the women described their experiences as different in the critical 
period (from abnormal screening mammography until final false positive diagnosis) compared to 
the period after the final diagnosis. They argued that some issues could be raised only after they had 
been declared “free from” cancer suspicion. Other issues could be raised both at invitation to 
screening, at time of screening, in the critical period and, after diagnosis. They classified these 
issues as negative consequences of an abnormal screening mammography. Issues exclusively 
relevant to the time after final diagnosis were classified as long-term consequences of a false 
positive. 
All questions in the PCQ-DK18 were found to be relevant as negative consequences of abnormal 
screening mammography. However, the women in the focus groups commented that several areas 
relevant to the negative consequences of abnormal screening mammography were not covered by 
the PCQ-DK18. As a result, 15 new items were generated; 12 by the first group and one new item 
by the second, third and fifth group each. Some of the 15 items covered new areas not covered by 
the PCQ namely, breast examination, sexuality and sick leave. Other new items covered areas such 
as anxiety, sense of dejection, symptoms and behavioural impact which were all related to the 
emotional and physical domains of the PCQ. The new items were validated in the subsequent 
groups. To verify that the content of the item suggested in fifth group was not relevant only for this 
particular group and for the sixth group, the tape recordings of the preceding four groups were re-
audited. The content of the new items is listed in table 2: 
The resulting questionnaire covering the negative consequences of abnormal screening-
mammography contains 33 items (PCQ-DK33), see table 2. 
The two modes of response options (“frequency” and “degree”) were accepted by the focus groups. 
In two new items concerning sexuality the interviewees wanted an extra response category; “not 
applicable”. For one new sick-leave-item the response categories: “0 days”, “1 – 2 days”, “3 – 4 
days”, and “5 or more days” were accepted by the groups. The different response options are given 
in table 2. 
The women participating in the telephone interviews all accepted the items in the PCQ-DK33 if 
given a thorough explanation on the front page about the purpose of the questionnaire. 
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Discussion 
This study revealed that the adequacy and applicability of the PCQ in measuring psychosocial 
consequences of false positives is doubtful.  
The translation and adaptation process for the present study utilised an internationally established 
and accepted method comprising two translation panels; a bilingual panel and a lay panel followed 
by field-testing for face and content validity via focus group interviews .22 An advantage of this 
method was that quality of the translation was checked and re-checked by bilingual translators and 
lay people and re-re-checked with sample respondents from the target population via the focus 
groups. This ensured a quality control during the translation and adaptation process.26 An a 
posteriori back translation which is often recommended was not used as this can be misleading and 
is not a guarantee for quality in the translation.27 However, four female state school teachers who 
formed the lay panel may have been too well-educated because the language of at least one item 
was regarded by the target population as being too academic. These pitfalls may not have been 
revealed if only a forward-backward translation procedure had been conducted. 
Problematical items may undermine the validity of the data collected with a questionnaire. For 
example, if an item contains two ideas, some respondents will answer “yes” only if both parts are 
true: however, others will answer “yes” if either part is true. The final result may not reflect the 
actual state of affairs.23 If an item is poorly worded, it may be misunderstood. The translation and 
adaptation process showed that several items in the original version of the PCQ were ambiguous or 
poorly worded. Women taking sleeping tablets or having problems falling asleep would not know 
how to respond to item 1 in the PCQ “Had trouble sleeping”. This lack of detail about sleeping 
problems resulted in three additional items. Splitting items containing more than one idea and 
reformulating unclear items increased the total number in the questionnaire. 
One of the results from the focus group discussions on content validity confirmed the findings by 
Cockburn when developing the PCQ: women having an abnormal screening mammography did not 
find items asking about positive consequences of participation in breast screening relevant before 
final diagnosis.10 The women in the focus groups argued that they only experienced negative 
consequences of having an abnormal screening mammography. Therefore, only the items in the first 
part of the PCQ that measures the negative psychological consequences of participation in breast 
cancer screening were relevant for the women in the critical period from abnormal screening until 
final diagnosis.  
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Furthermore, the second part of the PCQ that measures the positive consequences of the actual act 
of participation in breast screening was not relevant at all for the women having a false positive. 
The women argued that after being been declared “free from” cancer suspension it was neither 
negative nor positive psychosocial consequences they had experienced. The impact of a false 
positive resulted in changes to predominantly one area such as, relation to social network or 
existential values. These comments suggest that a totally new questionnaire would be required to 
cover the long-term psychosocial consequences of a false positive. It was decided that the 
development and validation of such a new measure would constitute a separate study. 
The study highlighted the importance of including the target population when scrutinising the 
content validity of an instrument. All women participating in the focus groups had experienced an 
abnormal screening mammography, which later was confirmed to be false-positive. Focus group 
participants were selected according to the additional examinations after abnormal screening 
mammography. The advantage of this homogeneity was that the discussion in the group was 
focused on experiences they had all had instead of having a discussion where the women compared 
different experiences between one another. As a result 15 new items were generated to cover the 
lack of content coverage of the original PCQ in the setting of abnormal screening mammography. 
The women interviewed at the recall clinic during the development of the original PCQ did not 
know if they had breast cancer or not.10 To conduct interviews with women under threat of breast 
cancer and therefore under stress may not be ideal. In the present study all interviewees knew that 
their abnormal screening mammography was false. This may have influenced their willingness to 
discuss their crises in the critical period. Studies have shown that women undergoing clinical 
mammography only in addition to screening mammography are those with less negative 
psychosocial consequences compared to those undergoing needle biopsy, surgery or early 
recall.14;15;17 Therefore, it is worth mentioning that 12 of the 15 new items were generated during 
the first focus group interview with participants who had undergone the least distressing additional 
examinations.  
There is no doubt that the PCQ captures important negative consequences of abnormal screening 
mammography. However, scrutinizing the content validity in this setting has shown that the PCQ 
does not cover all consequences for women after abnormal screening mammography. On the other 
hand, developing 15 new items only ensured a higher content validity and is no guarantee for 
perfect content coverage. However, the fact that only three new items were generated in the second 
to fifth focus group indicated a high degree of data saturation. 
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Conclusion 
Testing the PCQ linguistically and for content validity in a setting of abnormal screening 
mammography until data saturation has resulted in a new questionnaire with 33 items instead of the 
original twelve items. This extended questionnaire covers more negative consequences of abnormal 
screening mammography than the original Australian version. However, it does not cover all 
possible long-term consequences of false positives. Before using the new instrument a validation 
study should be conducted to assess its psychometric properties. 
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8. Discussion of article 2 
8.1. Major findings 
The psychosocial consequences experienced in the critical period from abnormal screening 
mammography until final false-positive diagnosis differ in some respects from those experienced 
after having the final diagnosis. In this critical period women do not experience any positive 
psychosocial consequences, only negative consequences. 
The negative part of the Psychological Consequences Questionnaire (PCQ) (including 12 items) had 
six problematic items. Three of the items were found to be double-barrelled in meaning; that is, they 
asked two questions in one item. Three other items were ambiguous and could be misunderstood.  
Translating and adapting the negative part of the PCQ into Danish and reformulating the six 
problematic items into twelve non-ambiguous items resulted in an 18-item Danish version of the 
PCQ. These 18 items were all relevant for women having an abnormal screening result; however, 
the 18 items did not cover the large spectrum of negative psychosocial consequences experienced 
by the women. To cover these consequences 15 additional items were developed, resulting in a new 
33-item questionnaire. 
 
8.2. Assessment of methods 
8.2.1. Translation and adaptation 
It is not straightforward to translate a questionnaire from the original language and culture into 
another. Several pitfalls should be taken into account.  
1. Languages are changing over time and thereby the meaning of words and phrases. For 
example the word “gay” has changed dramatically over the recent decades.61  
2. Cultural differences may also create problems. For example a bag of sugar comes in 
different sizes of weight in different countries so asking “can you lift a bag of sugar?” is 
inconsistent from one country to another. 
3. A too literate translation may change the meaning of an item.77  A literal translation of the 
PCQ-item “I have been panicky” into Danish is “Jeg har været ved at gå i panik”. The 
meaning of “panicky” in English is close to being scared while the meaning of “panik” in 
Danish is close to being terrified. Another example from the Nottingham Health Profile 
(NHP)102 is the translation of the item “I’m waking up in the early hours of the morning” 
which in English means that you wake up at 1-2 a.m. but in Danish means that you wake up 
at 5-6 a.m.103 
4. Problems occur especially when metaphors or items formulated in jargon are translated 
because they are specific to a culture at a specific time age. For example, the item “I’m 
feeling on edge” is taken from the NHP that was developed in the United Kingdom in the 
1980s. This expression is nowadays obsolete in English and has been exchanged with “I‘m 
feeling edgy”. None of these two expressions make sense if translated literally into Danish. 
 
Therefore, questionnaires used over many years should be checked frequently to ensure that the 
meaning of the items and the instructions remain relevant.61  
If it is necessary during the translation and adaptation process to change an item and select more 
specific or simpler words, the meaning of the original item should be maintained.78 
In paper 2 the translation and adaptation process of the PCQ was conducted using a bilingual panel 
and a lay panel. In the bilingual panel the discussion of the pitfalls mentioned above was taken into 
account and discussed. As a result of the discussion consensus could not always be reached and the 
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bilingual panel suggested two or three alternatives for such items. It was then for the lay panel to 
decide which of the alternatives was closest to lay-Danish. For every item and instruction the lay 
panel was asked 
1. What do you think is the meaning of this question?  
2. Can you answer the question?  
3. Do you think it is necessary to rephrase this question? And if yes, how?  
These questions were also suggested to ensure the quality in the translation process.77 
For detailed information of the translation and adaptation process see appendix III (page 123). 
 
8.2.2. Assessment of content validity 
Before the focus group interviews were conducted, relevant literature was searched. There were two 
purposes for conducting this literature search: writing an interview-guide and reviewing the 
adequacy of measurement of short-term and long-term consequences of false-positive screening 
mammography (hereafter referred to as a false positive).104 Individual interviews with three women 
who had had a false positive were conducted to find important topics missing from the literature; 
issues about death, thoughts about funeral arrangements and writing a personal will were revealed.  
A well established method to develop new items, scales and questionnaires is to interview members 
of a target population either by conducting single interviews or focus group interviews.61 The target 
population is the optimal source of information on their conditions and experiences.61;105 In the 
present study, focus group interviews with women having a false positive were used to assess 
content validity. The women were grouped according to their additional examinations after 
abnormal screening mammography to avoid discussion on different examination procedures in the 
critical period. In the group interviews the moderator emphasised that all participants had had an 
abnormal screening mammography and, for example, a needle biopsy examination before the final 
diagnosis. The women could then focus on the feelings, thoughts and consequences they had 
experienced after the screening mammography.  
The group interviews began with an open-ended discussion to capture issues not described in the 
literature and not found in the pilot interviews. As a result of the open-ended discussions “sick-
leave” and “feeling less attractive” were revealed as new issues. Some women had been on sick-
leave in the critical period. In the groups including women who had had surgery the women were 
unhappy about the scar on their breast - especially if the skin surrounding the scar had an 
indentation. The women felt less attractive, both in a sexual and social context. For example, when 
undressing in a public swimming pool they felt less attractive compared to women with no breast 
deformities. The women also discussed that they would feel less attractive after a mastectomy.  
After the open-ended discussion the moderator introduced specific issues to be discussed in the 
groups. When discussing the issues about death, thoughts about funeral arrangements and writing a 
personal will the groups agreed that these issues would be unacceptable in a questionnaire in the 
setting of screening mammography. Therefore, items covering these issues were not included. 
However, the item “I have kept busy to take my mind off things” was found acceptable and non-
offensive. This item covers issues related to thoughts about death. In one of the group interviews a 
woman told the group that she had cleared up the whole house to push away her thoughts about 
death. Another had selected a burial plot with her husband. 
When issues about sexuality were discussed in the first group interview, none of the participants 
confirmed that they had experienced a change in their sexuality. Answers to speculations on why 
these women did not raise the topic of sexuality could be:  
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• this group of women did not experience any negative impact on their sexuality 
• the women found that a discussion about sexuality was taboo among unfamiliar women 
• the presence of a male interviewer was a hindrance 
Both authors felt that the women were too embarrassed discussing sexuality in the group. Therefore, 
in the next focus group it was decided that the male author should leave the interview while 
discussing sexuality. The female author then began a discussion about sexuality in general and 
turned the discussion into psychosexual consequences of screening mammography resulting in 
topics generating two new items. The topic of sexuality and the two sexuality-items were discussed 
in the following four group interviews with the male moderator participating and were found 
acceptable and not offensive. 
The PLISSIT model offers an approach to communicating with people about sexuality. The “P” in 
the model stands for “Permission” and is meant as a reassurance given by the interviewer to people 
that they are not abnormal or perverted and it is also a permission to talk about sexuality. In the 
second focus group the female author gave permission to talk about sexuality and in the following 
four group interviews the two sexuality items were the permission to talk about sexuality.106  
 
8.3. Justification of conclusion 
Six of the original negative PCQ-items were found ambiguous which might have disturbed the 
sensitivity of the original version of the PCQ. However, the 18 items in the Danish version of the 
negative part of the PCQ were all found to be relevant in the group interviews. Therefore, the 
negative part of the PCQ might capture some of the psychosocial consequences women are 
experiencing after an abnormal screening mammography.  
To cover more of the spectrum of the psychosocial consequences of abnormal screening 
mammography, 15 items were added to the Danish 18-item version of the measure. Some of these 
negative consequences covered by the 33 items may last after final diagnosis. However, the 33 
items were not equal to the specific consequences occurring after final diagnosis.  
The 33-item questionnaire can be regarded as a new instrument, because the Danish version of the 
PCQ has not been statistically validated and 15 new items have been added. Therefore, the 33-item 
questionnaire ought to be statistically tested for its psychometric properties before it is used. 
 
8.4. Contribution to the current knowledge 
Article 1 showed that surveys using the PCQ all consistently reported negative short-term 
psychosocial consequences of false positives.104 However, the results were ambiguous in surveys on 
long-term consequences. A reason for this inconsistency could be the lack of content coverage of 
the negative part of the PCQ:  
• in terms of negative psychosocial consequences of abnormal screening mammography 
• and measuring specific psychosocial consequences only relevant after final diagnosis 
The present study supports the conclusion of article 1: any conclusions about the long-term 
psychosocial consequences of false positives must remain tentative.104 
In two studies pain in the breast and reduced sexual sensitivity of the breast after surgery have been 
reported as consequences of false positives.107;108 These issues are not covered by the PCQ.52 In the 
present study the item, “felt less attractive” partly covers these issues.  
Increased frequency of breast self-examination has been reported as a consequence of false 
positives.62;99-101 No items in the PCQ ask about breast self-examination. In the present study two 
new items; “I have examined my breasts” and “I have examined my breasts in the mirror” were 
generated to cover the topic. 
9. Article 3 
Validation of a condition-specific measure for women having an abnormal screening 
mammography. Submitted 
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Abstract 
Objectives 
The aim of this study is to assess the validity of a new condition-specific instrument measuring 
psychosocial consequences of abnormal screening mammography (PCQ-DK33).  
Material and method 
The draft version of the PCQ-DK33 was completed on two occasions by 184 women who had 
received an abnormal screening mammography and on one occasion by 240 women who had 
received a normal screening result. Item Response Theories and Classical Test Theories were used 
to analyse data. Construct validity, concurrent validity, known group validity, objectivity and 
reliability were established by item analysis examining the fit between item responses and Rasch 
models. 
Results 
Six dimensions covering: anxiety, behavioural impact, sense of dejection, impact on sleep, breast 
examination and sexuality were identified. One item belonging to the dejection dimension had 
uniform differential item functioning. Two items not fitting the Rasch models were retained because 
of high face validity. A sick-leave item added useful information when measuring side effects and 
socioeconomic consequences of breast cancer screening. Five “poor items” were identified and 
should be deleted from the final instrument. 
Conclusion 
Preliminary evidence for a valid and reliable condition-specific measure for women having an 
abnormal screening mammography was established. The measure includes 27 “good” items 
measuring different attributes of the same overall latent structure – the psychosocial consequences 
of abnormal screening mammography. 
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Introduction 
If a woman follows the EU-recommended biannual breast cancer screening programme for twenty 
years her lifetime-risk for a false-positive screening mammography will be 20 - 25%, possibly even 
higher.1 In the UK, where three-yearly screening is offered to women aged 50 - 65, more than 
50.000 women per year will receive a false-positive screening mammography (hereafter referred to 
as a false positive).2 False positives cause significant adverse consequences including costly follow-
up tests and an increased use of health care services.3-5 In addition, numerous studies have shown 
that women recalled for further investigations after an abnormal screening mammography, later 
confirmed as a false positive, experience significant adverse psychosocial effects.6 In these studies a 
variety of questionnaires have been used to measure the adverse effects. Except for one 
questionnaire most of the instruments have been developed for other purposes and have a more or 
less generic character.7  
A requirement for the validity of a questionnaire is that it has high content relevance and high 
content coverage.8 A condition-specific measure insures higher content coverage compared to 
measures developed for generic conditions.9 A review has shown that some of the most frequently 
used generic measures in the setting of breast cancer screening: the General Health Questionnaire, 
the Hospital Anxiety and Depression Scale and the State-Trait Anxiety Inventory, have problems 
with language, content relevance and content coverage.7 McCaffery and Barrat underline the 
importance of high content validity when using questionnaires to measure psychosocial 
consequences of screening.10 
The Psychological Consequences Questionnaire (PCQ) was developed in 1992 by Jill Cockburn to 
measure the short-term psychosocial consequences of the actual act of participation in breast cancer 
screening. It consists of twelve items covering negative aspects and ten items covering positive 
aspects of participation.11 The full PCQ (negative and positive items) has been used in only one 
study of the process of participating in breast cancer screening.12 The negative items have 
predominantly been used in studies of the adverse consequences of false positive and not of the 
consequences of the actual participation.6 However, the content validity of the PCQ has never been 
tested in the setting of abnormal and false positive screening mammography.7  
When summing raw scores of items in a scale an assumption of unidimensionality is made. That is 
that the items describe different aspects of the same construct and can be added.13;14 When the 
response options are categorical on an ordinal scale as in many questionnaires Item Response 
Theory (IRT) and Rasch models can be used to assess the psychometric properties of the 
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questionnaire. The Rasch models provide formal representation of perfect measurement. Where 
items are shown to fit a Rasch model the measure can be shown to posses criterion-related construct 
validity,15 to be objective,16 sufficient17 and, therefore, also reliable.18 If a measure has specific 
objectivity comparison between two persons with one part of a scale does not differ systematically 
from comparisons using another set of valid items from the scale. Similarly, comparison of two 
persons should not depend on measurements on other persons.16 For these reasons the Rasch model 
is considered a valuable “gold standard” against which measures should be compared. Reliability 
and different aspects of validity can also be assessed using Classical Test Theory (CTT).8 The 
relation between CTT and IRT has been described by Holland and Hoskens19 and it may be an 
advantage to combine the two theories. Item analyses by Rasch models explore in depth the degree 
to which the requirements of construct validity are met. Items are assumed to monotonically relate 
to one dimension and they are assumed to be locally independent. It is also assumed that there is no 
differential item functioning (DIF) that is, where an item functions differently in subpopulations 
such as in an intervention group and a control group.15;20 The sufficiency of the model support 
computation of the raw scores. IRT analyses also explore how the items included in each dimension 
are interrelated and ordered on a latent trait (e.g. psychosocial consequences of a false positive).21 
The strength of analyses based on the Rasch Model is that the model is build on pre-assumptions 
closer to reality than analyses based on Classical Test Theory.14;21 The Rasch models describe how 
item responses depend both on person and item parameters. The person parameter is assumed to be 
unidimensional but item parameters may be multidimensional when item responses are ordinal 
categories.  
The purpose of this study was to validate a new condition-specific instrument measuring 
psychosocial consequences of abnormal screening mammography (PCQ-DK33) using both IRT and 
CTT. 
 
Material and methods 
A qualitative study to assess the content validity of the PCQ was conducted in a setting of abnormal 
screening mammography. The qualitative study highlighted the need to make radical changes to the 
questionnaire if it was to be used in this setting. Therefore, the draft version of the questionnaire 
statistically tested in the present study can be regarded as a new condition-specific instrument with 
33 items (PCQ-DK33, see the summary in table 4). 
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Data were collected at two screening centres: the Copenhagen University Hospital and Odense 
University Hospital. 
Group 1 - Time I. Over a period of 20 weeks from November 2002 all women who were recalled 
because of an abnormal screening mammography were consecutively included in the study. Before 
any further examinations to establish if the abnormal screening result was true or false the women 
were asked to complete two questionnaires: 1) the PCQ-DK33 with the items randomly ordered and 
2) the Danish version of the Nottingham Health Profile (NHP).  
The NHP is a questionnaire measuring health status. It was originally developed in the UK22 and 
has been adapted into a large number of languages including Danish.23;24 The NHP consists of six 
sections covering energy, pain, emotional reaction, sleep, social isolation and physical mobility. It 
was selected as a comparator to assess concurrent validity8 for the present study because emotional 
reactions and sleep problems are well covered by the measure. It was hypothesised that the new 
instrument measuring psychosocial consequences of abnormal screening mammography would 
converge with the emotional section of the NHP and diverge from the pain and mobility sections. 
Group 1 -  Time II. Two weeks after having completed the first questionnaire package the women 
were sent the draft version of the PCQ-DK33. At this point most of the women would know if their 
abnormal screening result was false positive or if they had breast cancer. They were asked to 
complete the questionnaire and return it in an enclosed stamped addressed envelope. It was 
hypothesised that women diagnosed with breast cancer experienced more severe psychosocial 
consequences than women with a known false-positive screening result (known group validity and 
responsiveness).8;25 It was also hypothesised that there would be a decrease in the negative 
psychosocial consequences from abnormal to known false-positive screening result. 
Group 2. For each woman in Group 1 who had completed the questionnaires at Time I another two 
women were sent the draft version of the PCQ-DK33 and asked to return the completed 
questionnaire in an enclosed stamped addressed envelope. These women had had a normal 
screening mammography at the same time and at the same clinic as the women in Group 1, Time I. 
The recruitment procedure for women in Group 2 was: if the screening mammography of a woman 
was abnormal then the two women having a normal screening mammography and being screened 
just before and after this woman were included in Group 2. In contrast to Group 1, where informed 
consent was obtained at the recall clinics, it was not possible to obtained informed consent before 
posting the test-questionnaire to the women in Group 2. For ethical and legal reasons the test-
questionnaire was posted to the women by the screening clinics anonymously and only the age of 
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the participants was disclosed for the researchers. Therefore, it was not possible to send reminders 
to the women in Group 2. It was hypothesised that women with an abnormal screening result 
experienced more severe psychosocial consequences than women with a normal screening result 
(known group validity).8;25 
In Group 1 – Time I, 220 women were eligible. Of these, 16 (7.3%) were not invited to participate 
due to sick leave among the clinic staff. Of those asked to participate 90.2% agreed to complete the 
questionnaires. At Time II, 90.8% returned the PCQ-DK33 after one reminder. In Group 2, 400 
women received the questionnaire by post and 60% were returned. There were no statistically 
significant differences in mean and range of age between the women in the three groups. Figure 1 
illustrates the data collection including the numbers of women in each subgroup.  
 
Figure 1. Data collection of the PCQ-DK33 
 
 
 
 
 
 
 
Three questionnaires were returned without being completed. Among the remaining 588 
questionnaires 0.3% - 1.9% randomly distributed missing values per item were observed.  
Item responses were analysed by the conditional distribution of items given total person scores in 
order to avoid assumptions on the distribution of the latent trait being measured. The pairwise 
estimation procedure implemented in software program RUMM2020 was used to estimate the item 
parameters.26;27 The analysis of the fit of item responses to the Rasch model were based on analyses 
of residuals comparing observed to expected item responses, both for separate individuals and for 
different score groups. The overall fit of the model was assessed by the Wright-Panchapakesan χ2 
statistic summarising standardised residuals over score groups and items.28 Item fit statistics 
summarising standardised residuals in different score groups were used to identify misfitting items. 
Data from Group 1, Time I and Time II and data from Group 2 were pooled for IRT analyses. 
However, the sick-leave item was not included in the Rasch analyses because the response options 
2 weeks later 
Group 1, Time II 
167 of 184 women with: 
• 89 false-positive  
• 61 breast cancer 
• 17 undiagnosed Group 2 
240 women with normal 
screening mammography 
Group 1, Time I 
184 women with abnormal 
screening mammography 
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differed entirely from the response options in the remaining 32 items. Differential item functioning 
relative to person covariates was checked by analyses of variance examining the degree to which 
individual residuals for specific items depended on the covariates. Absence of evidence of 
interaction between the covariates and the estimated trait parameters were taken as evidence of DIF 
being uniform. A small subgroup of 17 women undiagnosed two weeks after their abnormal 
screening mammography was not included in the analyses of DIF. 
Finally, the assumption of local independence was checked by examination of the degree to which 
individual residuals were correlated.   
Reliability was assessed by Cronbach’s alpha defining the lower bound for the test-retest correlation 
of the raw scores29;30 and by the so-called Person Separation Index calculating the lower bound for 
the test-retest correlation of the estimated values of the latent trait being measured.31  
Data were analysed with CTT by using the software SPSS for Windows version 13.0 and the 
software Mplus 2.14 for confirmatory factor analysis.32 For IRT analyses the software RUMM2020 
was used. 26  
The study was approved by the local ethical committee. 
 
Results 
The initial item analysis of the complete set of 32 items rejected the Rasch model. Strong evidence 
of local dependence indicated that the PCQ-DK33 was not unidimensional. The subsequent separate 
analyses confirmed the multidimensionality expected from the qualitative study on face and content 
validity of the instrument.  
Six items covering anxiety formed one dimension and none of these items had DIF in either of the 
subgroups. In one of the six items, “felt terrified” (no 29), the thresholds of the response categories 
were not in order (figure 2). Of eight items covering the impact on behaviour after abnormal 
screening mammography, seven items fitted the Rasch model and no DIF was observed. Among the 
seven behavioural items the thresholds of item “difficulty doing everyday things around the house” 
(no 28) were not in order (figure 3). Six items describing the sense of dejection and sadness after 
abnormal screening mammography fitted the Rasch model forming one dimension. However, the 
item “felt sad” (no14) had uniform DIF in two of four subgroups as shown in figure 4. After 
deleting this item the five remaining items still fitted the Rasch model with all thresholds in order 
and no DIF.  
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Figure 2. Category Probability Curve of item 29 “terrified” 
 
The logit scale from -2 to +8 on the x-axis symbolises the latent trait of anxiety, with the severity of 
anxiety increasing towards the right. The y-axis symbolises the probability of affirming the 
response categories: 0 “not at all”, 1 “a bit”, 2 “quite a bit” and 3 “a lot”. 
 
 
Figure 3. Category Probability Curve of item 28 “difficulty doing things around the house” 
 
The logit scale from -3 to +4 on the x-axis symbolises the latent trait of behavioural impact, with 
the severity of negative impact increasing towards the right. The y-axis symbolises the probability 
of affirming the response categories: 0 “not at all”, 1 “a bit”, 2 “quite a bit” and 3 “a lot”. 
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Figure 4. Item characteristics curves (ICC) of item 14 “felt sad” showing uniform differential item 
functioning (no statistical significant difference between the slopes of the three ICC) between the 
group of women diagnosed with breast cancer (i14bc), the group of women having normal 
screening mammography (i14no) and the remaining women – women having abnormal and a false 
positive screening mammography (i14re). 
 
The logit scale from -7 to +5 on the x-axis symbolises the latent trait of sense of dejection, with the 
severity of dejection increasing towards the right. The y-axis symbolises the values of responses 
options: 0 “not at all”, 1 “a bit”, 2 “quite a bit” and 3 “a lot”. Locn symbolises the item location. 
 
 
From a content perspective the Rasch analyses confirmed three more dimensions each with two 
items. These three dimensions described impact on breast examination, sleep and sexuality. 
However, in the breast examination dimension both items had uniform DIF. The item “examined 
my breasts” (no 16) had uniform DIF in the group diagnosed with breast cancer compared to the 
remaining groups (figure 5) and the item “examined my breasts in the mirror” (no 21) had uniform 
DIF in the group with normal screening mammography compared to the remaining groups (figure 
6). In the sexuality dimension the thresholds of the item “less interest in sex” (no 31) were not in 
order (figure 7).  
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Figure 5. Item characteristics curves (ICC) of item 16 “examined my breasts” showing uniform 
differential item function (no statistical significant difference between the slopes of the two ICC) 
between the group of women diagnosed with breast cancer (i16bc) and the remaining women – 
women having an abnormal, a false positive and a normal screening mammography (i16re). 
 
The logit scale from -6 to +4 on the x-axis symbolises the latent trait of breast examination, with the 
severity of breast examination increasing towards the right. The y-axis symbolises the values of 
responses options: 0 “not at all”, 1 “a bit”, 2 “quite a bit” and 3 “a lot”. Locn symbolises the item 
location. 
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Figure 6. Item characteristics curves (ICC) of item 21 “examined my breasts in the mirror” showing 
uniform differential item functioning (no statistical significant difference between the slopes of the 
three ICC) between the group of women with a normal screening mammography (i21no) and the 
remaining women – women having an abnormal, a false positive and true positive (breast cancer) 
screening mammography (i21re). 
 
The logit scale from -6 to +4 on the x-axis symbolises the latent trait of breast examination, with the 
severity of breast examination increasing towards the right. The y-axis symbolises the values of 
responses options: 0 “not at all”, 1 “a bit”, 2 “quite a bit” and 3 “a lot”. Locn symbolises the item 
location. 
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Figure 7. Category Probability Curve of item 31 “not felt like having my breast caressed” 
 
The logit scale from -5 to +4 on the x-axis symbolises the latent trait of sexuality, with the severity 
of negative impact of sexuality increasing towards the right. The y-axis symbolises the probability 
of affirming the response categories: 0 “not at all”, 1 “a bit”, 2 “quite a bit” and 3 “a lot”. 
 
 
Besides testing the six identified dimensions for differential item function in the sampled groups 
(figure 1), DIF was also tested for age and screening centre. These tests showed no DIF. 
There was no local dependency among the items in the identified dimensions. 
The two sleeping items fitting the Rasch model and the item “taking sleeping tablets” are from a 
content point of view equal to three of the five items included in the sleep section of the NHP. 
Rasch analyses of the sleep section of the NHP showed that four of the five sleeping items fitted the 
Rasch model except for the sleeping-tablet item. 
The Wright-Panchapakesan Chi Squared fit Statistics, the Person Separation Index and the 
Cronbach’s alpha of the six dimensions fitting the Rasch model in the PCQ-DK33 are listed in 
Table 1. The fit statistic of the behavioural subscale is marginally significant (p = 0.039). Adjusting 
p-values in order to control the false discovery rate and so avoid spurious significant results due to 
multiple testing suggested that the result should be regarded as insignificant.33 
 
 62 
Table 1. Wright-Panchapakesan (WP) Fit statistics, Person Separation Index and the Cronbach’s 
alpha of six dimensions in the PCQ-DK33 
Dimensions 
(Number of items) 
WP 
χ2
Degrees of 
freedom 
p Person 
Separation 
Index 
Cronbach’s 
alpha 
Anxiety (6) 61.81 52 0.166 0.94 0.92 
Behavioural (7) 67.71 49 0.039 0.88 0.86 
Sense of dejection (5) 55.14 40 0.056 0.93 0.89 
Sleep (2) 8.49 9 0.486 0.89 0.90 
Breast examination (2 
or 4*) 
19.60(28.34*) 8(21*) 0.01(0.131*) 0.68(0.70*) 0.71 
Sexuality (2) 7.06 10 0.720 0.81 0.83 
*after item split according to the uniform DIF found. 
 
For each subgroup table 2 shows the mean score, the standard error of mean and the standard 
deviation for all six dimensions fitting the Rasch model. 
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Table 2. Mean scores. standard error of mean. and standard deviation of all six dimensions 
Anxiety 
 
Behavioural Dejection Dimensions 
A B C D E A B C D E A B C D E 
No** 178 52 97 16 232 173 50 97 16 231 179 52 96 15 234 
Mean 6.39 7.38 3.04 4.38 0.97 3.53 4.96 1.72 3.63 0.47 5.38 6.10 2.25 3.73 1.03 
S.E. Mean 0.36 0.73 0.42 1.24 0.13 0.28 0.61 0.27 1.04 0.11 0.29 0.60 0.34 1.14 0.12 
Std. deviation 4.77 5.30 4.18 4.95 2.00 3.68 5.30 2.63 4.16 1.63 3.94 4.33 3.29 4.42 1.84 
 
Sleep Breast examination Sexuality Dimensions 
A B C D E A B C D E A B C D E 
No** 179 52 97 16 235 181 52 97 16 235 173 50 97 16 235 
Mean 2.10 2.48 1.10 1.63 0.33 2.2* 1.7* 1.1* 1.1 0.7* 0.84 1.08 0.62 0.94 0.15 
S.E. Mean 0.15 0.34 0.18 0.46 0.06 0.1# 0.2# 0.1# 0.36 0.1# 0.11 0.26 0.15 0.46 0.04 
Std. deviation 2.00 2.43 1.73 1.82 0.94    1.44  1.50 1.82 1.43 1.84 0.67 
A) Group 1 - Time I B) Group 1 - Time II, women diagnosed with breast cancer. C) Group 1 - Time II, 
women with known false positive D) Group 1 - Time II, women undiagnosed. E) Group 2 
**Number of subjects included in the Rasch analyses. *Mean scores are estimated from the means of the 
person locations on the latent trait according to the uniform DIF found in item 16 &21. 
# The Standard Errors of Means (S.E. mean) are estimated from the S.E. means of the person locations. 
 
Items numbered 1, 7, 9, 10, 25, 27 and 30 did not fit the Rasch model. The face validity of these 
items was checked by re-auditing tape recordings from the focus group interviews conducted during 
the adaptation of the PCQ into Danish. The item “less attractive” (no 1) and the item “busy to take 
mind off things” (no 10) had significant face validity for women who had had surgery or had been 
on early recall after abnormal screening mammography.  
Cronbach’s alpha increased when deleting items 7, 25, 27 and 30 and dropped when deleting items 
1, 9 and 10. This indicated that items 7, 25, 27 and 30 were “poor” items because alpha is expected 
to decrease when valid items are deleted from a summated score. 
A subsequent confirmatory factor analysis was conducted to estimate how the six dimensions and 
the three single items (no’s 1, 10 and 14) were correlated. The analysis revealed a positive 
correlation between all six dimensions and the three single items. Only very weak evidence was 
disclosed against a model assuming that one latent trait lies behind the six dimensions and the three 
single items of the PCQ-DK33 (p = 0.0463). 
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When testing for known group validity a statistically significant difference was found between 
women having an abnormal screening mammography and those having a normal screening 
mammography. In all six dimensions and in the three single items the p-value of the Pearson Chi-
Square was less than 0.0005. In the single item about sick leave (no 33) the p-value was 0.026.  
There was a statistically significant difference between women diagnosed with breast cancer and 
those having a known false positive in five of the six dimensions and in the three single items (no’s 
1, 10 and 33) with the highest p-value as 0.016. The sexuality subscale could not differ between 
women diagnosed with breast cancer and those having a known false-positive screening result. 
Additional analyses on the sexuality subscales found no statistically significant difference between 
women having an abnormal screening mammography and those diagnosed with breast cancer. They 
also showed no difference between women having an abnormal screening mammography and those 
with a known false positive. 
As a test of concurrent validity the Pearson Correlation was established between the sections of the 
NHP and all the 27 “good” items (24 items in the six identified dimensions and items 1, 10 and 14). 
The Pearson Correlation was also established for each of the six Rasch-fitting dimensions. The 
results confirmed the hypothesis made before the analysis (table 3). 
 
Table 3. Concurrent validity (convergent and divergent validity) of 27 “good” items and the six 
identified dimensions of the PCQ-DK33 and the sections of the NHP at Time I - Group 1. 
NHP sections 27 “good” items Anxiety Behavioural Dejection Sleep Breast examination Sexuality 
Energy level 0.43 0,30 0,49 0,37 0,30 -0,05 0,30 
Pain 0.15 0,15 0,14 0,13 0,14 -0,13 0,09 
Emotional reaction 0.70 0,65 0,68 0,67 0,55 0,15 0,35 
Sleep 0.48 0,38 0,40 0,39 0,69 0,12 0,20 
Social isolation 0.26 0,27 0,29 0,24 0,25 0,01 0,11 
Physical mobility 0.16 0,10 0,17 0,10 0,10 -0,17 0,13 
The correlations are calculated as coefficients from the Pearson Correlation. 
 
A summary of the results from the psychometric analyses of the PCQ-DK33 are given in table 4. 
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Discussion 
Six Rasch-fitting dimensions were identified encompassing 24 items. The dimensions cover: 
anxiety, behavioural impact, sense of dejection, impact on sleep, breast examination and sexuality. 
The six dimensions had sufficient sensitive to distinguish between groups a prior hypothesised to 
be different. The correlations between the six Rasch-fitting dimensions and the NHP were also as 
could be expected from a content point of view.  
Two items not fitting the Rasch models were retained in the questionnaire because of high face 
validity. These were concerned with “feeling less attractive” and “kept busy to take mind off 
things”. An item “felt sad” belonged to the dejection dimension but had uniform DIF relative to 
diagnostic subgroups. The six dimensions and these three single items converged as expected with 
the emotional section of the NHP and diverged as expected with the pain and the physical mobility 
sections. 
The sick-leave item was not included in the original Australian version of the PCQ. However, it 
seems to add useful information when measuring side effects and socioeconomic consequences of 
breast cancer screening.  
Five “poor items” were identified. Four of these misfitted the Rasch model and had low face 
validity. Cronbach’s alpha also increased when they were deleted. The fifth “poor” item “being 
tired” showed an unclear picture. Although, it did not fit the Rasch model and had low face validity, 
Cronbach’s alpha dropped when it was deleted. Perhaps “being tired” describes a too general 
condition. Therefore, it is suggested that the five “poor” items should be deleted from the final 
instrument. It is worth mentioning that one of the “poor” items “keeping things from those who are 
close to you” is an item belonging to the original Australian version of the PCQ.11 
Collecting questionnaire data under two different conditions may result in biases. At Time I, the 
women completed the PCQ-DK33 at the recall clinic. Two weeks later at Time II the same women 
completed the PCQ-DK33 at home. Some women had the additional examinations at the recall 
clinic only one day after receiving the letter about the abnormal screening mammography. This 
short time interval made it necessary to complete the questionnaires at the recall clinic instead of 
receiving it by post. Women completing a questionnaire at a clinic may “smarten up” their answers 
to be polite. Therefore, the negative psychosocial consequences of an abnormal screening 
mammography would most likely be underestimated.  
Three items showed differential item functioning relative to diagnostic subgroups. If an item 
functions differently in subpopulations other psychometric properties should determine the 
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“destiny” of the item. The qualitative study preceding the present study showed that the two items 
forming the breast examination dimension cover an important area in the context of abnormal and 
false-positive screening mammography. The results from the concurrent validity tests confirmed 
that the breast examination dimension measured something different from the other five 
dimensions. Consequently, it would be unwise to remove these items. However, special precautions 
should be taken when calculating scores of this dimension. The content of the item “being sad” is 
close to the content of the other five items in the dejection dimension. Therefore, it seems 
reasonable to delete this item if future studies continuously show DIF. 
Three items from three different dimensions had problems with the order of thresholds. As seen in 
figures 2, 3 and 7 the disorder was caused by minor problems. If future studies show the same 
pattern it has to be decided if the response categories “A bit” and “Quite a bit” should be merged 
either by rescoring the items or re-designing the layout. 
Two items belonging to two different dimensions showed a marginal misfit of probability to the 
Rasch model (no’s 19 & 26, table 4). However, the overall fit of the dimensions were satisfactory. 
Future studies including the questionnaire will show if these findings are consistent. 
It was surprising that the sexuality dimension only distinguished between women having a normal 
and women having an abnormal screening mammography. This may indicate that the negative 
impact on sexuality after having an abnormal screening result had not declined or vanished one or 
two weeks after women were “free from” cancer suspicion.  
The convergence between the dimensions of anxiety, behaviour and dejection and the emotional 
section of the NHP indicates some overlap between these three dimensions. Only longitudinal 
studies will reveal if this overlap is caused by redundancy. However, removing any of the 
dimensions would decrease content coverage. The lack of convergence between the two dimensions 
“breast examination” and “sexuality” and the emotional section of the NHP contradicts redundancy 
among the six dimensions.  
The establishment of a traditional test-retest reliability coefficient requires at least two to four 
weeks where the condition for the respondents is stable.8;25 The condition for the women in Group 1 
changed dramatically from Time I to Time II. At time I all women had been told that their screening 
result was abnormal. At time II nearly all women knew their diagnosis: breast cancer or false-
positive. A satisfactory reliability of the measure was assessed with Cronbach’s alpha and Person 
Separation Index (table 1). 
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As shown in the Rasch analyses; four of five NHP sleep-items fitted the model. Two of the four 
items are content-wise equivalent to the two Rasch-fitting items of the PCQ-DK33. Therefore, 
adapting the two non-equivalent sleep-items from the NHP would probably add nuances to the sleep 
dimension of the new instrument.  
As in many other questionnaires, the response options of the PCQ-DK33 are ordered categories. 
Several models for ordinal categorical responses have been suggested. The model used in the 
present study is the partial credit model (PCM) in which the item parameters are sometimes 
described as threshold parameters.34 The thresholds in the PCM may differ between items. In 
contrast, the rating scale model assumes that thresholds are homogenous across items apart from an 
additive factor describing the item difficulty.35 Rating scale models were considered during the 
analysis but abandoned because of lack of fit between the model and the observed item responses.  
The present study has shown the advantages of combining analyses based on IRT and CTT when 
assessing the psychometric properties of a questionnaire including dimensionality and “good” and 
“poor” single items. After establishing unidimensionality with the Rasch model CTT analyses were 
subsequently conducted. This order of analyses had several advantages: Firstly, more than half of 
the Rasch-misfitting items were confirmed also to be “poor” by the analyses of Cronbach’s alpha. 
Secondly, the internal consistency expressed as a Cronbach’s alpha coefficient was calculated only 
on items included in the Rasch-fitting dimensions. Thirdly, the results of testing known group 
validity and concurrent validity were only established on “good” items. 
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Conclusion and perspectives 
In conclusion, the reliability and the construct validity of a condition-specific measure with high 
content validity for women having an abnormal screening mammography have been preliminary 
demonstrated. This new questionnaire covers the impact of experiencing an abnormal screening 
mammography on: anxiety, behaviour, dejection, sexuality, sleep and breast examination. In 
addition, the measure includes three single items covering: sick leave, feeling less attractive and 
kept busy to take mind off things.  
The new instrument is currently in use in a major Danish survey and has been translated into Dutch, 
English and Norwegian. Future analyses on data from surveys will hopefully give an answer to the 
questions left from the present study:  
• should all the three single items be retained in the final version of the measure? 
• do the four items covering sleep form one dimension? 
• will the item “felt sad” still have uniform DIF? 
• will some items still have threshold that are not in order? 
 
Acknowledgement 
We are in great debt to the late professor Jill Cockburn for her inspiration and strong supported of 
developing a condition-specific measure of psychosocial consequences of abnormal and false-
positive screening mammography. We want to thank the staff at the breast cancer screening clinic 
and the recall clinic at the Copenhagen University Hospital and at the Odense University Hospital 
for recruiting women to this study. 
 71
  
Reference List 
 
 1.  Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false 
positive screening mammograms and clinical breast examinations [see comments]. New 
England Journal of Medicine 1998;338:1089-96. 
 2.  NHS Cancer Screening Programmes. http://www.doh.gov.uk/public/sb0201.htm . 2003.  
 
 3.  Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC. The Economic 
Impact of False-Positive Cancer Screens. Cancer Epidemiol Biomarkers Prev 
2004;13:2126-32. 
 4.  Lidbrink E, Elfving J, Frisell J, Jonsson E. Neglected aspects of false positive findings of 
mammography in breast cancer screening: analysis of false positive cases from the 
Stockholm trial [see comments]. BMJ 1996;312:273-6. 
 5.  Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased patient 
concern after false-positive mammograms: clinician documentation and subsequent 
ambulatory visits. J.Gen.Intern.Med. 2001;16:150-6. 
 6.  Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of 
mammographic screening. A systematic review. Psychooncology. 2005;14:917-38. 
 7.  Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term 
consequences of false-positive screening mammography. Journal of Medical Screening 
2004;11:39-44. 
 8.  Streiner DL, Norman GR. Health measurement scales: A practical guide to their 
development and use. Oxford: Oxford University Press, 1995. 
 9.  Doward LC, Meads DM, Thorsen H. Requirements for Quality of Life Instruments in 
Clinical Research. Value in Health 2004;7:S13-S16. 
 10.  McCaffery KJ,.Barratt AL. Assessing psychosocial/quality of life outcomes in screening: 
how do we do it better? J Epidemiol Community Health 2004;58:968-70. 
 11.  Cockburn J, De LT, Hurley S, Clover K. Development and validation of the PCQ: a 
questionnaire to measure the psychological consequences of screening mammography. 
Social Science & Medicine 1992;34:1129-34. 
 12.  Lightfoot N, Steggles S, Wilkinson D., Bissett R., Bakker D., Darlington G. et al. The short-
term psychological impact of organised breast cancer screening. Current Oncology 
(Toronto, 1198-0052) 1994;1:206-11. 
 72 
 13.  Wright BD. Fundamental measurement for psychology. In Embretson SE, Hershberger SL, 
eds. The new rules of measurement: What every psychologist and educator should know, pp 
65-104. Mahwah, New Jersey and London: Lawrence Erlbaum Associates, 1999. 
 14.  Andrich D. Controversy and the Rasch model: a characteristic of incompatible paradigms? 
Med Care 2004;42:I7-16. 
 15.  Rosenbaum PR. Criterion-related construct validity. Psychometrika 1989;54:625-33. 
 16.  Rasch G. An Informal Report on a Theory of Objectivity in Comparisons. In Van der Kamp 
LJTh, Vlek CAJ, eds. Psychological Measurement Theory, pp 1-19. Leyden: University of 
Leyden, 1967. 
 17.  Andersen EB. Sufficient Statistics and Latent Trait Models. Psychometrika 1977;42:69-81. 
 18.  Bartholomew DJ. The Statistical Approach to Social measurement. San Diego: Academic 
Press, 1996. 
 19.  Holland PW,.Hoskens M. Classical Test Theory as a first-order Item Response Theory: 
application to true-score prediction from a possibly nonparallel test. Psychometrika 
2003;68:123-49. 
 20.  Holland PW, Wainer H. Differential Item Functioning. In Hilsdale NJ, ed. Lawrence 
Erlbaum Associates, 1993. 
 21.  Andrich D. Understanding resistance to the data-model relationship in Rasch's paradigm: a 
reflection for the next generation. J Appl.Meas. 2002;3:325-59. 
 22.  Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and 
epidemiologists. J R.Coll.Gen.Pract. 1985;35:185-8. 
 23.  Thorsen H, McKenna SP, Gottschalck L. The Danish version of the Nottingham Health 
Profile: its adaptation and reliability. Scand.J Prim.Health Care 1993;11:124-9. 
 24.  Thorsen H, McKenna SP, Gottschalck L. Perceived health in three groups of elderly people. 
A validity study of the Danish version of the Nottingham Health Profile. Dan.Med Bull. 
1995;42:105-8. 
 25.  McDowell I., Newell C. Measuring Health. A guide to rating scales and questionnaires. 
Oxford: Oxford University Press, 1996. 
 26.  Andrich, D., Sheridan, B., and Luo, G. RUMM2020. (Version 4.0 for Windows). 2005.  
RUMM Laboratory Pty Ltd. http://www.rummlab.com/.  
 
 27.  Andrich D,.Luo G. Conditional pairwise estimation in the Rasch model for ordered response 
categories using principal components. J Appl.Meas. 2003;4:205-21. 
 28.  Wright BD,.Panchapakesan N. A Procedure for Sample-free Item Analysis. Educational and 
Psychological Measurement 1969;29:23-48. 
 73
 29.  Cronbach LJ. Coeffcient alpha and the internal structure of tests. Psychometrika 
1951;16:297-334. 
 30.  Cronbach LJ. Internal consistency of tests: analyses old and new. Psychometrika 
1988;53:63-70. 
 31.  Smith EV, Jr. Evidence for the Reliability of Measures and Validity of Measure 
Interpretation: A Rasch Measurement Perspective. In Smith EV, Jr., Smith RM, eds. 
Introduction to Rasch Measurement. Theory, Models and Applications, pp 93-122. Maple 
Grove: JAM Press, 2004. 
 32.  Muthén, L., Muthén, B., Asparouhov, T., and Nguyen, T. Mplus. 2.14. 2005.  
http://www.statmodel.com/.  
 
 33.  Benjamini Y,.Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful 
Approach to Multiple Testing. Journal of the Royal Statistical Society.Series B 
1995;57:289-300. 
 34.  Masters GN. A Rasch Model for Partial Credit Scoring. Psychometrika 1982;47:149-74. 
 35.  Andrich D. A Rating Formulation for ordered Response Categories. Applied Psychological 
Measurement 1978;2:581-94. 
 
 
 
 74 
 75
10. Discussion of article 3 
 
10.1. Major findings 
Six Rasch-fitting dimensions encompassing 24 items covering; anxiety (6 items), behavioural 
impact (7 items), sense of dejection (5 items), impact on sleep (2 items), breast examination (2 
items) and sexuality (2 items) were identified among the items of the PCQ-DK33 (appendix IV, 
page 136 & appendix V, page 141).  
In addition two items not fitting the Rasch model were retained as single items in the questionnaire 
because of high face validity. One item “felt sad” belonged to the dejection dimension but had 
uniform differential item functioning relative to two of four diagnostic subgroups. Altogether these 
27 “good” items plus a sick-leave item, measure different attributes of the same overall latent 
construct – the psychosocial consequences of abnormal screening mammography. 
Five “poor items” were identified and should be deleted from the final instrument. 
For details see Table 4 in article 3 and the flow chart on page 103. 
 
10.2. Assessment of methods 
10.2.1. Data collection 
At the screening recall clinics the women had a table to sit at when completing the questionnaires. 
In Copenhagen the table was placed in a corridor remote from the normal waiting area. In Odense, 
the women were offered a more private separate room. Despite the two different conditions there 
was no statistically significant difference in the degree of negative psychosocial consequences of 
abnormal screening mammography measured at the two recall clinics.  
The difference in response rates between Group 1 and Group 2 may have different reasons: 
• the motivation for completing the PCQ-DK33 might have been greater among women 
having an abnormal screening mammography compared to women having a normal 
mammography 
• it might be easier not to participate in a survey when you are posted a questionnaire than 
when you are asked at a clinic 
• the women in Group 2 were not posted a reminder 
It would have been preferable to use the same administration procedures in the two groups and at 
the two different time points for Group 1.  
The procedures had to be accepted due to logistical, practical, ethical and legal issues. Nevertheless, 
they might have caused biases. However, such biases would most likely minimise the differences 
actually found between the psychosocial consequences of abnormal screening mammography 
compared to consequences of normal screening mammography.  
The women having a normal screening result were recruited according to which day and at which 
screening clinic they had an abnormal screening mammography. Women were invited to attend 
screening from the city of Copenhagen and from the council of Funen (Odense University Hospital) 
according to their permanent home addresses. At both screening centres the invitations are posted in 
clusters so that in the same period of time (days or weeks) the women aged 50 – 69 living in the 
same local area are invited. In the Funen council screening takes place in two different settings: at a 
screening centre at the University Hospital in the city of Odense and in a specially equipped 
screening-bus driving from one town to another and on the smaller Islands belonging to the council 
of Funen. There is no reason to believe that there would be any differences in income or education 
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levels between the groups and subgroups of women. The cluster-invitation procedure even makes 
differences in social groups less possible. 
 
10.2.2. Statistical methods in general 
Data were input manually by one person and proof-read by two other persons. The manual search 
for errors in the input of data showed 0.20% mistakes which were corrected before analyses.  
The main statistical method used to explore the psychometric properties of the PCQ-DK33 was the 
Rasch model (page 23). The Rasch model is a valuable tool for identifying dimensions and “poor” 
items of a questionnaire, for example when dealing with the items encompassing “sleep” in the 
present study: 
 
10.2.2.1. Sleep items 
Three items about sleeping problems were generated during the focus group interviews when the 
PCQ-DK33 was developed.109 While two of these items fitted the Rasch model the third item, 
“taking sleeping tablets”, did not. In the PCQ-DK33 the sleeping items have four response 
categories. In the NHP the items are dichotomous. The five sleeping items in the NHP were also 
analysed using the Rasch model. Four of the five NHP-sleeping items fitted the model. The content 
of the NHP-sleep item that did not fit the Rasch model was “taking sleeping tablets”. Therefore, the 
item “taking sleeping tablets” was regarded as a “poor” item as it did not measure the same 
construct as the other sleep items in both questionnaires. However, if the content of the item “taking 
sleeping tablets” had high face validity for women having an abnormal screening mammography 
the item could have been kept as a single item.  
 
10.2.2.2. Response categories and threshold order 
The Rasch model also explores the order of the response categories of the items. In the present 
study three items (no 28, 29 and 31) in three different dimensions (anxiety, behavioural impact and 
sexuality) had disordered response categories. The overall fit statistics of the three dimensions were 
sufficient. Therefore, the disorder of the response categories does not seem to be a matter of an 
illogical response pattern of the items. Item 28 and 29 are “extreme” items measuring the severest 
negative impact on the behavioural and anxiety latent variables respectively. It is possible that it is 
too difficult to differentiate between three nuances of impact when responding to extreme items; for 
example, distinguishing between “a bit”, “quite a bit” and “a lot” when asked if you have “felt 
terrified”. If only three items of 30 items have response categories that are not in order re-scoring 
these items is a better alternative than changing the layout of the questionnaire. 
 
10.2.2.3. Differential item functioning 
The reason for excluding 17 undiagnosed women from the DIF analyses was to avoid bias. The 
small number of women in this subgroup compared to the number of women in the other groups 
and subgroups could cause random errors. Furthermore, prior to the study no hypothesis was raised 
including this subgroup. Therefore, the group was also omitted from the test of known group 
validity. In previous surveys the impact on women of early recall has only been measured after final 
false-positive diagnosis and not while the women were still undiagnosed.110;111  
If future studies include women on early recall and measurements are conducted in the critical 
period then DIF analyses including this subgroup will be possible.   
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Calculations of sum scores of a dimension can be adjusted if an item in the dimension has DIF. The 
adjustment includes four steps: 
1) an item split is conducted 
2) the mean score of the person location on this new virtual latent trait for the particular subgroup is 
assessed  
3) the mean score of the person location on the new virtual latent trait for the remaining subgroups 
is assessed. 
4) the locations are input in the “Equating Tests” feature of the RUMM2020 calculating new mean 
scores of each of the locations.  
Such an adjustment will avoid over or underestimation of differences between groups. 
 
10.2.2.4. Combining Item Response Theory and Classical Test Theory 
The study has shown that there are several advantages to combining analyses based on Item 
Response Theory (IRT) and Classical Test Theory (CTT) when assessing the psychometric 
properties of a questionnaire.  
After conducting the Rasch analyses and identifying the six dimensions and the seven items not 
fitting the Rasch model further analyses based on CCT were conducted. Hence, the CTT analyses 
were conducted based on the results of the Rasch analyses, where the Rasch model was considered 
a valuable “gold standard”.  
Besides making the results of the CTT analyses more valid this approach also saves time. For 
example, assessing Cronbach’s alpha could be used to identify “poor” items. If the value of alpha 
increases or stays stable when an item is deleted from a pool of items then this particular item could 
be “poor”. 
The seven items not fitting the Rasch model were re-checked for face validity by re-auditing the 
tape recordings from the focus group interviews.109 They were then deleted one at a time from the 
remaining items and Cronbach’s alpha was assessed before and after each deletion. The alternative 
would have been to delete all the 33 items one at a time and reassess Cronbach’s alpha for the 32 
remaining items after each deletion. 
The Cronbach’s alpha analyses confirmed the results from the re-audition of the tape recordings in 
six of the seven items. Only one item did not ‘behave’ as presupposed: “being tired”.  
Two of the remaining seven non-fitting items were found to have especially high face validity for 
women having surgery and those on early recall. These were the items “less attractive” and “busy to 
take mind off things”. The content and meaning of these two items are described in article 2 (page 
36) and discussed in details on page 50. Some of the 17 undiagnosed women at Time II were on a 
waiting list for surgical examination or early recall. The decision to retain or delete these two items 
for the version of the questionnaire was postponed until analyses based on larger subgroups of 
women having surgery and being on early recall could be conducted. 
 
10.2.2.5. Test of concurrent validity 
In the test of concurrent validity the sleep dimension of the new measure is shown to specifically 
measure an impact on sleep. The correlation with the sleep section of the NHP is 0.69, while the 
correlations with the remaining five dimensions are less than 0.5. The two dimensions “breast 
examination” and “sexuality” contribute to the psychosocial consequences of abnormal screening 
mammography differently from the other four dimensions. Their correlations with the sections of 
the NHP are different from the remaining four dimensions and are also different form each other 
respectively.  
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The correlation between the sections of the NHP and the three dimensions, “anxiety”, “behavioural” 
and “sense of dejection” are all similar. This might indicate redundancy. If longitudinal studies 
confirm this redundancy it would be possible to delete two of the three dimensions without loosing 
the sensitivity of the instrument. However, women may feel that they are not being taken seriously 
if they are not asked about, for example, anxiety as this was an important topic for the women in the 
focus groups described in article 2 (page 36). Low response rate could in fact be a consequence of 
such a lack of content validity.  
The three dimensions; “anxiety”, “behavioural” and “sense of dejection” encompasses altogether 18 
items (or 19 items if “felt sad” is included in the dejection dimension) and the final instrument 
measuring psychosocial consequences of abnormal screening mammography will have a maximum 
of 30 items (the 27 “good” items, the sick-leave item and the two adapted NHP-sleep items). 
Completing a questionnaire with 30 relevant items will not overload respondents and so there is no 
need for item reduction.  
 
10.3. Justification of conclusion 
Rosenbaum reports that items of a measure fitting the Rasch model possess criterion-related 
construct validity.91 Messick describes construct validity as the overarching concept of validity and 
that “almost any kind of information about a test can contribute to an understanding of its construct 
validity”.112 Messick continues: “fundamentally, all validation is construct validation, in the sense 
that all validity evidence contributes to (or undercuts) the empirical grounding or trustworthiness 
of the score interpretation”.112 For example both content validity and criterion validitya are pieces 
of evidence for construct validity.112 “Construct validation is an ongoing process”61 and thereby 
dynamic and can probably never be fully achieved. Putting all the pieces of validity-evidence 
together can form a picture of the construct validity of a measure.  
It is suggested that the six Rasch-fitting dimensions encompassing 24 items, plus the three single 
items, plus the sick-leave item be retained in the final version of the questionnaire because together 
they have high content relevance and high content coverage in the setting of abnormal screening 
mammography. When testing these 27 items (the sick-leave item excluded) and the dimensions for 
concurrent validity, they diverge and converge as presupposed. The responsiveness of the 
dimensions and the single items and their ability to discriminate between known groups were found 
to be satisfactory.  
In summary, the statement in the conclusion of article 3: “preliminary evidence of construct validity 
of a condition-specific measure for women having an abnormal screening mammography has been 
established” can be justified. 
 
10.4. Contribution to the current knowledge  
As mentioned on page 19 the question: “Assessing psychosocial/quality of life outcomes in 
screening: how do we do it better?” has recently been raised.76 The psychometric properties and 
quality of the new condition-specific instrument goes beyond the criteria “reliable measurement 
tools with high criterion and content validity” raised by the questioner cited above.76 Preliminary 
evidence of construct validity of the new instrument has been established. Therefore, the 
development and validation of a condition-specific instrument measuring psychosocial 
consequences of abnormal screening mammography could be regarded as a contribution to the 
research field of better assessing psychosocial consequences of screening. 
                                                 
a Concurrent validity and predictive validity are unified into the term criterion validity.61;76;112 
 79
The current study also contributes to the previous discussion on one or more domains of 
psychosocial consequences of false positives. The original Australian version of the negative part of 
the Psychological Consequences Questionnaire (PCQ) encompasses five items covering an 
emotional domain, four covering a social domain and three a physical.52 When developing and 
validating the PCQ Jill Cockburn suggested summing the raw scores for each domain, with a higher 
score indicating a greater dysfunction. Organisation of the items into three domains was 
qualitatively based i.e. in agreement with expert judges as to whether the postulated domains could 
be distinguished on the basis of item content.52;104 In three studies113-115 this qualitatively based 
scaling of the PCQ was not confirmed by exploratory factor analyses: a British study identified a 
single factor with an eigenvalue of 7.7 explaining 65% of the variance,113 a Swedish study did not 
support the three underlying factors,114 and a Canadian study found two components115 with 
eigenvalues of 7.71 and 1.15.116  
The current study shows that having an abnormal screening mammography may have an impact on 
different psychosocial domains. Although the PCQ has a lack of content validity in a setting of 
abnormal screening mammography109 Cockburn was right in her qualitative approach that having an 
abnormal screening mammography can have an effect on different psychosocial domains. The 
reason why three studies cannot confirm these three domains in exploratory factor analyses could be 
that the negative part of the PCQ encompasses six ambiguous items.109 
The most frequently used questionnaires in a setting of false-positive screening mammography are: 
the General Health Questionnaire (GHQ), the Hospital Anxiety and Depression Scale (HADS), the 
PCQ and the State-Trait Anxiety Inventory (STAI).104 Rasch analyses have been conducted on data 
collected with the GHQ, HADS and the STAI.117-121 These studies found a difference between the 
“original” psychometric properties of the instruments when they were developed and the 
psychometric properties in new setting. The HADS has also been shown to have problems when 
analysed with confirmatory factor analyses in a new setting.122 In questionnaire surveys on 
consequences of false-positive screening mammography no Rasch analyses have been reported.104 
The present study is the first study in a setting of screening mammography where analyses based on 
the Rasch model have been conducted. 
Analyses of differential item functioning have regularly been used to check if item functioning is 
different after a questionnaire has been translated into another language.80 The most usual method 
to compared two groups in a questionnaire study is to compare the mean scores. It is important to 
eliminate items with DIF or alternatively adjust the mean score according to the DIF. Otherwise 
there is a possibility that the estimated differences between the groups are either too small or too 
large. In the present study DIF analyses was conducted relative to: 
• the diagnostic subgroups 
• the screening centres 
• age of the women 
to avoid bias when comparing mean scores. 
11. Article 4 
Development and validity of a condition-specific instrument measuring long-term psychosocial 
consequences of false-positive screening mammography 
 
John Brodersen (MD, GP, PhD student) and Hanne Thorsen (MD, PhD, senior researcher) both 
Department and Research Unit of General Practice, University of Copenhagen, Denmark 
 
Abstract 
Objectives 
The aim of this study is to develop a questionnaire with high content validity for long-term 
consequences of false-positive screening mammography and to test the construct validity of this 
new instrument. 
Method 
Content validity of the draft version of the questionnaire was assessed via six focus group 
interviews conducted with a total of 34 women. Questionnaire data were then subjected to analyses 
using Item Response Theory (IRT) and Classical Test Theory (CTT). Reliability, internal 
consistency, known group validity, construct validity and objectivity were established. 
Results 
Thirteen items with seven response categories each were generated during the group interviews 
covering long-term consequences of false-positive screening mammography. In the interviews some 
women remarked that is was difficult to choose between the response categories: “A little less” and 
“Less”, and between “A little more” and “More”. Rasch analyses confirmed that the same response 
categories had problems. The estimates of reliability were all acceptable.  
The analyses using IRT and CTT revealed three strongly correlated dimensions. No single items or 
“poor items” were identified. 
Conclusion 
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Preliminary evidence of the construct validity of a condition-specific measure with high content 
validity for long-term consequences for women having a false-positive screening mammography 
has been established. The new instrument covers the impact on the women’s existential values; 
relationship with their social network; being less or more relaxed/calm; and less or more anxious 
about breast cancer/belief in having or not-having breast cancer. A future reduction from seven to 
five response categories resulting in a new lay out of the questionnaire is suggested.  
Introduction 
Breast cancer is a substantial health problem in the western world for example will every tenth 
woman in Denmark be diagnosed with breast cancer.1 Many women in western countries are 
therefore offered breast screening programmes to reduce mortality of the breast cancer.2 In EU 
biennial breast screening is recommended for women aged 50 – 69.3 The incidence of breast cancer 
diagnosed in each screening round is approximately 0.5%.4 The specificity of biennial screening 
mammography has been reported as 97%,5 with a positive predictive values of 13%.6 A low 
positive predictive value results in a high rate of false positive screening results e.g. if a woman 
follows the EU recommendations, every fourth to fifth woman will have a false-positive screening 
mammography during 20 years of screening.7 In the UK, where three-yearly screening is offered to 
women aged 50 - 65, more than 50.000 women per year will have a false-positive screening 
mammography.8 
Several studies have investigated if women having a false-positive screening mammography have 
more negative short-term consequences than women having a normal screening mammography.9 
Regardless of outcome measures, nearly all studies conclude that there are significant short-term 
adverse psychosocial effects of having an abnormal screening mammography, later confirmed as a 
false-positive screening mammography (hereafter referred to as a false positive).10 In contrast, there 
are few studies on long-term psychosocial consequences of breast cancer screening: in these studies 
the follow-up period varies from 1 - 35 months and the results are ambiguous.9;10 
Apart from long-term psychosocial consequences a false positive seems to have an impact on 
participation in subsequent screening rounds. In three studies the participation in the subsequent 
screening round was higher among women who had a false positive compared to those who had a 
normal result.11-14 In another study it was lower15 and in one study the frequency of participation 
was unaffected.16 The use of health-care services has also been shown to increase among women 
after having had a false positive.17 Finally, an increased frequency of breast self-examination has 
been reported as a long-term consequence of false positives.18-21  
Questionnaire surveys have measured different aspects of long-term psychosocial consequences 
after a false positive.14;20-28 Some of these studies found that women having a false positive had 
measurable adverse psychosocial consequences at 5 - 35 months.14;21;24;26;27 Other studies found no 
long-term consequences22;25;28 and the interpretations of results in two studies are unclear.20;23 
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McCaffery and Barrat underline the importance of high content validity when using questionnaires 
to measure the psychosocial outcome of screening.29 None of the articles on long-term 
consequences of false positives report any pre-test of content relevance and content coverage of the 
questionnaires.10;21 It is therefore likely that the questionnaires were inadequate in measuring 
validly the long-term consequences of false positives and this may explain the ambiguity of the 
results in the surveys.10 
A study on content validity of the Danish version of the Psychological Consequences Questionnaire 
(PCQ) in measuring the psychosocial consequences of abnormal screening mammography has 
recently been conducted (article 2 of this thesis). In this study it was revealed that women’s 
experiences differ from one period to another. Women stated that their experiences in the critical 
period from abnormal screening mammography until final false-positive diagnosis differ entirely 
from those of the period after the final diagnosis. The women argued that some issues could be 
raised only after they had been declared “free from” cancer suspicion. Issues exclusively relevant to 
the period after final diagnosis were classified as long-term psychosocial consequences of false 
positives.  
The first aim of the present study is to investigate these consequences and develop a condition-
specific questionnaire covering long-term psychosocial consequences of false-positive. 
 
When summing raw scores of items in a scale, an assumption of unidimensionality is made i.e. that 
the items describe different aspects of the same construct and can be added.30;31 When the response 
options are categorical on an ordinal scale as in many questionnaires Item Response Theory (IRT) 
models can be used to assess the psychometric properties of the questionnaire. The Rasch models 
(an IRT model) are a formal representation of perfect measurement. Where items are shown to fit a 
Rasch model the measure can be shown to posses criterion-related construct validity,32 to be 
objective,33 sufficient34 and, therefore, also reliable.35 For these reasons the Rasch model is 
considered a valuable “gold standard” against which measures should be compared. Item analyses 
by Rasch models explore in depth the degree to which the requirements of construct validity are 
met. Items are assumed to monotonically relate to one dimension, they are assumed to be locally 
independent and it is assumed that there is no differential item functioning.32 The sufficiency of the 
model support computation of the raw scores. IRT analyses also explore how the items included in 
each dimension are interrelated and ordered on a latent trait.36 
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The second aim of this study is to explore the psychometric properties of a new condition-specific 
instrument covering long-term psychosocial consequences of false-positive using IRT and CTT 
analyses. 
Material and methods 
Development of items 
Six focus group interviews were conducted with women who had been screened for breast cancer in 
the year prior to the interviews. The women had experienced that their screening mammography 
was abnormal and later false-positive. Details are reported in article 2 on how the participants were 
grouped in the six interviews and how the interviews were conducted. 
Data collection 
Data were collected at the screening centre of the Copenhagen University Hospital from 24.01.2003 
to 27.02.2003. 
After conducting the six focus group interviews a draft version of the questionnaire was posted to 
women who had had a false positive in the previous 1 – 6 months (Group A - Time I). Women were 
asked to complete the test questionnaire and return it in an enclosed stamped addressed envelope. If 
they had not responded after two weeks, they were posted a reminder including a covering letter, a 
test questionnaire and a stamped addressed envelope. 
Two weeks after having completed the test questionnaire at Time I, the same women were again 
posted the same questionnaire (Group A -  Time II), asked to complete it and return it in an enclosed 
stamped addressed envelope. This second data set with the data set from Time I was used to assess 
the test-retest reliability.  
For each woman who had received the test questionnaire at Time I (Group A), another two women 
were posted the test questionnaire and asked to return it completed in an enclosed stamped 
addressed envelope (Group B). These women had had a normal screening mammography at the 
same time as the women in Group A, Time I. It was hypothesised that women with a false-positive 
screening result would experience more long-term psychosocial consequences compared to those 
with a normal screening result (known group validity).37;38 For ethical and legal reasons the draft 
version of the questionnaire was posted to the women in Group B by the screening clinics 
anonymously and only the age of the participants was disclosed for the researchers. Therefore it was 
not possible to send reminders to the women in Group B. 
In Group A, 127 of 150 women (84.7%) returned the test questionnaire at Time I. At Time II, 105 
(82.7%) of the women in Group A returned the test questionnaire. In Group B, 300 women received 
the questionnaire by post and 197 (65.7%) returned the questionnaire. There were no statistically 
significant differences in mean and range of age between the women in the three groups. 
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Statistical analyses 
Item responses were analysed by the conditional distribution of items given total person scores in 
order to avoid assumptions on the distribution of the latent trait being measured. The pairwise 
estimation procedure implemented in software program RUMM2020 was used to estimate the item 
parameters.39;40 The analysis of the fit of item responses to the Rasch model were based on analyses 
of residuals comparing observed to expected item responses both for separate individuals and for 
different score groups. The overall fit of the model was assessed by the Wright-Panchapakesan χ2 
statistic summarising standardised residuals over score groups and items.41 Item fit statistics 
summarising standardised residuals in different score groups were used to identify misfitting items. 
Data from Group A, Time I and Time II and data from Group B were pooled for IRT analyses. 
Differential item functioning (DIF) relative to person covariates was checked by analyses of 
variance examining the degree to which individual residuals for specific items depended on the 
covariates. Absence of evidence of interaction between the covariates and the estimated trait 
parameters were taken as evidence that DIF was uniform. Finally, the assumption of local 
independence was checked by examination of the degree to which individual residuals were 
correlated.   
Reliability was assessed by Cronbach’s alpha defining the lower bound for the test-retest correlation 
of the raw scores42;43 and by the so-called Person Separation Index calculating the lower bound for 
the test-retest correlation of the estimated values of the latent trait being measured.44 The test-retest 
reliability was assessed by the Pearson correlation between Time I and Time II for Group A. 
Data were analysed with CTT using the software SPSS for Windows version 13.0 and the software 
Mplus 2.14 for confirmatory factor analysis.45 For IRT analyses the software RUMM2020 was 
used. 39 
The study was approved by the local ethical committee. 
 
Results 
Development of items 
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Inspired by the ten items in the PCQ covering positive aspects of participation in breast cancer 
screening the women in the first focus group discussed their experiences after final diagnosis. They 
agreed that the consequences after final diagnosis were not only positive. Compared to the time 
before participation in screening, the women argued that consequences after final diagnosis should 
be described as on-going changes e.g. negative as well as positive changes in their “relationship to 
friends”.  
In the first focus group it was revealed that the subject matter of the question in seven of the ten 
positive PCQ-items was relevant as long-term psychosocial consequences of false positives. The 
subject matter of these seven relevant questions was:  
• Improved relationship to friends or relations 
• Getting on better with those around you 
• Feeling more relaxed 
• A greater sense of well being 
• Hopeful about future 
• Reassurance of not having breast cancer 
• Less anxious about breast cancer 
The question: “Improved relationship with friends or relations” was considered double-barrelled 
and was split into two questions. However, the subject matter of the resulting eight questions was 
insufficient to cover all long-term psychosocial consequences of false positives. The women in the 
first focus group suggested five more issues to be covered. These issues were confirmed in the 
following group interviews: accordingly, five new questions were generated (table 1).  
 
Table 1. The subject matter of questions covering long-term consequences of false positives 
1 belief that I do not have breast cancer 8   thoughts about the future 
2 anxiety about breast cancer 9   enjoyment of life* 
3 feeling relaxed 10 value life* 
4 feeling calm* 11 awareness of life* 
5 relationship with my family 12 thought about the broader aspects of life* 
6 relationship with friends 13 sense of well-being 
7 relationship with other people  
* new items generate from focus group interviews 
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The response options from the PCQ were found irrelevant and incomprehensive when asking about 
long-term psychosocial consequences. In the first focus group the women suggested three response 
categories: “No”, “The same as before” and “Yes”. This was confirmed in the second focus group: 
however, the participants in this group found “No” and “Yes” too categorical. Therefore the number 
of response options was extended from three to seven and presented to the participants in the 
subsequent focus groups (table 2). 
 
Table 2. Seven response categories 
 
Much less 
 
Less 
 
A little less 
 
The same as before
 
A little more
 
More 
 
Much more
? ? ? ? ? ? ? 
 
The women who participated in the last four focus groups found that the seven response options 
were relevant and allowed differentiated answers.  
As part of the focus group interviews the participants completed the test questionnaire. After this 
exercise, some women remarked that it was difficult to choose between “a little less” and “less”, 
and between “a little more” and “more”. Conversely, it seemed that selecting “much less”, “much 
more”, or “the same as before” was easier. Despite the contradictory statements, it was decided to 
statistically test the questionnaire with seven response categories following each of the thirteen 
items. In addition the thirteen items were re-worded to fit the seven response options. 
 
Rasch analyses on the data of the draft version of the new questionnaire 
The response pattern showed that between 0 – 11% responded to one of the three response 
categories “much less”, “less”, and “a little less” (table 2). It was therefore decide to perform Rasch 
analyses after transforming the data. The data from the three categories were recoded in three 
different ways: 
• as missing data 
• as if they all were a response to the category “the same as before” 
• laterally reversed, therefore a response to “much less” became a response to “much more”, 
“less” became “more”, and “a little less” to “a little more”. 
Rasch analyses were conducted independently on each of the three recoded data sets. Irrespective of 
how the data were transformed, the differences of the results of the Rasch analyses were as 
described below: 
• The thirteen items did not form a unified dimension 
• The response category “a little more” had problems in ten to twelve of the thirteen items 
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• In item 6 (relationship with friends) the two response categories “a little more” and “more” 
had problems in two of the three transformed datasets 
• Item 12 was the only item where all the four response categories worked sufficiently in all 
the analyses. 
In a Category Probability Curve the likelihood of a response can be compared with the person 
location. If a response category is informative and works well, an “open window” should appear in 
the Category Probability Curve. In this “open window” the likelihood of responding to the category 
is greater than responding to the remaining categories. As an example, figure 1 shows how the two 
response categories in item 6 “a little more” and “more” did not work. Figure 2 shows how these 
two response categories were able to work sufficiently and give additional information compared to 
the other two response categories after they were collapsed. 
 
Figure 1. Category Probability Curve of item 6 (“relationship with friends” see table 3) before 
collapsing response categories 
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The logit scale from -2 to +4 on the x-axis symbolises the latent trait of long-term psychosocial consequences of false-
positives, with the severity increasing towards the right. 0 “the same as before”, 1 “a little more”, 2 “more” and 3 “much 
more”. 
Figure 2. Category Probability Curve of item 6 (“relationship with friends” see table 3) after 
collapsing response categories  
 
The logit scale from -2 to +4 on the x-axis symbolises the latent trait of long-term psychosocial consequences of false-
positives, with the severity increasing towards the right. 0 “the same as before”, 1 “a little more” and “more” and 2 
“much more”. 
 
As a consequence of the Rasch analyses it was decided to collapse the two response categories “a 
little more” and “more” in all thirteen items and rescore accordingly. The results of the Rasch 
analyses on the three rescored data sets were: 
• The response categories in all thirteen items were in order 
• The thirteen items still failed to form a unified dimension 
• Six items covering an impact on existential values formed one dimension (item 8 - 13, table 
2) 
• Three items covering an impact on social relations formed a second dimension (item 5 – 7, 
table 2) 
• Two items about being relaxed or calm formed a third dimension (item 3 + 4, table 2) 
• Two items describing anxiety and reassurance about breast cancer formed a fourth 
dimension (item 1 + 2, table 2) 
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The Wright-Panchapakesan Chi Squared fit Statistics, the Person Separation Index and the 
Cronbach’s alpha of the four dimensions fitting the Rasch model are listed in Table 3. This 
information is given with four response categories and with three response category (before and 
after collapsing the two response categories “a little more” and “more”) and for all three recoded 
data sets.  
 
TABLE 3 ABOUT HERE 
 
Item no 13 “sense of well-being” had uniform DIF relative to diagnostic subgroup in all three data 
sets and so had item no 8 “thoughts about the future” in one data set. 
To estimate how the four dimensions were correlated a subsequent confirmatory factor analysis was 
conducted. The analysis revealed a latent trait behind the three dimensions: “social relations”, 
“being relaxed or calm” and “anxiety and reassurance about breast cancer” with p-values in the 
three recoded and rescored data sets between 0.12 – 0.42. 
Know group validity 
In all four dimensions there was a statistically significant difference, insofar as women with a false 
positive had experienced more long-term psychosocial consequences than women with a normal 
screening result. P-values were less than 0.0005. The distribution of the relative frequencies in the 
five response categories (with the response categories “a little less ” and “less” collapsed and “a 
little more” and “more” collapsed) in the existential dimension are shown in figure 3. 
 
Figure 3. The relative frequencies in the existential dimension 
Existential values
0%
20%
40%
60%
80%
100%
much
less
less same as
before
greater much
greater
Response categories
Normal
False positive
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“Normal”, the women that had a normal screening mammography (group B) and “False positive”, the women who had 
a false-positive screening mammography (Group A, Time I)  
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Test-retest reliability 
The test-retest correlation coefficient with seven response categories varied on the single item level 
from 0.64 – 0.79. 
 
Discussion 
In contrast to the study on the development of the original version of the PCQ,46 where women who 
had undergone surgery or early recall were not included, these groups of women were included in 
the present study. The women in the group interviews stated that some issues concerning long-term 
psychosocial consequences of false positives were not covered by the PCQ. However, the long-term 
consequences already covered by some PCQ-items had to be re-worded and the response options re-
designed. The subject matter of the items was maintained but the final version of the test 
questionnaire was different from the PCQ and therefore was regarded as a new instrument.  
The women in the focus groups emphasised that some questions could be asked only after final 
diagnosis. This is in agreement with the result obtained during the development of the PCQ46 and 
with a study on quality of life following a false positive.47 
It is noteworthy that the subject matter of the five new items was generated during the first focus 
group interview with participants who had undergone the least distressing additional examinations. 
The fact that the subject matter of these items was confirmed in the following five group interviews 
and that no new issues were raised after the first focus group indicates a high degree of data 
saturation and thereby a high content validity of the new instrument.  
In a questionnaire it is essential to avoid asking questions that are irrelevant. On the other hand, it is 
also important to include all relevant issues revealed in the qualitative pre-test of the questionnaire. 
It was therefore decided to include response options in each item indicating “no change” and 
changes in two opposite directions so that, for example, indicating either more or less confidence in 
not having breast cancer was made possible in the same item. This decision was taken to comply 
with the results obtained in the focus group interviews. The decision is supported by results of a 
study showing that women diagnosed with breast cancer experience both positive and negative 
consequences of their disease.48 Another reason for designing the new instrument with response 
options including changes in two opposite directions was to avoid complicated layout of the 
questionnaire e.g. skip patterns and mutually exclusive items.  
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However, this way of constructing a questionnaire demands a particular item scoring system. It is 
important not to score the changes so that they neutralise each other: therefore, an assessment of a 
mean score of the dimensions do not express the actual distribution of changes. Instead, the range of 
the relative or absolute frequencies in all the response categories of the dimensions should be 
assessed.  
It was planned to apply IRT analyses together with analyses of CTT to optimise the psychometric 
validation of the instrument. The Rasch model presupposes that “changes” occur in one direction 
only. Because only 0 – 11% of responses covered the three categories: “a little less”, “less” and 
“much less” it was decided as a compromise to transform the data so analyses based on the Rasch 
model were possible.  
Although some of the women in the focus groups were reluctant to accept as many as seven 
response categories, it was decided to maintain these categories in the test version of the 
questionnaire. The Rasch analyses confirmed the findings from the interviews that the women had 
difficulties distinguishing between “a little less/more” and “less/more”. Therefore, both qualitative 
and quantitative results support a future reduction in the number of response options, resulting in a 
new layout of the questionnaire. Although the reliability estimates found in the present study are all 
acceptable, a future reduction in the number of response options may also enhance the reliability of 
the re-designed instrument.  
Only weak evidence was disclosed against the six existential items (no. 8 - 13, table 1) forming one 
dimension (p-values from 0.004 – 0.06 in table 3). Five of the six existential items showed 
sufficient fit to the Rasch model in all the analyses. However, item no 10 “value life” showed a 
marginal misfit of probability to the Rasch model in all three recoded data sets (with four response 
categories) and also in the three rescored data sets (with three response categories). If item no 10 
was removed from the existential dimension the overall fit of the dimension increased so that p > 
0.05 in all the analyses. This might indicate that item no 10 has to be regarded as a single item not 
belonging to the existential dimension. Future studies with the previous suggested new layout of the 
questionnaire will show if these findings are consistent. 
Studies to come with the re-designed questionnaire will also show if item no 13 “sense of well-
being” consistently has DIF. If so, item no 13 could be deleted from the final version of the 
measure. Alternatively, the scores in the existential dimension have to be adjusted according to the 
apparent DIF so differences between diagnostic subgroups are not under or overestimated. 
 92 
 
Conclusion 
The construct validity of a condition-specific measure with high content validity for long-term 
psychosocial consequences for women having a false-positive screening mammography has 
preliminary been established. This new instrument encompasses four dimensions covering the 
impact on the women’s existential values; relationship with their social network; being less or more 
relaxed/calm; and less or more anxious about breast cancer/belief in having or not-having breast 
cancer. The last three dimensions are strongly correlated with a latent trait behind them. 
 
Perspectives for future research 
For measuring psychosocial consequences of screening in the setting of breast cancer a two-part 
valid condition-specific instrument, COS-BC (Consequences of Screening on Breast Cancer), 
measuring: 
1. psychosocial consequences of abnormal screening mammography (part 1) 
2. long-term psychosocial consequences of false positives (part 2) 
is now available.  
The COS-BC has been translated into Dutch, English and Norwegian and  is currently in use in a 
major Danish survey. Data from this survey and from studies from other countries will allow 
statistical re-evaluation of the psychometric properties of the re-designed part 2.  Hopefully these 
analyses will answer the questions remaining from the present study concerning part 2 of the COS-
BC: 
• are five, instead of seven, response categories sufficient? 
• will the reliability and internal consistency of the re-designed questionnaire be improved? 
• are the remaining psychometric properties of the part 2 of the COS-BC consistent with the 
results of the present study after the changes in layout? 
• will item no 13 “sense of well-being” have DIF? 
• will item no 10 “value life” belong to the existential dimension or will the item have to be 
regarded as a single item? 
Another important target would be to establish the minimal important difference of the subscales in 
the dimensions of the COS-BC including the single items.  
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Some items and/or some of the dimensions of the COS-BC are specific for women participating in 
breast cancer screening. There is a need for valid instruments with high content validity and good 
psychometric properties in the research area of psychosocial consequences of cancer 
screening.10;29;49-51 The relevance of the COS-BC, without the breast cancer specific items, is 
currently being explored in the setting of lung cancer screening. The aim is to establish core 
questions relevant for any kind of cancer screening. The core-questionnaire, COS, should then have 
specific items added, depending on which cancer the screening programmes are targeted at. 
 
Acknowledgement 
 94 
We would like to thank MSC, associate professor Svend Kreiner, Department of Biostatistics, 
Institute of Public Health, University of Copenhagen, for his great help with the interpretation of the 
statistical analyses. We also thank the staff at the breast cancer screening clinic and the recall clinic 
at the Copenhagen University Hospital for recruiting women to this study. 
 Reference List 
 
 1.  Sundhedsstyrelsen. Cancer incidence in Denmark 1996. Copenhagen: Sundhedsstyrelsen, 
1999. 
 2.  Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast Cancer Screening: A Summary of 
the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-60. 
 3.  Arbyn M, Oyen HV, Lynge E, Mickshe M. European consensus on cancer screening should 
be applied urgently by health ministers. BMJ 2001;323:396. 
 4.  Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. 
Mammography Screening Evaluation Group. APMIS 1998;Supplementum. 83:1-44. 
 5.  Mushlin AI, Kouides RW, Shapiro DE. Estimating the accuracy of screening mammography: 
a meta-analysis. American Journal of Preventive Medicine 1998;14:143-53. 
 6.  Ward J. Population-based mammographic screening: does 'informed choice' require any less 
than full disclosure to individuals of benefits, harms, limitations and consequences?. 
Australian & New Zealand Journal of Public Health 1999;23:301-4. 
 7.  Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false 
positive screening mammograms and clinical breast examinations [see comments]. New 
England Journal of Medicine 1998;338:1089-96. 
 8.  NHS Cancer Screening Programmes. http://www.doh.gov.uk/public/sb0201.htm . 2003.  
 
 9.  Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of 
mammographic screening. A systematic review. Psychooncology. 2005;14:917-38. 
 10.  Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term 
consequences of false-positive screening mammography. Journal of Medical Screening 
2004;11:39-44. 
 11.  Pisano ED, Earp J, Schell M, Vokaty K, Denham A. Screening behavior of women after a 
false-positive mammogram. Radiology 1998;208:245-9. 
 12.  Pisano ED, Earp JA, Gallant TL. Screening mammography behavior after a false positive 
mammogram. Cancer Detection & Prevention 1998;22:161-7. 
 13.  Pinckney RG, Geller BM, Burman M, Littenberg B. Effect of false-positive mammograms on 
return for subsequent screening mammography. Am.J.Med. 2003;114:120-5. 
 14.  Lipkus IM, Halabi S, Strigo TS, Rimer BK. The impact of abnormal mammograms on 
psychosocial outcomes and subsequent screening. Psychooncology. 2000;9:402-10. 
 95
 15.  McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent 
screening attendance and risk of cancer. Breast Cancer Res. 2002;4:R11. 
 16.  Lampic C, Thurfjell E, Sjoden PO. The influence of a false-positive mammogram on a 
woman's subsequent behaviour for detecting breast cancer. Eur.J Cancer 2003;39:1730-7. 
 17.  Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased patient concern 
after false-positive mammograms: clinician documentation and subsequent ambulatory visits. 
J.Gen.Intern.Med. 2001;16:150-6. 
 18.  Dean C, Roberts MM, French K, Robinson S. Psychiatric morbidity after screening for breast 
cancer. Journal of Epidemiology & Community Health 1986;40:71-5. 
 19.  Bull AR,.Campbell MJ. Assessment of the psychological impact of a breast screening 
programme [see comments]. British Journal of Radiology 1991;64:510-5. 
 20.  Aro AR, Pilvikki Absetz S, van ET, van dP, van dK, LJ. False-positive findings in 
mammography screening induces short-term distress - breast cancer-specific concern prevails 
longer. European Journal of Cancer 2000;36:1089-97. 
 21.  Absetz P, Aro AR, Sutton SR. Experience with breast cancer, pre-screening perceived 
susceptibility and the psychological impact of screening. Psychooncology. 2003;12:305-18. 
 22.  Cockburn J, Staples M, Hurley SF, De LT. Psychological consequences of screening 
mammography. Journal of Medical Screening 1994;1:7-12. 
 23.  Scaf-Klomp W, Sanderman R, van dW, HB, Otter R, van den Heuvel WJ. Distressed or 
relieved? Psychological side effects of breast cancer screening in The Netherlands. Journal of 
Epidemiology & Community Health 1997;51:705-10. 
 24.  Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening 
suffer adverse psychological consequences? A multi-centre follow-up study comparing 
different breast screening result groups five months after their last breast screening 
appointment. Journal of Public Health Medicine 1998;20:396-403. 
 25.  Gilbert FJ, Cordiner CM, Affleck IR, Hood DB, Mathieson, Walker LG. Breast screening: the 
psychological sequelae of false-positive recall in women with and without a family history of 
breast cancer. European Journal of Cancer 1998;34:2010-4. 
 26.  Olsson P, Armelius K, Nordahl G, Lenner P, Westman G. Women with false positive 
screening mammograms: how do they cope?. Journal of Medical Screening 1999;6:89-93. 
 27.  Brett J,.Austoker J. Women who are recalled for further investigation for breast screening: 
psychological consequences 3 years after recall and factors affecting re-attendance. J.Public 
Health Med. 2001;23:292-300. 
 28.  Lampic C, Thurfjell E, Bergh J, Sjoden PO. Short- and long-term anxiety and depression in 
women recalled after breast cancer screening. Eur.J.Cancer 2001;37:463-9. 
 96 
 29.  McCaffery KJ,.Barratt AL. Assessing psychosocial/quality of life outcomes in screening: how 
do we do it better? J Epidemiol Community Health 2004;58:968-70. 
 30.  Wright BD. Fundamental measurement for psychology. In Embretson SE, Hershberger SL, 
eds. The new rules of measurement: What every psychologist and educator should know, pp 
65-104. Mahwah, New Jersey and London: Lawrence Erlbaum Associates, 1999. 
 31.  Andrich D. Controversy and the Rasch model: a characteristic of incompatible paradigms? 
Med Care 2004;42:I7-16. 
 32.  Rosenbaum PR. Criterion-related construct validity. Psychometrika 1989;54:625-33. 
 33.  Rasch G. An Informal Report on a Theory of Objectivity in Comparisons. In Van der Kamp 
LJTh, Vlek CAJ, eds. Psychological Measurement Theory, pp 1-19. Leyden: University of 
Leyden, 1967. 
 34.  Andersen EB. Sufficient Statistics and Latent Trait Models. Psychometrika 1977;42:69-81. 
 35.  Bartholomew DJ. The Statistical Approach to Social measurement. San Diego: Academic 
Press, 1996. 
 36.  Andrich D. Understanding resistance to the data-model relationship in Rasch's paradigm: a 
reflection for the next generation. J Appl.Meas. 2002;3:325-59. 
 37.  Streiner DL, Norman GR. Health measurement scales: A practical guide to their development 
and use. Oxford: Oxford University Press, 1995. 
 38.  McDowell I., Newell C. Measuring Health. A guide to rating scales and questionnaires. 
Oxford: Oxford University Press, 1996. 
 39.  Andrich, D., Sheridan, B., and Luo, G. RUMM2020. (Version 4.0 for Windows). 2005.  
RUMM Laboratory Pty Ltd. http://www.rummlab.com/.  
 
 40.  Andrich D,.Luo G. Conditional pairwise estimation in the Rasch model for ordered response 
categories using principal components. J Appl.Meas. 2003;4:205-21. 
 41.  Wright BD,.Panchapakesan N. A Procedure for Sample-free Item Analysis. Educational and 
Psychological Measurement 1969;29:23-48. 
 42.  Cronbach LJ. Coeffcient alpha and the internal structure of tests. Psychometrika 1951;16:297-
334. 
 43.  Cronbach LJ. Internal consistency of tests: analyses old and new. Psychometrika 1988;53:63-
70. 
 44.  Smith EV, Jr. Evidence for the Reliability of Measures and Validity of Measure Interpretation: 
A Rasch Measurement Perspective. In Smith EV, Jr., Smith RM, eds. Introduction to Rasch 
Measurement. Theory, Models and Applications, pp 93-122. Maple Grove: JAM Press, 2004. 
 45.  Muthén, L., Muthén, B., Asparouhov, T., and Nguyen, T. Mplus. 2.14. 2005.  
http://www.statmodel.com/.  
 97
 
 46.  Cockburn J, De LT, Hurley S, Clover K. Development and validation of the PCQ: a 
questionnaire to measure the psychological consequences of screening mammography. Social 
Science & Medicine 1992;34:1129-34. 
 47.  Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. British 
Journal of Cancer 1990;62:1018-22. 
 48.  Carver CS,.Antoni MH. Finding benefit in breast cancer during the year after diagnosis 
predicts better adjustment 5 to 8 years after diagnosis. Health Psychol. 2004;23:595-8. 
 49.  Brodersen J, Thorsen H, Cockburn J. The validity of short-term consequences of cancer 
prevention and screening activities? J Clin Oncol 2004;In press. 
 50.  Brodersen J, Thorsen H, McKenna S, Doward L. Assessing psychosocial/quality of life 
outcomes in screening: how do we do it better? J Epidemiol Community Health 2005;59:609. 
 51.  Rimer BK,.Bluman LG. The psychosocial consequences of mammography. [Review] [27 
refs]. Journal of the National Cancer Institute 1997;Monographs.:131-8. 
 
 98 
 
 99
12. Discussion of article 4 
 
12.1. Major findings 
During focus group interviews thirteen items with seven response categories each were generated 
covering long-term psychosocial consequences of false-positive screening mammography (hereafter 
referred to as a false positive). The long-term psychosocial consequences differ entirely from those 
in the critical period from abnormal screening mammography until final false-positive diagnosis 
and could be asked about only after the women had been declared “free from” cancer suspicion. 
In the interviews some women stated that is was difficult to choose between the response options 
“A little less” and “Less” and between “A little more” and “More”.  
Rasch analyses confirmed that the same response categories had problems. Therefore, a future 
reduction from seven to five response categories resulting in a new layout of the questionnaire is 
suggested. 
The new instrument encompassed four dimensions covering:  
• the impact on the women’s existential values 
• the relationship with their social network 
• being less or more relaxed/calm 
• less or more anxious about breast cancer/belief in having or not-having breast cancer 
The last three dimensions were shown to be strongly correlated in a confirmatory factor analysis.  
 
12.2. Assessment of methods 
Translation and adaptation 
The pitfalls of translating and adapting questionnaires from one language to another are discussed 
previously on page 49. For detailed information of the translation and adaptation process see 
appendix III (page 123). 
 
12.2.1. Assessment of content validity 
The details of how the focus group interviews were prepared and conducted are described and 
discussed in article 2 (page 36) and on page 50.  
In the open-ended discussion of the first group interview it became obvious that a discussion of the 
psychosocial consequences of an abnormal and false-positive screening mammography had to be 
divided into two separate discussions. This was confirmed in the following five group interviews. 
The discussion of the psychosocial consequences of the critical period from abnormal screening 
mammography until final false-positive diagnosis is reported in article 2 and in the following 
discussion of the paper. 
The women in the first group also stated that the psychosocial consequences experienced after 
receiving a known false-positive diagnosis was of a more abstract nature compared to the 
experiences they had had in the critical period. When the women were given the translated Danish 
version of the PCQ they all agreed that the subject matter of some of the positive items of the PCQ 
were relevant from their own experiences after final false-positive diagnosis.  
Two of the original positive PCQ-items (no’s 3 and 8, appendix III, page 123) describe the 
women’s relationship to their social network. Item 3 “Improved relationship with friends or 
relations” was found to be double-barrelled and was therefore divided into two items (appendix III, 
page 123). This resulted in three items covering social relationships. The women in the interviews 
wanted these three items on the same page of the questionnaire and in a particular order. They 
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recommended that the item about relationship to family had to precede the item about relationship 
with friends and the item about relationship to other people should come last. If the items about 
family and friends did not precede the item about other people then the women found the last item 
hard to interpret. The meaning of “other people” was unclear if this item was asked before the other 
two social network items. Presenting the three social items in this particular order resulted in an 
interpretation of “other people” as people that the women were not close to such as neighbours, 
colleagues, the hairdresser etc. 
As the psychosocial consequences experienced after final false-positive diagnosis were of a more 
abstract nature than in the critical period, the overall introduction to the positive part of the PCQ: 
“All things considered, would you say your experiences at the Breast X-ray Program have caused 
any of the following” was adapted into Danish. It was not relevant to set a time frame of, for 
example, “over the last week” as used for the negative PCQ-item (appendix IV & V) and in the 
PCQ-DK33 (article 2 and 3, page 36 and 52). 
Three positive PCQ-items were the same as three negative PCQ-items, but the meaning was 
reversed. The content of these items are: 
1. Feeling more able to do things which I normally do 
2. Feeling more able to meet my home and/or work responsibilities 
3. Been sleeping better 
These three original positive PCQ-items were excluded from the instrument because: 
Re. 1) Firstly, the women in the group interviews stated that the three items were not relevant for 
the period after final diagnosis. Some of them stated that they slept better than in the critical 
period but none of the women stated that they slept better than before they were screened.  
Re 2) Secondly, the three items could be misunderstood because the women did not know if they 
were supposed to compare the statements with the time before screening or with the time in 
the critical period.  
Re 3) Finally, it is problematic to have two items in the same questionnaire asking about the same 
issue where one item is asking positively and the other negatively. It is most likely that some 
respondents will give opposing answers. Therefore, the validity of such items are 
questionable. Other respondents might be suspicious that a hidden agenda exists such that 
the real interest is not in the person’s answer but more a test of the person’s ability to answer 
consistently. This might result in a reduced response rate. 
 
12.2.2. Data collection 
The difference in response rates between Group A (82.7% - 84.7%) and Group B (65.7%) may be 
the result of the following reasons: 
• the motivation for completing the questionnaire might have been greater among women 
having a false positive compared to women having a normal mammography 
• the women in Group B were not posted a reminder 
It would have been preferable to have posted a reminder to both groups. However, this was not 
feasible for practical, ethical and legal reasons. The different procedures in the two groups had to be 
accepted despite the fact that it might have caused biases. Future surveys where the instrument is 
used (and where it will be possible to send reminders to all the participants) will show if the 
differences in long-term psychosocial consequences actually found in the present study were biased.  
A copy of the 13-item questionnaire with seven response categories posted to the women is found in 
appendix VI, page 146 and appendix VII, page 151. 
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12.2.3. Statistical methods in general 
Data were input and proof-read by two persons. The manual search for errors in the input of data 
showed 0.14% mistakes that were corrected before analyses. 
The response pattern showed that between 0 – 11% responded to one of the three response 
categories “much less”, “less”, and “a little less”. However, 28 of the 127 (22%) women that 
returned the questionnaire in Group A, time I had affirmed at least one of the three response options 
in at least one item.  
The data were recoded in three different ways to allow Rasch analyses to be conduct. Confirmatory 
factor analyses (CFA) were also conducted on the recoded raw scores which confirmed the 
existence of three of the four dimensions (with p-values greater than 0.05). The existential 
dimension was not confirmed by this process. After collapsing the two response categories “a little 
more” and “more” CFA was repeated. Again this provided evidence for three dimensions with p > 
0.05 but the forth, the existential dimension, did not fit the model. This misfit of the existential 
items in the CFA might be caused by: 
• the disorder of the response categories in the three recoded data sets 
• the differential item functioning (DIF) found in item 13 
• the misfit of item 10 in the existential dimension  
When item 10 was deleted from the existential dimension and CFA repeated on the recoded and 
rescored data sets, the resulting p-value was between 0.0126 – 0.0501 with a model of a latent 
factorial structure supporting the five remaining existential items. This, together with the Rasch 
analyses, indicates that item 10 should either be regarded as a single item or that it should belong to 
the existential dimension. However, it is premature to conclude on this issue because the evidence is 
based on data that have both been recoded and rescored. Therefore, further decisions of the destiny 
of item 10 will be taken after a re-evaluation of the psychometric properties of the re-designed 
questionnaire with five response categories. 
 
12.2.3.1. Order of response categories 
In most of the items the response categories were not in order when Rasch analyses were conducted 
on data with four response categories (before recoding the data which corresponded to seven 
response categories). After collapsing the four response categories to three (which corresponded to 
a reduction from seven to five categories) the probabilistic fit to the Rasch model changes in the 
four dimensions respectively (Table 3 in article 4). In most of the cases the probability of fit 
increased but in some instances it decreased. Except for the existential dimension none of the p-
values decreased to a level of misfit. This indicates that the reason for the disorder of the response 
categories is not a matter of an illogical response pattern between “a little less” and “less” and 
between “a little more” and “more”. A more plausible reason is that the differences in the quantity 
of information between “a little less” and “less” and between “a little more” and “more” is too small 
compared to the differences in the quantity of information between “the same as before” and the 
two extreme options “much less” and “much more”. This confirms the results from the group 
interviews where some of the women had difficulties choosing between the response options “a 
little less” and “less” and between “a little more” and “more”. 
 
12.3. Justification of conclusion 
The content of all the thirteen items in the instrument were generated during the first focus group 
and confirmed in the following five group interviews. As no new issues were raised after the first 
focus group, this indicates a high degree of data saturation and hence a high content validity of the 
new instrument. 
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Between ten and twelve of the thirteen items had disordered response categories. After collapsing 
the response categories from seven to five categories the disorder disappeared and the probability to 
the Rasch model increased in most of the analyses. These facts, together with the information from 
the qualitative interviews support the reduction in numbers of response options as suggested and the 
necessity of a new layout of the questionnaire.  
The estimates of reliability were all acceptable, with relative high Cronbach’s alphas, high Person 
Separation Indexes and acceptable test-retest coefficients. A reduction in response categories will 
probably result in a higher reliability.  
No local dependency among the items was identified in the Rasch-fitting dimensions. 
Combining the validity-evidence provides preliminary justification for asserting that evidence of the 
construct validity of a condition-specific measure with high content validity for long-term 
consequences of false positives has been established.  
 
12.4. Contribution to the current knowledge 
In a study from 1990 Gram et al.108 reported long-term consequences of false-positive screening 
mammography such as: 1) pain and reduces sexual sensitivity of the breast after surgery, 2) anxiety 
about breast cancer and 3) finding ones life more precious. Two other studies from 1986 and 1990 
reported higher levels of worry and anxiety about breast cancer99;107 as a long-term consequence of 
false positives and one woman stated she had reduced sexual sensitivity and pain of the breast after 
surgery.107 The present study confirms these findings. 
It is a well known that after traumas and existential crisis people may change their view on values 
and meaning of life. These changes can be interpreted by the individual as positive and negative or 
a combination of both. This has been seen in a qualitative study on Danish cancer patients’ 
reactions one or more years after diagnosis.123 Antonovsky also reported similar complex reactions 
in interviews with former Jewish victims of the Second World War who had spent time in 
concentration camps. Antonovsky described a concept of sense of coherence as a salutogenic model 
on the relationship between health and disease.124 He found that the victims either had greater or 
lesser sense of coherence as a consequence of their traumas.124;125 Antonovsky did not use the 
positive reactions or greater sense of coherence as justification for sending people to concentration 
camps. In comparison, Gram et al. reported an overall positive impact on life as long-term 
consequences of false positives. However, the authors emphasised that it would be unreasonable to 
put these positive changes on the positive side of the balance sheet of breast cancer screening, 
“since first the fear, then the relief, are induced by the same screening”.108 
In the present study women stated that the long-term impact on different aspect of life could be 
positive as well as negative. The instrument was designed so the response options were 
comprehensive to these statements and it was made possible to affirm an item both in a positive or 
negative direction. A change in either the positive or the negative direction from the response option 
“the same as before” must be seen as a psychosocial consequence of screening. The test of known 
group validity in the current study showed that there was a statistical significant difference between 
the group of women having a normal and a false-positive screening mammography. Women having 
a false positive had experienced greater changes and more impact on existential values, in the sense 
of being calm/relaxed, in relationship to their social network and in their anxiety/belief in having or 
not-having breast cancer. These changes, whether positive or negative, were the result of a process. 
Firstly, the abnormal screening mammography raised uncertainty and fear which was followed by 
the final false positive diagnosis. After being declared “free from” cancer suspicion some women 
reacted with relief while others did not. These greater changes that were observed in the group of 
women having false positives can only be regarded as harm arising from screening. 
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13. The process of the PhD study 
 
 
 
The Psychological Consequences Questionnaire (PCQ) 
Negative part: 
12 items 
Positive part: 
10 items 
33-item new questionnaire 
All 18 items 
found to be 
relevant 
15 new items 
generated to 
cover the area 
3 items 
found to be 
irrelevant
The content of 8 
items found to 
be relevant
5 new items 
generated to cover 
the area
The Danish version of the PCQ 
Negative part: 
18 items 
Positive part: 
11 items 
13-item new questionnaire 
5 “poor” 
items 
identified 
Consequences of Screening – in Breast Cancer (COS-BC) 
COS-BC part 2 (13 items) 
Four dimensions: 
• existential values (6) 
• social network (3) 
• feeling relax/calm (2) 
• anxiety about/belief in 
(not) having breast 
cancer (2) 
No single items 
Reformulated 
COS-BC part 1 (28 items) 
Six dimensions: 
• anxiety (6) 
• behavioural (7) 
• sense of dejection (6) 
• sleep (2) 
• breast examination (2) 
• sexuality (2) 
Three single items 
Statistical test of the psychometric properties of the PCQ and the Nottingham Health Profile (NHP)
6 ambiguous items reformulated 
Translation and adaptation process including a bilingual panel and a lay panel 
1 ambiguous item reformulated 
Abnormal screening mammography 
Focus group interviews assessing the content validity of the PCQ-DK18 including women 
who had had an abnormal screening mammography later confirmed to be false-positive 
False-positive screening mammography 
2 sleep-items from 
NHP suggested to be 
added to part 1 
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14. Conclusions and implications for practice and research 
 
14.1. Conclusion 
 
This PhD study began with a literature review concluding that generic instruments are inadequate 
for measuring psychosocial consequences of cancer screening. The most appropriate questionnaire 
identified for assessment of short-term psychosocial consequences of false-positive screening 
mammography was the Psychological Consequences Questionnaire (PCQ). However, little 
evidence was found to suggest that this, or any other instrument, could adequately detect long-term 
psychosocial consequences of screening mammography.  
 
After translating and adapting the PCQ into Danish the instrument was tested for content validity in 
a setting of abnormal and false-positive screening mammography. It was found that the PCQ 
captured important negative psychosocial consequences of abnormal screening mammography. 
However, the measure lacked content coverage for women receiving abnormal and false-positive 
screening results.  
 
Fifteen new items were added to the Danish version of the PCQ in order to broaden the spectrum of 
the psychosocial consequences of abnormal screening mammography covered by the measure. The 
additional items stem entirely from the qualitative findings of the study. This process resulted in a 
new draft questionnaire containing 33 items. The psychometric properties of the 33-item measure 
were explored in groups of women having normal, abnormal and false-positive screening 
mammography and women diagnosed with breast cancer.  
 
The statistical analyses (using international gold standards) revealed 27 “good” items measuring 
different attributes of the same overall construct; the psychosocial consequences of abnormal 
screening mammography. Six subscales (including altogether 25 items) covered anxiety, behaviour, 
dejection, sexuality, sleep and breast examination. Two single items covered feeling less attractive 
and keeping busy to take mind off things.  
The instrument also included an additional single item measuring sick leave. 
 
The 33-item questionnaire was not relevant and did not cover the specific psychosocial 
consequences occurring after final false-positive diagnosis. To cover these specific psychosocial 
consequences a draft version of a new measure containing 13 items was developed.  
 
The statistical analyses (again using international gold standards) exploring the psychometric 
properties of this 13-item questionnaire revealed four subscales. The subscales covered the impact 
on the women’s existential values, relationship with their social network, being less or more 
relaxed/calm, and less or more anxious about breast cancer/belief in having or not-having breast 
cancer 
 
As a result of this work preliminary evidence for a valid and reliable condition-specific instrument 
measuring psychosocial consequences of abnormal and false-positive screening mammography has 
been established. This valid condition-specific questionnaire consists of two parts, measuring; 
1. psychosocial consequences of abnormal screening mammography (part 1) 
2. long-term psychosocial consequences of false-positive screening mammography (part 2) 
The instrument is entitled Consequences of Screening on Breast Cancer (COS-BC). 
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The PhD study shows that none of the quantitative studies of the psychosocial consequences of 
screening mammography conducted previously, have used adequate questionnaires. Although using 
inadequate measures, all of these studies reported consistently negative short-term psychosocial 
consequences of false-positive screening mammography. In contrast, the results of studies of long-
term psychosocial consequences were ambiguous. This is most likely due to the inadequacy of the 
measures used.  
 
Given the inadequacy of the measure used to assess long-term psychosocial consequences, the 
results of previously conducted studies do not provide conclusive evidence of such consequences. 
Hence, the conclusions drawn from these studies regarding long-term psychosocial consequences of 
false-positive results of screening mammography should remain tentative. 
 
This PhD study shows that having an abnormal screening mammography causes significant 
negative psychosocial consequences. Two weeks after abnormal screening mammography the 
negative consequences decrease. However, they are still of measurable significance. The study also 
shows that women’s attitudes towards existential values change significantly from one to six 
months after a false-positive screening mammography. Women also experienced an impact on the 
relationship to their social network, they felt more or less relaxed and calm and, finally, they were 
either more or less confident/anxious about having breast cancer.  
 
The changes after the false-positive result can only be regarded as effects of a fear induced by the 
abnormal screening mammography and later the relief induced by the final false-positive result. It is 
difficult to regard these changes as anything but harm caused by the screening programme. 
 
14.2. Implications for practice and research 
14.2.1. Implications for practice 
This study shows that there are substantial negative psychosocial consequences associated with 
having an abnormal screening mammography later confirmed to be false-positive. Consequently, 
the number of women having false-positive screening mammography should be kept to a minimum.  
Letters and folders posted at invitation to screening should contain information on the negative 
psychosocial consequences arising from abnormal and false-positive screening results. This 
information should be based on the new understanding of psychosocial consequences of screening 
mammography revealed in the present study. This would make the information on benefits and 
harm of breast cancer screening more balanced and allow the women invited to make an informed 
choice. 
 
14.2.2. Implications for research 
The COS-BC has been translated into Dutch, English and Norwegian and is currently in use in a 
major Danish survey. Data from the Danish survey and from studies in other countries may provide 
valid new knowledge, especially about the long-term psychosocial consequences of false-positive 
screening mammography.  
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With an adequate instrument available it would be of interest if more studies on psychosocial 
consequences of breast cancer screening were conducted in countries running breast screening 
programmes. Countries that have not yet implemented breast cancer screening should conduct 
studies on psychosocial consequences of false-positive screening mammography prior to their 
implementation in order to fulfil the international criteria of screening.  
 
Results from new surveys using the COS-BC may generate additional new understanding of the 
detailed measurement of psychosocial consequences of screening mammography. The results from 
such studies would contribute to the balance sheet of the benefits versus the harm of the screening 
programme. This can be used as a part of the decision-making process for the implementation, or 
non-implementation, of breast cancer screening.  
 
There is a need for valid instruments with high content validity and good psychometric properties in 
the research area of psychosocial consequences of screening for any cancers. Some items of the 
COS-BC are specific for women participating in breast cancer screening. The relevance of the 
COS-BC, without the breast cancer specific items, is currently being explored in the setting of lung 
cancer screening. It is also planned to test the instrument in a setting of cervical cancer screening 
and hopefully in the future, in other cancer screening programmes. 
 
The ultimate goal is to establish core-items and core-subscales relevant for any kind of cancer 
screening. Using the core-questionnaire, COS, specific items can be added, relevant to the specific 
cancer screening programme and generated from interviews with the target populations. 
  
The core-questionnaire COS would make it possible to potentially compare the extent of the 
psychosocial consequences of false-positive screening results in different cancer screening 
programmes. Adding specific items relevant to each cancer screening programme to the COS would 
potentially make it possible to demonstrate the psychosocial consequences of false-positive results 
in a particular screening programme, for example in colorectal cancer screening. 
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16. Abbreviations and professional terms 
 
 
Carcinoma in situ, CIS Carcinoma in situ is a condition in between being healthy and 
having a cancer. 
 
CFA Confirmatory factor analyses. 
 
Condition-specific questionnaire A condition-specific questionnaire measures a specific 
condition in a specific population in contrast to a generic 
questionnaire that measures overall concepts e.g. health status, 
anxiety, depression, psychiatric morbidity etc. 
 
COS An acronym of Consequences of Screening. COS is a core-
questionnaire that encompasses core-items and core-subscales 
relevant for any kind of cancer screening. 
 
COS-BC An acronym of Consequences of Screening on Breast Cancer. 
The COS-BC is a condition-specific questionnaire consisting 
of two parts, measuring: 
• psychosocial consequences of abnormal screening 
mammography (part 1) 
• long-term psychosocial consequences of false-positive 
screening mammography (part 2) 
 
CTT Classical Test Theory. 
 
Differential item functioning, DIF Differential item functioning is where an item functions 
differently in subpopulations such as in an intervention group 
and a control group. 
 
DNBH The Danish National Board of Health. 
 
EU The European Union. 
 
False negative screening result A sick person having a normal screening test. 
 
False positive Abbreviation for “false-positive screening mammography”. 
 
False positive screening result A healthy person having an abnormal screening test result. 
 
Focus group interviews Group interviews where both the issue(s) discussed and the 
participants in the group are focused. 
 
Generic questionnaire A generic questionnaire measures overall concepts e.g. health 
status, anxiety, depression, psychiatric morbidity etc. in 
contrast to a condition-specific measures that is developed to 
measure a specific condition in a specific population. 
 
GHQ The General Health Questionnaire, a generic questionnaire 
designed as a screening tool of psychiatric disorders in non-
psychiatric clinical settings such as primary care or general 
medical out-patients. 
 117
 
HADS The Hospital Anxiety and Depression Scale, a generic 
questionnaire developed to provide a reliable screening test 
for psychiatric disorders in patients in non-psychiatric hospital 
departments. The HADS has two subscales; a depression and 
an anxiety subscale. 
 
Incidence screening round The second or following screening rounds. 
 
Interval cancer A cancer that appears in between two screening rounds. 
 
IRT Item Response Theory. 
 
Item A question with its corresponding response options. 
 
Latent variable, latent trait A variable which is unobservable but is supposed to enter into 
the structure of a system under study, such as for example 
depression.  
 
Long-term consequences Consequences that occur more that three months after the 
event. 
 
Mammography X-ray examination of the breast. 
 
Mastectomy Surgical removal of the breast. 
 
Meta-analysis The summarisation of evidence on an issue by combined 
analysis of distinct studies. 
 
Needle biopsy Cells that have been taken out with a thin piece of metal. 
 
NHP The Nottingham Health Profile, a generic health status 
questionnaire. 
 
Occult For example a disease not accompanied by readily discernible 
signs or symptoms. 
 
PCQ The Psychological Consequences Questionnaire. 
 
PCQ-DK The Danish version of the Psychological Consequences 
Questionnaire. 
 
PCQ-DK33 A 33-item Danish questionnaire with high content validity for 
women having an abnormal screening mammography. 
 
Pilot study A study, usually on a small scale, carried out prior to the main 
study, primarily to gain information to improve the efficiency 
of the main study. 
 
PLISSIT model A model that offers an approach to communicating with 
people about sexuality. 
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Positive predictive value The positive predictive value of a screening test expresses 
how many persons with a positive screening result actually 
have the disease. 
 
Prevalence The prevalence of e.g. disease is the number of existing 
persons with the disease in a population at a designated time. 
 
Prevalence screening round The first screening round. 
 
Psychometric properties Psychometric is relating to the measurement of mental 
abilities and qualities. Psychometric properties are in this 
context an overarching term for the validity and reliability of a 
psychometric measure. 
 
Randomised controlled trial In a randomised trial persons are by lottery chosen to be put in 
either one or more intervention groups or a control group. In 
the control group persons are having for example placebo 
treatment or health care as usual. The persons in the 
intervention group are given the treatment or the intervention 
explored. 
 
Response categories The available possibilities of responses to a question in an 
item. 
 
Response options The different possibilities of responding to a question in an 
item. 
 
Salutogenic Salutogenesis is a view of health which suggests that health is 
a dynamic process between opposite positions of total 
wellness and total illness. The development of positive 
resources is required for good health. These resources are 
infinitely variable and unique to the individual. They may be 
personal such as high self-esteem and cognitive ability or 
external such as living in a safe environment and having a 
good social support. 
 
Screening mammography A screening mammography is one done in women who have 
no signs of breast cancer. It usually involves two X-rays of 
each breast. 
 
Screening recall clinics Persons having an abnormal screening test will have further 
examinations to find out if the screening test result is true or 
false. These further examination are conducted in so called 
recall clinics.  
 
Sensitivity A screening test’s ability to find persons with disease. 
 
SF-36 Short-form-36, a generic health status questionnaire. 
 
Short-term consequences Consequences that occur within three months after the event. 
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Specificity A screening test’s ability to identify healthy persons. 
 
STAI The State-Trait Anxiety Inventory, a generic questionnaire 
measuring both state and trait anxiety in normal adults. 
 
Validity, concurrent Contains convergent validity and divergent validity, for 
example when a new measure is correlated to a existing valid 
measure the correlation between the measure can converge 
and diverge. 
 
Validity, construct  The overarching concept of validity. Almost any kind of 
information about a test can contribute to an understanding of 
its construct validity. Fundamentally, all validation is 
construct validation, in the sense that all validity evidence 
contributes to (or undercuts) the empirical grounding or 
trustworthiness of the score interpretation”. 
 
Validity, content Content validity encompasses content relevance and content 
coverage. If questions, response categories and/or items are 
relevant for the target population they are said to have content 
relevance. If questions, response categories and/or items are 
covering the area explored they are said to have content 
coverage. 
 
Validity, criterion Concurrent validity and predictive validity are unified into the 
term criterion validity. For further explanation see those kinds 
of validity. 
 
Validity, known group Also called extreme groups validity. A test where the measure 
is given to two groups; one of which has the trait or behaviour, 
and the other which does not. The former group should score 
significantly higher (or lower) on the instrument. 
 
Validity, predictive An example of predictive validity could be a test’s ability to 
predict if students tested before they were admitted to 
university whether or not they would graduate three years later 
as bachelors.  
Concurrent validity and predictive validity are unified into the 
term criterion validity. For further explanation see those kinds 
of validity. 
 
WHO World Health Organisation. 
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17. Appendix I - the Psychological Consequences Questionnaire (PCQ) 
 
Part 1, negative psychological consequences of the actual act of participation in breast cancer 
screening: 
 
We would like to find out about women’s experiences of the Breast X-ray Program. We would 
therefore like you to answer the questions on this questionnaire as best you can: 
 
Over the last week how often have you experienced the following things because of thoughts and 
feelings about breast cancer? 
 
1. Had trouble sleeping (P) 
2. Experienced a change in appetite (P) 
3. Been unhappy or depressed (E) 
4. Been scared and panicky (E) 
5. Felt nervous or strung up (E) 
6. Felt under strain (E) 
7. Found you have been keeping things from those who are close to you (S) 
8. Found yourself taking things out on other people (S) 
9. Found yourself noticeable withdrawing from who are close to you (S) 
10. Had difficulty doing things around the house which you  normally do (P) 
11. Had difficulty meeting work or other commitments (P) 
12. Felt worried about your future (E) 
 
 
Response options: 
 
0) Not at all 
1) Rarely 
2) Some of the time 
3) Quite a lot of the time 
 
 
 
Sub-scales:  
 
(E) Emotional 
(P) Physical 
(S) Social 
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Part 2, positive psychological consequences of the actual act of participation in breast cancer 
screening: 
 
All things considered, would you say your experiences at the Breast X-ray Program have caused 
any of the following? 
 
1. A sense of reassurance that you do not have breast cancer (E) 
2. Feeling more relaxed (E) 
3. Improved relationship with friends or relations (S) 
4. Feeling more able to do things which I normally do (P) 
5. Feeling more able to meet your home and/or work responsibilities (P) 
6. Feeling more hopeful about the future (E) 
7. Feeling less anxious about breast cancer (E) 
8. Getting on better with those around you (S) 
9. Been sleeping better (P) 
10. A greater sense of well being (E) 
 
 
 
Response options: 
 
0) Not at all 
1) A little bit 
2) Quite a bit 
3) A great deal 
 
 
 
Sub-scales:  
 
(E) Emotional 
(P) Physical 
(S) Social 
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18. Appendix II - overall search strategy 
 
The overall search strategy for the database MEDLINE: 
 
("stress"[MeSH Terms] OR stress[Text Word] OR "nervous system physiology"[MeSH Terms] OR 
nervous system physiology[Text Word] OR "behavioral disciplines and activities"[MeSH Terms] 
OR "psychological phenomena and processes"[MeSH Terms] OR "behavior and behavior 
mechanisms"[MeSH Terms] OR "adverse effects"[Subheading] OR adverse effects[Text Word] OR 
"arousal"[MeSH Terms] OR arousal[Text Word] OR "adaptation, psychological"[MeSH Terms] 
OR coping[All Fields] OR (adverse[All Fields] AND consequences[All Fields]) OR (emotional[All 
Fields] AND consequences[All Fields]) OR “false positive reactions”[MeSH Terms] OR false 
positive reactions[Text Word] OR false positive[All Fields] OR "diagnostic errors"[MeSH Terms] 
OR diagnostic errors[Text Word]) AND ("mammography"[MeSH Terms] OR mammography[Text 
Word] OR "breast"[MeSH Terms] OR breast[Text Word]) AND ("mass screening"[MeSH Terms] 
OR mass screening[Text Word] OR screening[All Fields]) AND ("Outcome Assessment (Health 
Care)"[MeSH Terms] OR Outcome Assessment (Health Care)[Text Word] OR 
"Questionnaires"[MeSH Terms] OR Questionnaires[Text Word]) 
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19. Appendix III - translation report 
 
Psychological Consequences Questionnaire (PCQ): 
 
Spørgeskema om psykiske følger af røntgenundersøgelse af brystet (mammografi). 
(sprogpanel) 
 
Spørgeskema 
til kvinder der har fået 
brystet røntgen-undersøgt (mammografi). 
(lægpanel) 
 
 
 
 
Grundlæggende beslutninger for del 1 
 
Hanne & John, efter fokusgruppe130202, i perioden 13. til 20. februar 2002: 
 
Besvarelserne skal så vidt mulig være grader. Det er i langt de fleste tilfælde mere naturligt at 
besvare de eksisterende spørgsmål - og de nye spørgsmål - med grader og ikke frekvenser. Hvor det 
ikke er muligt at besvare spørgsmålene med grader bruges frekvenser. 
 
Graderne bliver: 
• Ja, meget 
• Ja, noget 
• Ja, lidt 
• Nej Slet 
 
Alternativt til den af sprogpanelet foreslåede frekvens-svarmulighederne (som blev godkendt af 
lægpanelet og ingen i fokusgruppen 130202 havde bemærkninger til), foreslås nedenstående 
svarmuligheder:  
• Ja, mange gange  
• Ja, nogle gange 
• Ja, få gange 
• Nej, slet ikke 
 
Til fokusgruppen 200202 præsenteredes ovenstående svarmuligheder, både grader, og de to 
frekvens- svarmuligheder. Fokusgruppen 200202 valgte den nye forslåede frekvens-svarmulighed. 
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We would like to find out about women’s experiences of the Breast X-ray Program. We would 
therefore like you to answer the questions on this questionnaire as best you can: 
 
Del 1 
 
Vi vil gerne vide hvilke oplevelser kvinder har i forbindelse med røntgen-
undersøgelse af brystet (mammografi). Derfor vil vi bede Dem besvare de følgende 
spørgsmål, så godt De kan. (sprogpanel) 
 
For at blive bedre til vort arbejde, vil vi gerne vide hvilke oplevelser De har haft i 
forbindelse med røntgen-undersøgelse af brystet (mammografi). Besvar derfor 
venligst følgende spørgsmål, så godt De kan. (lægpanel) 
 
Gennem dette spørgeskema, håber vi på, at få at vide hvilke oplevelser De har haft i 
forbindelse med røntgen-undersøgelse af brystet (mammografi). Besvar derfor 
venligst følgende spørgsmål. (H&J 180202) 
 
Gennem dette spørgeskema, håber vi på, at få at vide hvordan kvinder, der bliver 
inviteret til en befolkningsundersøgelse, har det før og efter røntgen-undersøgelse af 
brystet (mammografi). Besvar derfor venligst følgende spørgsmål uanset om De agter 
at få brystet undersøgt. (H&J 280202) 
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Over the last week how often have experienced the following things because of thoughts and 
feelings about breast cancer: 
 
Hvor ofte har De i den sidste uges tid oplevet følgende på grund af følelser og tanker 
om brystkræft? (sprogpanel) 
 
 
 
Del 1 
 
Hvor ofte har De - i den sidste uges tid - oplevet følgende på grund af tanker om 
brystkræft? (lægpanel) 
 
Har De - i den sidste uges tid - oplevet følgende på grund af tanker om brystkræft? 
(HT og JB, 150202). 
 
 
 
 
 
De originale svarmuligheder fra PCQ ? Not at all 
? Rarely 
? Some of the time 
? Quite a lot of the time
Svarmuligheder oversat af sprogpanel og godkendt af lægpanel 
 
? Nej, slet ikke 
? Ja, men sjældent 
? Ja, ind imellem 
? Ja, ofte 
Svarmuligheder oversat af sprogpanel og godkendt af lægpanel med 
anden grafisk layout (H&J180202) 
 
Ja, ofte ? 
Ja, ind imellem ? 
Ja, men sjældent ? 
Nej, slet ikke ? 
Svarmuligheder foreslået af HT og JB, alternativt til ovenstående 
frekvenser med anden grafisk layout og anden rækkefølge (180202). 
 
Ja, mange gange ? 
Ja, nogle gange ? 
Ja, få gange ? 
Nej, slet ikke ? 
Nye svarmuligheder foreslået af HT og JB, der hvor ”grader” er mere 
forståelige og anvendelige en ”frekvenser”. Desuden er layout ændret og  
ligeså rækkefælgen (180202). 
 
Ja, meget ? 
Ja, noget ? 
Ja, lidt ? 
Nej, slet ikke ? 
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Nyt design og de nye svarmuligheder som fokusgruppen 200202 fortrak frem for det tidligere 
design og den af sprogpanelet foreslåede svarmulighed. De valgte selv hvor man skulle svare 
med grader og hvor man skulle svare med frekvenser. 
 
Har De - i den sidste uges tid - oplevet følgende på grund af tanker om brystkræft? 
 
Ændret pga. ovenstående generelle betragtninger 280202 Nej, 
slet ikke 
Ja, 
lidt 
Ja, 
noget 
Ja, 
meget 
 Nej, 
slet ikke 
Ja, 
få 
gange 
Ja, 
nogle 
gange
Ja, 
mange 
gange 
1.   Jeg har været længe om at falde i søvn. ? ? ? ? 
 
Fokusgruppe 130302: Hvis man ikke længere er seksuel 
aktiv, og dermed ikke har gjort sig tanker om 
nedenstående, mangler svarmuligheden ”Ved ikke” til 
disse to items. 
Nej, 
slet 
ikke 
Ja, 
lidt 
Ja, 
noget 
Ja, 
meget
Ved 
ikke 
30. Jeg har haft mindre lyst til sex. ? ? ? ? ? 
31. Jeg har haft mindre lyst til at få kærtegnet mit bryst. ? ? ? ? ? 
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1. 
Had trouble sleeping (P)
(sprogpanel) Jeg har haft søvnproblemer. 
 (lægpanel) Jeg har haft søvnproblemer.
På båndet fra fokusgruppe130202, er der både problemer med at sove, og falde i søvn. 
Søvnproblemer opfattes som om man har svært ved at sove, hvorfor dem der har svært ved at 
falde i søvn, ikke nødvendigvis ville krydse af i andet end ”Nej slet ikke”. Derfor erstattes dette 
spørgsmål med to spørgsmål fra NHP’s søvnskala, spørgsmål 4 og 5. I fokusgruppen 200202 
fortalte en kvinde desuden at hun havde måtte tage sovepiller for at sove, NHP 1, søvnskala:
(H&J efter fokusgruppe130202)  1a – Jeg er længe om at falde i søvn.
(H&J efter fokusgruppe130202) 1b – Jeg sover dårligt om natten.
(H&J efter fokusgruppe200202) 1c - Jeg har taget piller for at sove.
(H&J efter fokusgruppe270202)  1a – Jeg har været længe om at falde i søvn.
(H&J efter fokusgruppe270202) 1b – Jeg har sovet dårligt om natten.
(H&J efter fokusgruppe270202) 1c - Jeg har taget piller for at sove.
2. 
Experienced a change in appetite (P)
(sprogpanel) Min appetit har ændret sig.
(lægpanel) Min appetit har ændret sig.
3. 
Been unhappy or depressed (E)
(sprogpanel) Jeg har været ked af det eller deprimeret.
(lægpanel) 3a - Jeg har været ked af det.
(lægpanel) 3b - Jeg har været deprimeret.
4. 
Been scared and panicky (E)
(sprogpanel) Jeg har været angst og har været ved at gå i panik.
(sprogpanel) Jeg har været bange og har været ved at gå i panik.
(lægpanel)  4a - Jeg har været bange for at have brystkræft
(H&J – kvinder med brystkræft skal også udfylde skemaet og mere tro mod originalskemaet)
4a - Jeg har været bange.
(lægpanel) 4b – Jeg har været ved at gå i panik.
5. 
Felt nervous or strung up (E)
(sprogpanel) Jeg har været nervøs.
(lægpanel) Jeg har været nervøs.
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6. 
Felt under strain (E)
(sprogpanel) Jeg har været stresset.
(lægpanel) Jeg har oplevet hverdagen uoverkommelig.
(fokusgruppe130202, forståelsesproblem med ”uoverkommelig”, foreslås)
(fokusgruppe130202) Det har været svært at komme gennem hverdagen.
(fokusgruppe270202, forståelsesproblemer og overlap, foreslås) 
(fokusgruppe270202, og godkendt af fokusgruppe130302) Jeg har følt, at tiden har været lang.
7. 
Found you have been keeping things from those who are close to you (S)
 (sprogpanel) Jeg har holdt mine tanker for mig selv.
(lægpanel) Jeg har holdt mine tanker for mig selv.
8. 
Found yourself taking things out on other people (S)
(sprogpanel) Jeg har ladet det gå ud over andre.
(lægpanel) Jeg har været opfarende.
(fokusgruppe130202, forståelsesproblem med ordet ”opfarende”, hvorfor følgende foreslås. Der 
var enighed om at ”irritabel” og ”uligevægtig”, var to forskellige ting og ”pirrelig” og 
”irritabel” lignede hinanden) 
(fokusgruppe130202, fortrukket af fokusgruppe200202) 8a - Jeg har været irritabel.
(fokusgruppe130202, fravalgt af fokusgruppe200202) Jeg har været pirrelig.
(fokusgruppe130202. Fokusgruppe270202, sprogligt problem med uligevægtig)
Jeg har været uligevægtig.
(fokusgruppe270202) 8b - Jeg har været ude af balance.
9. 
Found yourself noticeable withdrawing from who are close to you (S)
(sprogpanel) Jeg har trukket mig væk fra mine nærmeste.
(lægpanel, fravalgt af fokusgruppe200202) Jeg har trukket mig væk fra mine nærmeste.
(fokusgruppe130202) Jeg har trukket mig ind i mig selv.
(fokusgruppe130202) Jeg har været mere stille.
(fokusgruppe,bånd130202, fravalgt af fokusgruppe200202) Jeg har været mere tavs.
Fokusgruppe200202 blev præsenteret for de ovenstående spørgsmål og angav at de to øverste 
lignede hinanden og de fortrak nummer to og at de to nederste også lignede hinanden og de 
fortrak de øverste af disse to, således at dette item herefter er to items:
(fokusgruppe200202) 9a - Jeg har trukket mig ind i mig selv.
(fokusgruppe130202) 9b – Jeg har været mere stille.
(fokusgruppe200202) 9b – Jeg har mere stille.
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10. 
Had difficulty doing things around the house which you  normally do (P)
(sprogpanel) Jeg har haft svært ved at klare det huslige arbejde.
(lægpanel) Jeg har haft svært ved at klare opgaver i hjemmet.
11. 
Had difficulty meeting work or other commitments (P)
(sprogpanel) Jeg har haft svært ved at klare mit arbejde eller lignende opgaver.
(lægpanel) Jeg har haft svært ved at klare mit arbejde eller andre lignende opgaver.
12. 
Felt worried about your future (E)
(sprogpanel) Jeg har været bekymret for min fremtid.
(lægpanel) Jeg har været bekymret for min fremtid.
Ekstra 
(fokusgruppe130202) Jeg har haft hovedpine.
Ekstra 
(fokusgruppe130202) Jeg har været træt.
Ekstra 
(fokusgruppe130202) Jeg har været bekymret.
Ekstra 
(fokusgruppe130202) Jeg har ryddet mere op i hjemmet.
(H&J280202 ændre dette spørgsmål, fokusgruppe130202 foreslog selv noget i denne retning 
som supplerende items) Jeg har flygtet fra min tanker, ved at foretage mig noget praktisk.
 
Ekstra 
(fokusgruppe,bånd130202) Jeg har undersøgt mit brystet mere.
(fokusgruppe,bånd200202) Jeg har undersøgt mit brystet.
Ekstra 
(fokusgruppe,bånd130202) Jeg har betragtet mit bryst i spejlet mere.
(fokusgruppe,bånd200202) Jeg har betragtet mit bryst i spejlet.
Ekstra 
(fokusgruppe,bånd130202) Jeg har haft flere symptomer (prikken, stikken, smerter) fra mit 
bryst.
(fokusgruppe,bånd200202) Jeg har haft symptomer (prikken, stikken, smerter) fra mit bryst.
Ekstra 
(fokusgruppe,bånd130202) Jeg har haft svært ved at koncentrere mig.
Ekstra 
(fokusgruppe,bånd130202) Jeg har været urolig.
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Ekstra 
(fokusgruppe,bånd130202) Jeg har været sygemeldt.
 (fokusgruppe200202)Hvor mange sygedage har De haft i den sidste uges tid?
0 dage, 1-2 dage, 3-4 dage, 5 eller mere
Ekstra 
 
(fokusgruppe,bånd130202) Jeg har været rastløs.
Ekstra 
 
(fokusgruppe130302) Jeg har følt mig mindre attraktiv som kvinde.
Ekstra 
 
(fokusgruppe200302) Jeg har haft mindre lyst til sex, end jeg plejer.
(fokusgruppe270302) Jeg har haft mindre lyst til sex.
Ekstra 
 
(fokusgruppe200302) Jeg har haft mindre lyst til at få kærtegnet mit bryst.
Ekstra 
 
(fokusgruppe260902) Jeg har følt mig handlingslammet.
 
Subscales:  
 
(E) Emotionel 
(P) Physical 
(S) Social 
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Grundlæggende beslutninger for del 2 
 
Hanne & John, efter fokusgruppe130202 i perioden 13. til 20. februar 2002: 
 
Svarmulighederne foreslået af fokusgruppen130202 virker ikke. Man kan ikke kun have ”ja, nej og  
det samme”. De originale virker slet ikke. Det er ændringer vi er interesseret i at måle, hvorfor der 
bør være flere svarmuligheder. I Health Measuring Questionaire er der ni svarmuligheder, fire 
negative, en neutral (det samme som før) og fire positive. Vi har valgt at have tre grader/frekvens i 
første del af dette spørgeskema, hvorfor det ville være logisk at have syv svarmuligheder i del to, 
nemlig tre negative, et neutralt og tre positive.  Vi vælger derfor også at ændre grafikken radikalt. 
 
I de originale svarmuligheder er der et problem, da nogle af spørgsmålene er identiske eller 
sammenfaldende i de to dele. Det gælder disse spørgsmål angivet med originale numre: 
 
Del 1, spørgsmål 6 og del 2 spørgsmål 4 
Del 1, spørgsmål 10 og del 2 spørgsmål 5 
Del 1, spørgsmål 11 og del 2 spørgsmål 5 
Del 1, spørgsmål 1 og del 2 spørgsmål 9 
 
Hvis man forestiller sig, at en kvinde ved baseline-målingen svarer at hun ingen søvnproblemer har. 
Derefter svarer hun i udredningsfasen som falsk positiv at hun har mange søvnproblemer. En måned 
efter svarer hun at hun har nogen eller lidt søvnproblemer. Samtidig skal hun nu for første gang 
besvare del 2 og her krydser hun måske af, at hun har fået lidt mindre søvnproblemer end før 
undersøgelser. Årsagen kan være at hun har glemt hvordan hun havde det ved baseline, men krydser 
af i forhold til den bedring hun har oplevet fra udredningsfasen til nu. 
 
Der er således klare problemer med ovenstående sammenfaldende spørgsmål i del 1 og 2. Desuden 
er det vi ønsker at måle som ændringer i ”positive” eller ”negativ” retning ikke små konkrete 
hændelser, men større diffuse eksistentielle ændringer. Det er også sådanne spørgsmål kvinderne 
selv foreslår i fokusgruppen130202. 
 
Med ovenstående to argumenter, besluttes det at sløjfe spørgsmålene 4,5 og 9, fra det originale 
spørgeskemas del 2. Det giver i den oversatte form, der er godkendt af lægpanelet, spørgsmålene 
4,5,6 og 10. 
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All things considered, would you say your experiences at the Breast X-ray Program have caused 
any of the following: 
Del 2 
Har Deres oplevelser med røntgenundersøgelse af brystet, alt taget i betragtning, 
medført noget af følgende: (sprogpanel) 
 
Del 2 
Har Deres oplevelser efter røntgen-undersøgelsen af brystet, alt taget i betragtning, 
medført følgende: (lægpanel) 
 
Del 2 
Har Deres oplevelser efter undersøgelserne af brystet er afsluttet, alt taget i 
betragtning, medført følgende: (fokusgruppe130202) 
 
 
 (fokusgruppe260902) Sær kun ét kryds ved hvert spørgsmål 
 
De originale svarmuligheder fra PCQ ? Not at all 
? A little bit  
? Quite a bit 
? A great deal 
Oversatte svar muligheder fra sprogpanel og godkendt af lægpanel ? Nej, slet ikke 
? Ja, lidt 
? Ja, noget 
? Ja, meget 
Svarmuligheder forslået af fokusgruppe130202 ? Nej 
? Det samme som før 
? Ja 
 
Svarmuligheder og grafik foreslået af H&J: 
 
? ? ? ? ? ? ? 
Meget mindre Noget mindre Lidt mindre Det samme 
som før 
Lidt mere Noget mere Meget mere
 
Mindre 
 
  
Mere 
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1. 
A sense of reassurance that you do not have breast cancer (E)
(sprogpanel) Jeg har tillid til, at jeg ikke har brystkræft.
(lægpanel) Jeg stoler på, at jeg ikke har brystkræft.
Da brystkræft patienter også skal besvare spørgeskemaet, må dette spørgsmål og spørgsmål 7 
(begge del 2) fjernes fra de spørgeskemaer som udsendes til kvinder med sandt positiv svar. 
Fokusgrupperne 200202 og 270203 fandt dette og spørgsmål 7 relevante.
(Efter beslutningen om nyt grafisk design med 7 svarmuligheder, kan ”stole på” ikke fastholdes, 
hvorfor H&J180202 foreslår at det erstattes med ”tillid”):
Efter undersøgelserne har jeg tillid til at jeg ikke har brystkræft.
Fokusgruppe 130302 fandt dette spørgsmål relevant, men påpegede at man skal passe på når der 
står et ”ikke” i spørgsmålet. H&J130302 foreslår derfor:
(fokusgruppe200202) Efter undersøgelserne er min tillid til, at jeg ikke har brystkræft.
 
2.    
Feeling more relaxed (E)
(sprogpanel) Jeg er mere afslappet
(lægpanel) Jeg er mere afslappet end før røntgen-undersøgelsen
(fokusgruppe130202) Jeg er mere afslappet end før undersøgelserne
(fokusgruppe200202) Efter undersøgelserne føler jeg mig: og så afslappet i svarmulighederne
3. 
Improved relationship with friends or relations (S)
(sprogpanel) Mit forhold til venner og familie er blevet bedre
(sprogpanel) Jeg har fået det bedre med mine venner eller familie
(lægpanel) Mit forhold til familie og venner er blevet bedre
3a (fokusgruppe130202) Mit forhold til familien er blevet tættere end før undersøgelserne
3b (fokusgruppe130202) Mit forhold til vennerne er blevet tættere end før undersøgelserne
Er disse to spørgsmål sammenfaldene med spørgsmål 8? Skal diskuteres i fokusgruppe200202.
 3a (fokusgruppe200202) Efter undersøgelserne er mit forhold til min familie:
3b (fokusgruppe200202) Efter undersøgelserne er mit forhold til vennerne:
4. 
Feeling more able to do things which I normally do (P)
(sprogpanel) Jeg har lettere ved at gøre det, jeg plejer
(sprogpanel) Jeg kan bedre klare det, jeg plejer
(lægpanel) Hverdagen er blevet mere overkommelig
(fokusgruppe130202) Det er lettere at komme gennem hverdagen end før undersøgelserne
UDGÅR 
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5. 
Feeling more able to meet your home and/or work responsibilities (P)
(sprogpanel) Det er lettere for mig at klare opgaver i hjemmet og/eller på arbejde
5a – Det er blevet lettere for mig at klare opgaver i hjemmet
(lægpanel) Det er blevet lettere for mig at klare mit arbejde eller andre lignende opgaver
(fokusgruppe130202) Det er blevet lettere for mig at klare mit arbejde eller andre lignende 
opgaver end før undersøgelserne
UDGÅR 
6. 
Feeling more hopeful about the future (E)
(sprogpanel) Jeg ser lysere på fremtiden
(lægpanel) Jeg ser lysere på fremtiden
(fokusgruppe130202) Jeg ser lysere på fremtiden end før undersøgelserne
(fokusgruppe200202) Efter undersøgelserne er mit syn på fremtiden blevet: og så ”lys” i 
svarmulighederne
7.  
Feeling less anxious about breast cancer (E)
(sprogpanel) Jeg er mindre bekymret for brystkræft
(lægpanel) Jeg er blevet mindre bekymret for brystkræft
(H&J, efter nyt design og svarmuligheder) Efter undersøgelserne er jeg er blevet mindre bekymret 
for brystkræft:
(fokusgruppe200202) Efter undersøgelserne er min bekymring for brystkræft:
8. 
Getting on better with those around you (S)
(sprogpanel) Jeg har det bedre med andre mennesker
(lægpanel) Jeg har fået det bedre med andre mennesker
(fokusgruppe200202) Efter undersøgelserne er mit forhold til andre mennesker:
Se spørgsmål 3a og 3b. 
9. 
Been sleeping better (P)
(sprogpanel) Jeg sover bedre
(lægpanel) Jeg sover bedre 
(fokusgruppe130202) Jeg sover bedre end før undersøgelserne 
UDGÅR 
10. 
A greater sense of well being (E)
(sprogpanel) Jeg har en større følelse af velvære end før undersøgelserne
(lægpanel) Jeg har fået en større følelse af velvære 
(fokusgruppe130202) Jeg har fået en større følelse af velvære end før undersøgelserne
(fokusgruppe200202) Efter undersøgelserne er min følelse af velvære:
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Ekstra 
(fokusgruppe130202) Jeg har fået mere ro end før undersøgelserne
(fokusgruppe260902) Efter undersøgelserne er min fornemmelse af indre ro:
Ekstra 
(fokusgruppe130202) Jeg er blevet mere glad for livet end før undersøgelserne
(fokusgruppe200202) Efter undersøgelserne er min glæde ved livet:
 
Ekstra 
(fokusgruppe130202) Jeg tænker mere over livet end før undersøgelserne
(fokusgruppe200202) Efter undersøgelserne har jeg tænkt over livet:
 
Ekstra 
(fokusgruppe130202) Jeg sætter mere pris på livet end før undersøgelserne
(fokusgruppe200202) Efter undersøgelserne værdsætter jeg livet:
 
Ekstra 
(fokusgruppe130202) Jeg er mere bevidst om at leve end før undersøgelserne
(fokusgruppe260902) Efter undersøgelserne er jeg bevidst om at leve
 
 
Subscales:  
 
(E) Emotionel 
(P) Physical 
(S) Social 
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20. Appendix IV - the PCQ-DK33 (Danish version) 
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Spørgeskema 
til kvinder, der har fået 
brystet røntgen-undersøgt (mammografi) 
 
 
 
 
 
 
 
 
 
 
 
 
Gennem dette spørgeskema, håber vi på at få at vide, hvordan kvinder 
har det før og efter røntgen-undersøgelse af brystet (mammografi).  
 
 
  
 
 
 
Det er vigtigt, at De svarer på alle spørgsmålene. 
 
 
 
 
© Danmark: John Brodersen, Afdeling for Almen Medicin, IFSV, Københavns Universitet 2002 
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Har De - i den sidste uges tid - oplevet følgende på grund af tanker om brystkræft? 
 
 Nej, 
slet ikke 
Ja, 
lidt 
Ja, 
noget
Ja, 
meget
1.   Jeg har følt mig mindre attraktiv som kvinde. 
 
? 
 
? 
 
? 
 
? 
2.   Jeg har været bekymret. 
 
? 
 
? 
 
? 
 
? 
3.   Jeg har været bekymret for min fremtid. 
 
? 
 
? 
 
? 
 
? 
4.   Jeg har været bange. 
 
? 
 
? 
 
? 
 
? 
  
 
Nej, 
slet ikke 
 
 
Ja, 
lidt 
 
 
Ja, 
noget
 
 
Ja, 
meget
5.   Jeg har været irritabel. 
 
? 
 
? 
 
? 
 
? 
6.   Jeg har været stille. 
 
? 
 
? 
 
? 
 
? 
7.   Jeg har holdt mine tanker for mig selv. 
 
? 
 
? 
 
? 
 
? 
8.   Jeg har sovet dårligt om natten. 
 
? 
 
? 
 
? 
 
? 
9.   Jeg har været træt. 
 
? 
 
? 
 
? 
 
? 
  
 
Nej, 
slet ikke 
 
 
Ja, 
lidt 
 
 
Ja, 
noget
 
 
Ja, 
meget
 
10. Jeg har flygtet fra min tanker, ved at foretage mig noget 
      praktisk. 
 
? 
 
? 
 
? 
 
? 
11. Jeg har haft svært ved at koncentrere mig. 
 
? 
 
? 
 
? 
 
? 
12. Jeg har følt, at tiden har været lang. 
 
? 
 
? 
 
? 
 
? 
13. Min appetit har ændret sig. 
 
? 
 
? 
 
? 
 
? 
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Har De - i den sidste uges tid - oplevet følgende på grund af tanker om brystkræft? 
 
 Nej, 
slet ikke 
Ja, 
lidt 
Ja, 
noget
Ja, 
meget
14. Jeg har været ked af det. 
 
? 
 
? 
 
? 
 
? 
15. Jeg har været ude af balance. 
 
? 
 
? 
 
? 
 
? 
16. Jeg har undersøgt mit bryst. 
 
? 
 
? 
 
? 
 
? 
17. Jeg har været rastløs. 
 
? 
 
? 
 
? 
 
? 
  
 
Nej, 
slet ikke 
 
 
Ja, 
lidt 
 
 
Ja, 
noget
 
 
Ja, 
meget
18. Jeg har været nervøs. 
 
? 
 
? 
 
? 
 
? 
19. Jeg har været urolig. 
 
? 
 
? 
 
? 
 
? 
20. Jeg har været længe om at falde i søvn. 
 
? 
 
? 
 
? 
 
? 
21. Jeg har betragtet mit bryst i spejlet. 
 
? 
 
? 
 
? 
 
? 
  
 
Nej, 
slet ikke 
 
 
Ja, 
lidt 
 
 
Ja, 
noget
 
 
Ja, 
meget
22. Jeg har trukket mig ind i mig selv. 
 
? 
 
? 
 
? 
 
? 
23. Jeg har følt mig handlingslammet. 
 
? 
 
? 
 
? 
 
? 
24. Jeg har været deprimeret. 
 
? 
 
? 
 
? 
 
? 
 
25. Jeg har haft symptomer (prikken, stikken, smerter) 
      fra mit bryst. 
 
? 
 
? 
 
? 
 
? 
 
Vend 
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Har De - i den sidste uges tid - oplevet følgende på grund af tanker om brystkræft? 
 
 Nej, 
slet 
ikke 
Ja, 
få 
gange 
Ja, 
nogle 
gange 
Ja, 
mange 
gange 
 
26. Jeg har haft svært ved at klare mit arbejde eller andre 
      lignende opgaver. 
 
? 
 
? 
 
? 
 
? 
27. Jeg har haft hovedpine. 
 
? 
 
? 
 
? 
 
? 
28. Jeg har haft svært ved at klare opgaver i hjemmet. 
 
? 
 
? 
 
? 
 
? 
29. Jeg har været ved at gå i panik. 
 
? 
 
? 
 
? 
 
? 
30. Jeg har taget piller for at sove. 
 
? 
 
? 
 
? 
 
? 
 
 
 Nej, 
slet ikke
Ja, 
lidt 
Ja, 
noget
Ja, 
meget
Ved 
ikke 
31. Jeg har haft mindre lyst til sex. ? ? ? ? ? 
32. Jeg har haft mindre lyst til at få kærtegnet mit bryst. ? ? ? ? ? 
 
 
 
 
33. Hvor mange sygedage har De haft i den sidste uges tid? 
0 dage 1 - 2 dage 3 - 4 dage 5 dage eller mere 
 
? 
 
? 
 
? 
 
? 
 
Tak for hjælpen 
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21. Appendix V - the PCQ-DK33 (English version) 
 
All the items in the English version of the PCQ-DK33 has been translated and adapted using a 
bilingual panel and a lay panel. However, the five identified “poor” items (no’s 7, 9, 25, 27 and 30) 
have not been translated using the two panels but only been ad hoc translated for this thesis. The 
English version of the questionnaire has not been field tested and statistically validated. 
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Questionnaire 
for women 
who have undergone 
breast screening 
 
 
 
 
 
 
 
 
 
 
 
 
With this questionnaire we hope to find out how women feel both 
before and after breast screening.  
 
 
 
 
It is important that you answer all questions. 
 
 
 
 
© Denmark: John Brodersen, Department of General Practice, University of Copenhagen 2004 
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To what extent - over the last week - have you experienced the following because of thoughts 
about breast cancer? 
 
 Not 
at all 
A bit Quite 
a bit 
A lot 
1.   I have felt less attractive. 
 
? 
 
? 
 
? 
 
? 
2.   I have been worried. 
 
? 
 
? 
 
? 
 
? 
3.   I have been worried about my future. 
 
? 
 
? 
 
? 
 
? 
4.   I have felt scared. 
 
? 
 
? 
 
? 
 
? 
  
Not 
at all 
 
A bit 
 
Quite 
a bit 
 
A lot 
5.   I have been irritable. 
 
? 
 
? 
 
? 
 
? 
6.   I have been quieter than normal. 
 
? 
 
? 
 
? 
 
? 
 
7.   Found you have been keeping things from those who are  
      close to you 
 
? 
 
? 
 
? 
 
? 
8.   I have slept badly. 
 
? 
 
? 
 
? 
 
? 
9.   I have been tired. 
 
? 
 
? 
 
? 
 
? 
  
Not 
at all 
 
A bit 
 
Quite 
a bit 
 
A lot 
 
10. I have kept busy to take my mind off things. 
 
? 
 
? 
 
? 
 
? 
11. I have found it hard to concentrate. 
 
? 
 
? 
 
? 
 
? 
12. I have felt time passed slowly. 
 
? 
 
? 
 
? 
 
? 
13. My appetite has changed. 
 
? 
 
? 
 
? 
 
? 
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To what extent - over the last week - have you experienced the following because of thoughts 
about breast cancer? 
 
 Not 
at all 
A bit Quite 
a bit 
A lot 
14. I have felt sad. 
 
? 
 
? 
 
? 
 
? 
15. I have been upset. 
 
? 
 
? 
 
? 
 
? 
16. I have examined my breasts. 
 
? 
 
? 
 
? 
 
? 
17. I have felt restless. 
 
? 
 
? 
 
? 
 
? 
  
Not 
at all 
 
A bit 
 
Quite 
a bit 
 
A lot 
18. I have been nervous. 
 
? 
 
? 
 
? 
 
? 
19. I have been uneasy. 
 
? 
 
? 
 
? 
 
? 
20. It has taken me a long time to fall asleep. 
 
? 
 
? 
 
? 
 
? 
21. I have examined my breasts in the mirror. 
 
? 
 
? 
 
? 
 
? 
  
Not 
at all 
 
A bit 
 
Quite 
a bit 
 
A lot 
22. I have withdrawn into myself. 
 
? 
 
? 
 
? 
 
? 
22. I have felt unable to cope. 
 
? 
 
? 
 
? 
 
? 
23. I have been depressed. 
 
? 
 
? 
 
? 
 
? 
 
25. I have had symptoms from my breasts (pins and needles). 
 
? 
 
? 
 
? 
 
? 
 
Please turn over 
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To what extent - over the last week - have you experienced the following because of thoughts 
about breast cancer? 
 
 Not 
at all 
A bit Quite a 
bit 
A lot 
 
26. I have had difficulty dealing with my work or other 
      commitments. 
 
? 
 
? 
 
? 
 
? 
27. I have had headache. 
 
? 
 
? 
 
? 
 
? 
 
28. I have had difficulty doing everyday things around 
      the house. 
 
? 
 
? 
 
? 
 
? 
29. I have felt terrified. 
 
? 
 
? 
 
? 
 
? 
30. I have taken pills to sleep. 
 
? 
 
? 
 
? 
 
? 
 
 
 Not 
at all 
A bit Quite a 
bit 
A lot Not 
applicable
31. I have felt less interest in sex. ? ? ? ? ? 
32. I have not felt like having my breast caressed. ? ? ? ? ? 
 
 
 
 
33. How many days sick leave have you had during the last week? 
0 days 1 - 2 days 3 - 4 days 5 or more days 
 
? 
 
? 
 
? 
 
? 
 
Thank you for your help. 
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22. Appendix VI – part 2 of the measure (Danish version) 
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Spørgeskema 
til kvinder, der har fået 
brystet røntgen-undersøgt (mammografi) 
 
 
 
 
 
 
 
 
 
 
 
 
Gennem dette spørgeskema, håber vi på at få at vide, hvordan kvinder 
har det efter røntgen-undersøgelse af brystet (mammografi).  
 
 
  
 
 
 
Det er vigtigt, at De svarer på alle spørgsmålene. 
 
 
 
 
© Danmark: John Brodersen, Afdeling for Almen Medicin, IFSV, Københavns Universitet 2002 
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Har Deres oplevelser efter undersøgelserne af brystet er afsluttet, alt taget i betragtning, 
medført følgende: 
 
Sæt kun ét kryds ved hvert spørgsmål
 
 
1. Efter undersøgelserne er min tillid til, at jeg ikke har brystkræft: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre 
Den samme 
som før 
Lidt 
større 
Noget 
større 
Meget 
større 
 
Mindre tillid  
 
  
Større tillid 
 
2. Efter undersøgelserne er min bekymring for brystkræft: 
 
? ? ? ? ? ? ? 
Meget 
større 
Noget 
større 
Lidt 
større 
Den samme 
som før 
Lidt 
mindre 
Noget 
mindre 
Meget 
mindre 
 
Større bekymring  
 
  
Mindre bekymring 
 
3. Efter undersøgelserne føler jeg mig: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
afslappet 
Noget 
mindre 
afslappet 
Lidt 
mindre 
afslappet 
Det samme 
som før 
Lidt 
mere 
afslappet 
Noget 
mere 
afslappet 
Meget 
mere 
afslappet 
 
Mindre afslappet 
 
  
Mere afslappet 
 
4. Efter undersøgelserne er min fornemmelse af indre ro: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre 
Den samme 
som før 
Lidt 
større 
Noget 
større 
Meget 
større 
 
Mindre ro  
 
  
Mere ro 
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Har Deres oplevelser efter undersøgelserne af brystet er afsluttet, alt taget i betragtning, 
medført følgende: 
 
Sæt kun ét kryds ved hvert spørgsmål
 
 
5. Efter undersøgelserne er mit forhold til min familie: 
 
? ? ? ? ? ? ? 
Meget 
mindre tæt 
Noget 
mindre tæt 
Lidt mindre 
tæt 
Det samme 
som før 
Lidt 
mere tæt 
Noget 
mere tæt 
Meget 
mere tæt 
 
Mindre tæt  
 
  
Mere tæt 
 
6. Efter undersøgelserne er mit forhold til vennerne: 
 
? ? ? ? ? ? ? 
Meget 
mindre tæt 
Noget 
mindre tæt 
Lidt mindre 
tæt 
Det samme 
som før 
Lidt 
mere tæt 
Noget 
mere tæt 
Meget 
mere tæt 
 
Mindre tæt  
 
  
Mere tæt 
 
7. Efter undersøgelserne er mit forhold til andre mennesker: 
 
? ? ? ? ? ? ? 
Meget 
dårligere 
Noget 
dårligere 
Lidt 
dårligere 
Det samme 
som før 
Lidt 
bedre 
Noget 
bedre 
Meget 
bedre 
 
Dårligere 
 
  
Bedre 
 
8. Efter undersøgelserne er mit syn på fremtiden blevet: 
 
? ? ? ? ? ? ? 
Meget 
mindre lyst 
Noget 
mindre lyst
Lidt 
mindre lyst
Det samme 
som før 
Lidt 
mere lyst 
Noget 
mere lyst 
Meget 
mere lyst 
 
Mindre lys fremtid  
 
  
Mere lys fremtid 
 
Vend 
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Har Deres oplevelser efter undersøgelserne af brystet er afsluttet, alt taget i betragtning, 
medført følgende: 
Sæt kun ét kryds ved hvert spørgsmål
 
 
9.  Efter undersøgelserne er min glæde ved livet: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre  
Den samme 
som før 
Lidt 
større 
Noget 
større 
Meget 
større 
 
Mindre glæde  
 
  
Større glæde 
 
10. Efter undersøgelserne værdsætter jeg livet: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre  
Det samme 
som før 
Lidt 
mere 
Noget 
mere 
Meget 
mere 
 
Værdsætter livet mindre  
 
  
Værdsætter livet mere 
 
11. Efter undersøgelserne er jeg bevidst om at leve: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre  
Det samme 
som før 
Lidt 
mere 
Noget 
mere 
Meget 
mere 
 
Mindre bevidst om at leve 
 
  
Mere bevidst om at leve 
 
12. Efter undersøgelserne har jeg tænkt over livet: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre  
Det samme 
som før 
Lidt 
mere 
Noget 
mere 
Meget 
mere 
 
Færre tanker over livet  
 
  
Flere tanker over livet 
 
13. Efter undersøgelserne er min følelse af velvære: 
 
? ? ? ? ? ? ? 
Meget 
mindre 
Noget 
mindre 
Lidt 
mindre  
Det samme 
som før 
Lidt 
større 
Noget 
større 
Meget 
større 
 
Mindre velvære  
 
  
Større velvære 
 
Tak for hjælpen 
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23. Appendix VII – part 2 of the measure (English version) 
 
All the items in the English version of part 2 of the measure has been translated and adapted using a 
bilingual panel and a lay panel. However, the translation and adaptation was only conducted with 
five response categories. Therefore, the two response categories at each side of the response option 
“the same as before” are ad hoc translated for this thesis. The English version of the questionnaire 
has not been field tested and statistically validated. 
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Questionnaire 
for women 
who have undergone 
breast screening 
 
 
 
 
 
 
 
 
 
 
 
 
With this questionnaire we hope to find out how women feel after 
breast screening.  
 
 
 
 
It is important that you answer all questions. 
 
 
 
© Denmark: John Brodersen, Department of General Practice, University of Copenhagen 2004 
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Taking everything into account, has your experience of the Breast Screening Programme 
caused any of the following: 
 
Please tick only one box for each question
 
 
1.  After the examinations my belief that I do not have breast cancer is: 
 
? ? ? ? ? ? ? 
Much less Less A little less The same 
as before 
A little 
greater 
Greater Much 
greater 
 
Less belief  
 
  
Greater belief 
 
2.  After the examinations my anxiety about breast cancer is: 
 
? ? ? ? ? ? ? 
Much 
greater 
Greater A little 
greater 
The same 
as before 
A little less Less Much less 
 
Greater anxiety  
 
  
Less anxiety 
 
3.  After the examinations I feel: 
 
? ? ? ? ? ? ? 
Much less 
relaxed 
Less 
relaxed 
A little less 
relaxed 
The same 
as before 
A little more 
relaxed 
More 
relaxed 
Much more 
relaxed 
 
Less relaxed 
 
  
More relaxed 
 
4.  After the examinations I feel: 
 
? ? ? ? ? ? ? 
Much less 
calmer 
Less calm A little less 
calm 
As calm as 
before 
A little 
calmer 
Calmer Much 
calmer 
 
Less calm  
 
  
Calmer 
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Taking everything into account, has your experience of the Breast Screening Programme 
caused any of the following: 
 
Please tick only one box for each question
 
 
5.  After the examinations my relationship with my family is: 
 
? ? ? ? ? ? ? 
Much less 
close 
Less close A little less 
close 
The same 
as before 
A little 
closer 
Closer Much 
closer 
 
Less close  
 
  
Closer 
 
6.  After the examinations my relationship with friends is: 
 
? ? ? ? ? ? ? 
Much less 
close 
Less close A little less 
close 
The same 
as before 
A little 
closer 
Closer Much 
closer 
 
Less close  
 
  
Closer 
 
7.  After the examinations my relationship with other people is: 
 
? ? ? ? ? ? ? 
Much 
worse 
Worse A little 
worse 
The same 
as before 
A little 
better 
Better Much 
better 
 
Worse 
 
  
Better 
 
8.  After the examinations my thoughts about the future are: 
 
? ? ? ? ? ? ? 
Much more 
pessimistic 
More 
pessimistic 
A little more 
pessimistic 
The same 
as before 
A little more 
optimistic 
More 
optimistic 
Much more 
optimistic 
 
More pessimistic  
 
  
More optimistic 
Please turn over 
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Taking everything into account, has your experience of the Breast Screening Programme 
caused any of the following: 
Please tick only one box for each question
 
9. After the examinations my enjoyment of life is: 
 
? ? ? ? ? ? ? 
Much less Less A little less The same 
as before 
A little more More Much more
 
Less enjoyment  
 
  
More enjoyment 
 
10. After the examinations I value life: 
 
? ? ? ? ? ? ? 
Much less Less A little less The same 
as before 
A little more More Much more
 
Value life less  
 
  
Value life more 
 
11. After the examinations my awareness of life is: 
 
? ? ? ? ? ? ? 
Much 
less 
Less A little less The same 
as before 
A little 
greater 
Greater Much 
greater 
 
Less awareness of life 
 
  
Greater awareness of life 
 
12. After the examinations I have thought about the broader aspects of life: 
 
? ? ? ? ? ? ? 
Much less Less A little less The same 
as before 
A little more More Much more
 
Fewer thoughts about life  
 
  
More thoughts about life 
 
13. After the examinations my sense of well-being is: 
 
? ? ? ? ? ? ? 
Much less Less A little less The same 
as before 
A little 
greater 
Greater Much 
greater 
 
Less sense of well-being  
 
  
Greater sense of well-being 
Thank you for your help 
